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Abstract
Glaucoma is a degenerative disease that damages the nerve fiber layer in the retina of the
eye. Its mechanisms are not fully known and there is no fully-effective strategy to prevent
visual impairment and blindness. However, if treatment is carried out at an early stage, it is
possible to slow glaucomatous progression and improve the quality of life of sufferers. Despite
the great amount of heterogeneous data that has become available for monitoring glaucoma,
the performance of tests for early diagnosis are still insufficient, due to the complexity of
disease progression and the difficulties in obtaining sufficient measurements.
This research aims to assess and extend Bayesian Network (BN) models to investigate the
nature of the disease and its progression, as well as improve early diagnosis performance. The
flexibility of BNs and their ability to integrate with clinician expertise make them a suitable
tool to effectively exploit the available data. After presenting the problem, a series of BN
models for cross-sectional data classification and integration are assessed; novel techniques
are then proposed for classification and modelling of glaucoma progression. The results
are validated against literature, direct expert knowledge and other Artificial Intelligence
techniques, indicating that BNs and their proposed extensions improve glaucoma diagnosis
performance and enable new insights into the disease process.
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Chapter 1
Introduction
Glaucoma is an optic neuropathy that affects the retinal nerve fibre layer of the eye. It is the
second leading cause of blindness worldwide and is an irreversible disease. Its mechanisms
are not fully known, but it has been shown that early medication can slow its progression.
However, early diagnosis is often inaccurate due to the high inter- and intra-subject vari-
ability. In addition, tests of both healthy and glaucomatous patients are subject to a large
degree of fluctuation, which makes it difficult to decide whether any observed change is due
to inherent variation or real progression of the disease between examinations.
While technology provides several methods to monitor glaucoma and large amounts of
data, there is no gold standard definition of glaucoma progression. Thus, in clinical practice,
decisions are based on subjective interpretation of test results by expert clinicians, who are
not able to fully exploit all the available data. Artificial Intelligence (AI) techniques suit
this type of problem very well, being able to analyse and integrate large and heterogeneous
datasets. In fact, several AI techniques have been successfully applied to glaucoma. Among
these, Bayesian Networks (BNs) have shown promising results both for modelling and classi-
fication of glaucoma. Their flexibility and ability to integrate with clinician expertise make
them a suitable tool for more effectively exploring the available data.
This research aims to assess and extend BNs to investigate the nature of glaucoma and its
progression, as well as to improve early diagnosis performance. After presenting the problem,
a series of BNs for cross-sectional data classification and integration are assessed; in the
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second phase of the work, novel techniques are proposed for classification and modelling of
glaucoma progression. The methods and the results of this research are discussed throughout
the thesis in relation to their performance and potential for use in clinical practice. The
remainder of this chapter presents the motivations, aims and contributions of the thesis.
An overview of glaucoma and the available data is presented in section 1.1. Following this,
section 1.2 sets out the aims and research questions of this thesis, while its contributions are
listed in section 1.3. The structure of the thesis is outlined in section 1.4.
1.1 Modelling Glaucoma
Glaucoma is a leading cause of irreversible blindness worldwide. The primary site of glau-
comatous damage is the retina and optic nerve (optic disc), and raised intraocular pressure
(IOP) is a major risk factor for the development and progression of the disease. No cure is
available for glaucoma; however, reducing IOP may slow disease progression. IOP-reduction
may be attained through the use of medication or by surgical means. Trabeculectomy is
one such surgical procedure, which creates an alternative route for aqueous humour to drain
from the anterior eye, thereby reducing IOP. The timing of intervention is a key factor in
glaucoma treatment, so early diagnosis is highly desirable.
Glaucoma may be monitored through imaging of the retina over time to detect changes
in its structure. Alternatively, the disease can be monitored by measuring eye function-
ality, specifically through the use of visual field (VF) testing, known as perimetry. Both
approaches have recently undergone a technological revolution, making more data available.
For example, in the past a photo of the retina was used to assess the optic disc conditions,
while now hundreds of parameters are provided by advanced computerised tomographies of
the retina. In the same fashion, automated VF tests are used to build a 52-point map of
VF sensitivity of a patient, in less time than was possible before using manual perimetry.
Despite the technological advances and the great amount of data available, the performances
of glaucoma tests to diagnose the condition remain unacceptable. Furthermore, the rate of
glaucoma incidence is snowballing so it is becoming increasingly necessary to utilise all of the
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available data in order to more efficiently identify glaucomatous patients as early as possible,
and to understand why and how sufferers develop glaucoma, while other individuals do not.
To improve classification performance it is useful to recognise the inherent characteristics
of the disease and problems associated with the data available. In fact, glaucoma is a
set of pathological and physiological conditions, and thus develops from different starting
conditions, at different rates and exhibits different patterns of damage. Several recurrent
spatial patterns of VF defects have been identified, but there is no understanding as to why
certain patients develop certain patterns. Furthermore, the degeneration of the optic nerve
is a physiological process that occurs naturally with ageing, therefore there is an overlap
between the condition of the structure in healthy individuals and patients with glaucoma. In
this context, there is no gold standard definition of glaucoma. Instead, different studies have
used different criteria and diagnosis metrics, in relation to the instrument used. Moreover,
the results of functional tests often do not agree with those from structural tests, even
though the functional manifestation of glaucoma is caused by structural damage. Finally,
the data from all instruments in subject to very high ”noise” (variability). Patients exhibit
large variability in their measurements even if tests are conducted on the same day. In
the case of VF testing, differences can be explained by the complex nature of the task; the
subjects reaction time, physical conditions and attitude to the test all greatly influence its
measurements.
Many data analysis techniques have been proposed to exploit the available data in order
to perform better classification and gain insights into glaucoma. Simple statistical techniques
are implemented in screening instruments, but these tend to suffer from all the issues de-
scribed in the previous paragraph. Advanced Machine Learning (ML) techniques have also
been proposed, mainly only with cross-sectional data, showing promising results. Among
these, the so called white-box models are of particular interest to clinicians because they
are easy to understand and can give meaningful insights. This thesis focuses on one such
model, called the Bayesian Network (BN). This is a graphical model that may be used in
this context to model spatial and anatomical-functional relationships of glaucoma, as well as
provide an efficient probabilistic parametrisation of the data.
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1.2 Thesis Aims
The previous section introduced motivations for the use of data analysis techniques to help
clinicians in making decisions and understanding the mechanisms behind glaucoma. It also
discussed the characteristics of the data and problems associated with them.
With respect to cross-sectional data, the identified key aspects of the problem include data
integration, inter-subject variability, noise and biases in the data. Regarding the progression
of glaucoma, the problem of non-stationary time dependencies is appointed as a key aspect
in the modelling.
The objective of the research presented in this thesis is to overcome these issues and
build a set of models that are able to gain insights into the field and enhance classification
performance. To achieve this, simple and extended BN models are explored.
The main contributions of this thesis can be described as a knowledge-building process.
Starting with cross-sectional glaucoma modelling and classification, the research describes
glaucoma metrics and data integration, before covering the less-explored field of modelling
glaucoma progression. Using the cross-sectional data available, a set of ad-hoc BN models is
built. The extension into semi-supervised and unsupervised models is proposed in order to
avoid metric biases, while data integration is tackled by the use of ensembles of classifiers.
To increase performances in classification, special learning algorithms are implemented. A
novel approach to cluster the data is also presented. To tackle the more complicated issue
of describing glaucoma progression, BN models are extended to deal with longitudinal data
that account for non-stationarity in the data. The proposed techniques are also able to
simultaneously cluster patients into different stages of disease.
While high diagnosis performance is pursued throughout this research, particular focus is
given to gaining insight with regards to the glaucoma disease process and its manifestation.
However, the proposed techniques represent a general framework that can be applied to a
wide range of problems.
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1.3 Thesis Contributions
The key contributions of this thesis are outlined below:
• A set of supervised, semi-supervised and unsupervised BN to model glau-
coma and increase classification performance.
A set of expertise-driven and data-driven supervised models is obtained using both
anatomical and functional glaucoma data. To avoid metric biases, unsupervised and
semi-supervised models are also proposed. Empirical results demonstrate an increase
in performance and insights gained with respect to state-of-the-art approaches.
• An ensemble of classifiers to model anatomical and functional metrics and
combine different BNs.
A BN model is used as a stacked ensemble of classifiers to increase classification perfor-
mance by integrating different base models. In particular, anatomical and functional
metrics are integrated and evaluated by the model, allowing understanding of how
metrics interact and impact on the final decision. Comparisons with expertise and
empirical evaluations show the utility of this approach in glaucoma.
• A metric-independent VF clustering BN-based model.
With regards to functional data, a new algorithm is proposed to model metric-independent
variance and investigate clusters in glaucoma VF data. A novel algorithm that makes
use of an heuristic search to perform clustering and classification is used. Results show
insights are gained with respect to state-of-the-art algorithms.
• An extension of BN models for classification and modelling of longitudinal
data.
A new model is proposed as an extension of BNs for longitudinal data. The model is
able to extract key disease stages and discover patterns in temporal data. It also can
be used for classification with empirical results showing promise.
• A new technique for modelling and clustering non-stationary temporal pro-
cesses.
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A novel algorithm based on Non-Stationary Dynamic BNs is developed and assessed
using the longitudinal functional data available. The model can capture non-stationary
variation as well as cluster groups of patients into different temporal patterns. The
process is independent of any clinical metric and allows key disease stages to be iden-
tified. Empirical evaluations and comparison with expert knowledge demonstrate that
such models are of great interest for understanding glaucoma.
1.4 Thesis Outline
The remainder of the thesis is structured as follows:
• Chapter 2 illustrates the physiology of glaucoma and gives an overview of the process
of monitoring the condition. Screening instruments and different types of data are also
introduced, followed by a comparative analysis of state-of-the-art AI techniques for
glaucoma.
• Chapter 3 introduces BN models in relation to other AI models. The issues related to
the data are also outlined and simple BN models are evaluated.
• Chapter 4 assesses specific ad-hoc BN models. Supervised, semi-supervised and unsu-
pervised BN models are built using clinical expertise as well as anatomical and func-
tional data. The resulting models are then integrated using an ensemble of classifiers.
A model to describe metric-independent variance and extract clusters in the data is
also proposed. Part of the work included in this chapter has been published in (Ceccon
et al., 2010b; Ceccon et al., 2010a; Ceccon et al., 2011a), and has also been submitted
to IEEE Journal of Health and Biomedical Informatics (currently in the second cycle
of the review process).
• Chapter 5 describes glaucoma progression and classification, and develops a model
to take into account non-stationarities in the data. An extension of Non-Stationary
Dynamic Bayesian Networks for clustering temporal processes is also explored. The
work presented in this chapter has been published in (Ceccon et al., 2011b; Ceccon et
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al., 2012a; Ceccon et al., 2012b) and has also been submitted to Artificial Intelligence
in Medicine.
• Chapter 6 presents contributions and conclusions of this research, and discusses limi-
tations of the current work and potential paths for further research.
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Chapter 2
Glaucoma and Machine Learning
Glaucoma is a major eye disease and is the second leading cause of blindness in the world. In
recent years, new technologies to monitor glaucoma have become available, producing a great
amount of data. In this context, Machine Learning (ML) techniques represent a tool that can
be used to improve diagnosis performance and shed light on the disease process. This chapter
forms the literature review of this thesis. In the first section, glaucoma and its mechanisms
are introduced, followed by an overview of the instruments available. Section 2.3 presents
and discusses the ML techniques that have been explored in the context of glaucoma, while
in section 2.4 a comparative review of the results obtained using such techniques is presented.
Finally, section 2.5 closes the chapter and draws conclusions that form the motivations for
research in this thesis.
2.1 Glaucoma, the Sneak Thief of Sight
The World Health Organization (WHO) has estimated that the percentage of blindness due
to glaucoma is around 20% in western countries (Resnikoff et al., 2004). Visual impairment
can occur without a sufferer noticing, and it is projected that about 50% of individuals with
glaucoma in North America (and most likely the western world) are not aware they have
the disease (Quigley, 1996). For this reason, glaucoma is often referred to as the sneak thief
of sight. In fact, glaucoma is often unnoticed until irreversible damage occurs in the retina.
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Glaucoma is an increasing problem: in 2010, there were 60.5 million people with the disease,
but according to (Quigley and Broman, 2006) and the WHO Vision 2020 (Pizzarello et al.,
2004), in 2020 there will be 79.6 million people with glaucoma, given the growing longevity
of the world’s population.
The American Academy of Ophthalmology, in 2010, defined glaucoma (open-angle vari-
ant) as ”a progressive, chronic optic neuropathy” in which there is a ”characteristic acquired
atrophy of the optic nerve and loss of retinal ganglion cells and their axons” (American
Academy of Ophthalmology, 2010). The characteristics of glaucoma are based on ”reliable
and reproducible visual field (VF) abnormalities” or ”optic disc or retinal nerve fibre layer
structural abnormalities”. Early glaucoma is defined as characteristic optic nerve abnormal-
ities and a normal VF. However, among past and recent studies, there is a lack of consistency
in how glaucoma is defined (Pizzarello et al., 2004). For example, also in 2010, the American
Optometric Association (American Optometric Association, 2010) defined early glaucoma
according to optic nerve and nerve fibre layer appearance, and an abnormal VF. Other re-
cent studies also include functional measurements in the definition of early glaucoma (Artes
and Chauhan, 2005; Bathija et al., 1998). In the past, increased intraocular pressure (IOP)
was typically included in the definition of glaucoma. However, researchers demonstrated
that IOP values may overlap considerably between normal and glaucomatous groups and
that IOP is influenced by many factors (Kronfeld, 1952; Podos and Becker, 1973; Shields
et al., 1996). Furthermore, several studies have indicated that a sizeable percentage of pa-
tients have a ”low” IOP (Sommer and Doyne, 1996; Shiose et al., 1991); this condition is
commonly referred to as Normal Tension Glaucoma.
Glaucoma is, in fact, a set of quite diverse eye conditions, and about 60 different types
of glaucoma are known. The most common type of glaucoma is the Primary Open Angle
Glaucoma (POAG). Major population studies found prevalence of POAG ranges from 0.9%
to 2.4% in Caucasians (Dielemans et al., 1994; Leske et al., 1994; Mitchell et al., 1996;
Bengtsson, 1981; Klein et al., 1992; Tielsch et al., 1991), and from 3,9% to 8,8% in African-
Caribbeans and African-Americans (Tielsch et al., 1991; Leske et al., 1994; Mason et al.,
1989; Wormald et al., 1994). In the same studies, Primary Angle Closure Glaucoma (PACG)
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prevalence has been quoted to range from 0.04% to 0.9%, and other secondary glaucomas
from 0.09% to 0.27%. However, as already stated, it is estimated that 50% of those with
glaucoma do not know they have it (Coffey et al., 1993; Mitchell et al., 1996; Sommer et
al., 1991b), a percentage that rises to over 90% in developing nations with poor access to
health-care. (Buhrmann et al., 2000; Ramakrishnan et al., 2003)
2.1.1 Mechanisms of the Disease
For most forms of glaucoma, IOP is a major causative risk factor for the development and
progression of the disease (Yanoff and Duker, 2008). Elevation of IOP is caused by the
production of aqueous humor by the non-pigmented epithelium of the ciliary body, indicated
in Figure 2.1.
Figure 2.1: The aqueous humor outflow pathway. Adapted from (National Eye Institute, 2006).
This tissue actively transports ions and nutrients into the posterior chamber, which then
flow into the anterior chamber through the pupil, to eventually reach the Schlemm’s canal
through the trabecular meshwork. From here, liquid diffuses into the aqueous veins and
general circulation. Identification of the site (and nature) of any impediment to the aqueous
flow is extremely useful to diagnose glaucoma. If the site is at the pupil (pupillary block),
the increased size of the lens blocks the flow through the pupil, which results in a gradient of
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pressure that causes the iris to bow forward and mechanically cover the trabecular meshwork,
increasing IOP. This is known as PACG. If the obstruction is at the level of the trabecular
meshwork then the condition is known as open-angle glaucoma. In this case there are many
different reasons for the block, which lead to numerous different subtypes of glaucoma. For
example, if the obstruction is caused by abnormalities in the extracellular matrix of the
trabecular meshwork, it is referred to as POAG.
The mechanism of optic nerve injury in glaucoma is not well-characterised, but there
is evidence that elevated IOP damages the Optic Nerve Head (ONH) (Yanoff and Duker,
2003). This is the location where the optic nerve (ON) joins the retina. The ONH is also
referred to as the Optic Disc (OD), because of its disc-like shape. Damage to the ONH
causes injury to retinal ganglion cell axons; either their local blood supply is compromised
(Quigley and Anderson, 1976), or they are mechanically pinched (Quigley and Addicks, 1981;
Anderson, 1996). Recently, it has been argued that, given the non-uniform clinical phenotype
of glaucoma, it is likely that multiple mechanisms account for initiation or progression of
glaucomatous damage, each of them with a variable impact on the phenotype seen clinically
(Yanoff and Duker, 2008). All these different stimuli eventually activate the programmed
death of retinal ganglion cells. This process is thought to occur by apoptosis and results in
a so-called cupping of the ONH. As highlighted in the left part of Figure 2.2, the cup is an
empty space in the middle of the ON, surrounded by optic fibres (the so-called neuro-retinal
rim). It resembles a cup if looked from above in 3-dimensions. When glaucoma progresses,
the fibres of the external part of the ONH die (thinning of the neuro-retinal rim) making
the cup larger. Functional impairment typically begins with loss of peripheral vision and
progresses to so-called tunnel vision, where only a central spot of the VF is preserved. The
loss of vision is also described as a loss of VF sensitivity. Figure 2.2 (right) shows a simulation
of how driving appears to patients with moderate glaucoma.
2.1.2 Risk Factors for Glaucoma
The risk factors for developing glaucoma can be broadly grouped into demographic, ocular,
genetic and other. The known demographic factors include age and ethnic origin. Increasing
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Figure 2.2: Left: Drawing of the retina illustrating the optic disc, cup, and neuroretinal rim. Source:
(Wikstrand et al., 2010). Right: Simulation of impaired vision due to moderate glaucoma. Source: (Crabb,
2012)
age is a major risk factor for glaucoma that has been described in all population-based
studies of glaucoma where age has been examined (Tielsch, 1991). Ethnic origin has recently
been confirmed by large-population studies to be an important factor as well. In particular,
individuals of African, African-American and African-Caribbean origin are at higher risk of
POAG (Leske et al., 1994; Tielsch et al., 1991; Klein et al., 1992; Wormald et al., 1994). The
ocular risk factors associated with glaucoma are IOP, ONH, hypermetropia and systemic
hypertension. IOP is known to be strongly related with glaucoma, and strong evidence
supports this: POAG incidence and prevalence increase with increasing IOP (Buhrmann
et al., 2000; Ramakrishnan et al., 2003; Sommer et al., 1991b). Moreover, the rate of VF loss
due to glaucoma is slowed or even prevented when IOP is lowered (Kass et al., 2002; Leske
et al., 2003; Heijl et al., 2002) and, in eyes with asymmetric IOP, VF loss is more severe in the
eye with higher IOP than in the other eye (Cartwright and Anderson, 1988; Chrichton et al.,
1989). Although IOP is strongly related to glaucoma, it has been shown that it is a poor
diagnostic tool. The cut-off value of 21 mmHg commonly used to separate normal tension
glaucoma and high tension glaucoma is not a threshold level of any particular biological
importance and has poor diagnostic performance. In (Quigley et al., 2001), a cut-off of 22
mmHg would result in only 80% of POAG patients being diagnosed. This is consistent with
other studies demonstrating that among patients with characteristic POAG, 20-30% patients
have lOPs consistently below 21 mmHg (Sommer and Doyne, 1996; Kamal and Hitchings,
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1998). Although a very high IOP results in glaucomatous damage, this is not inevitable for
lower IOP (Davanger et al., 1991). It is therefore suggested that the relationship between lOP
and glaucoma is a continuum, much like the relationship between systemic hypertension and
stroke. A realistic concept is to consider that an individual’s ON has a level of IOP that it can
or cannot withstand, manifested at a clinical level by the presence or absence of VF damage.
Since other factors also contribute with IOP to produce characteristic glaucomatous changes,
IOP is considered a risk factor but not a diagnostic requisite for glaucoma. Structural
changes at the ONH are an important marker of glaucoma, and play a pivotal role in disease
pathogenesis. Disc variation and vertical and horizontal cup-to-disc-disc ratios correlate with
subsequent VF loss (Shiose and Tsukahara, 1990). In addition, African groups, who are more
susceptible to glaucoma, have been noted to have larger discs and cup-to-discs ratios than
Caucasians (Zangwill et al., 2004; Sommer and Doyne, 1996). Myopia has also been found
to be associated with POAG, with rates 2 to 4 times higher for myopes (Ramakrishnan et
al., 2003; Mitchell et al., 1999). In the Baltimore Eye Survey (Tielsch et al., 1995) a strong
association between POAG prevalence and low diastolic perfusion pressure was found. The
latter is a measure obtained from systemic blood pressure. A hypothesis is that ON damage
may occur in these subjects because of poor optic nerve perfusion. Among the genetic factors,
there is little doubt that glaucoma is more common if there is a positive family history; a
5 to 20 times increase in prevalence rate occurs in those who have a positive family history
(Yanoff and Duker, 2003). Unbiased population studies, such as the Baltimore Survey, have
also shown that family history is a significant risk factor for POAG (odds ratio of 3.69 for
those with siblings with disease, 2.17 for those with parents and 1.12 for those with children).
The decision on how to treat glaucoma is a complex task that aims to preserve the
vision and therefore the quality of life of patients, while taking into consideration the risk of
side effects and complications. Lowering eye pressure using medication is the most effective
treatment in glaucoma management, but surgery can also give excellent IOP control. An
operation, called trabeculectomy, is one such surgical procedure which creates an alternative
route for aqueous humor to drain from the anterior eye, thereby reducing IOP (Khaw, 2001).
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2.2 Progression of Glaucoma: Structure and Function
Glaucoma onset is often unnoticed until later stages of the disease. Early diagnosis, treat-
ment and follow up are key to the management of the disease, therefore understanding the
mechanisms involved in the onset and progression of glaucoma is of great value for clinicians.
In this context, it is necessary to consider the complex relationship between structure (i.e.
the anatomical characteristics of the nerve fibre layer and optic disc) and function (i.e. qual-
ity or ”sensitivity” of vision). The nature of relationship remains unclear and controversial,
especially in the progression of glaucoma. However, it is known that the relative utilities of
structural and functional tests vary at different stages of disease (Strouthidis et al., 2006),
and in many cases VF test results or OD imaging results alone may not be sufficient for
accurate diagnosis or disease monitoring. For example, the OD in a patient suspected of
glaucoma may change, yet remain within the large ”healthy” range of physiological between-
subject variability. Likewise, detectable change over time in the VF can be highly suggestive
of disease, even if distinct VF measurements may appear well within normal limits (Artes
and Chauhan, 2005). It is frequently reported that OD examination has more utility during
the earlier stages of the disease than VF analysis and can predict future VF progression
(Chauhan et al., 2009). It is also purported that particular functional tests have greater
utility than others in early glaucoma (Demirel and Johnson, 2000).
2.2.1 Investigating Glaucoma Progression
Current methods for determining glaucomatous progression can be grouped into four cat-
egories (Spry and Johnson, 2002): clinical judgement, defect classification systems, event
analyses and trend-based analyses. Clinical judgement methods involve subjective grading
of the OD and VF, and categorise progressing and non-progressing eyes without any stan-
dardisation of the criteria used for change. Consequently, inter-observer and intra-observer
agreement are often poor (Kamal et al., 1999; Azuara-Blanco et al., 2003; Viswanathan et al.,
2003), and classification is usually binary. Defect classification systems for ODs and VFs use
specific criteria to stratify loss as a discrete score and define progression if the score changes
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over time. An example is the Advanced Glaucoma Intervention Study (AGIS) scoring system
for VFs (Gaasterland et al., 1994). The AGIS defect scoring system depends on the number
and depth of clusters of adjacent depressed VF points in the Humphrey Field Analyzer II
(HFA II) VF instrument. The AGIS score ranges from 0 (no defect) to 20 (all test points
deeply depressed). Another category of methods for classification of ODs and VFs is event
analyses, in which a follow-up examination is compared to a baseline VF and changes are
compared to variability limits defined from ”stable” glaucoma patients; if the change exceeds
this limits, progression is deemed to have occurred. The last category of methods for as-
sessing change in VFs and ODs is trend-based analyses. These involve testing a dependent
variable (such as VF sensitivity or OD rim area) sequentially over time with standard linear
regression analysis. Linear regression accounts, to some extent, for variability within each
subject, but often requires many examinations and/or follow up time to establish progres-
sion (Vesti et al., 2003). These approaches are available in the most common imaging and
perimetry instruments, but determining progression in individual patients remains one of
the most challenging aspects of glaucoma management.
One advantage of clinical judgement to define glaucomatous progression is that clinicians
are trained to identify typical patterns of VF damage that are associated with glaucoma
that are difficult to classify precisely using current scoring systems, events analyses or trend
analyses. These patterns include sensitivity changes across the horizontal meridian, espe-
cially in the nasal portion of the field (i.e. the part of the VF that is closer to the nose)
and shallow defects occurring in the Bjerrum area (an arcuate area in the superior half of
the VF), generalised loss of retinal sensitivity, other typical arcuate scotomas (i.e. areas of
degenerated sensitivity), enlargement of the blind spot, and selective loss of sensitivity in
the nasal periphery (Drance, 1969; Hart Jr and Becker, 1982; Spry and Johnson, 2002; Artes
and Chauhan, 2005; Yanoff and Duker, 2003). Characteristic OD changes over time are also
well-known and are investigated using disc photography (Tuulonen and Airaksinen, 1991;
Airaksinen et al., 1992) and more recently high-resolution scanners (Chauhan et al., 2001;
Kamal et al., 1999). Typical structural changes observed are enlargement of the OD cup and
Retinal Nerve Fibre Layer (RNFL) thinning.
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2.2.2 The ”Structure-Function” Relationship
The cross-sectional relationship between visual function measurements and structural mea-
surements of the OD or nerve fibre layer has been studied for many years. In (Garway-Heath
et al., 2000), an anatomical relationship between VF test points and regions of the ONH was
established. The technique used was to superimpose a VF grid onto RNFL images, and
calculate the proximity of test points to RNFL defects and/or prominent bundles. ODs were
divided into six sectors, relating to six VF areas. Figure 2.3 shows the structure-function
map proposed in the study. The results show that in 95% of cases the VF test point was
associated with a position at the ONH within 14◦ either side of the mean. A good correla-
tion with previous studies was also found (Wirtschafter et al., 1982; Weber et al., 1990). The
Figure 2.3: Anatomic relationship between Humphrey 24-2 VF test-points (left) and optic nerve head disc
sectors (right). A black rectangle indicates the nasal step. Sectors are also referred to as T (Temporal), Ti
(Temporal-Inferior), Ts (Temporal-Superior), N (Nasal), Ns (Nasal-Superior) and Ni (Nasal-Inferior).
Source: (Garway-Heath et al., 2000)
structure-function relationship in glaucoma was also investigated in (Johnson et al., 2000;
Strouthidis et al., 2006) and good correlations were found between VF locations and angu-
lar distance at the corresponding part of the ONH. However, (Artes and Chauhan, 2005)
demonstrated that in the eyes of 84 patients with OAG and 41 healthy subjects, a remark-
ably poor correlation exists between VF and OD changes. According to the authors, this
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does not demonstrate that the actual relationship is weak, but rather that structural and
functional measurements are subject to high variability. Even between different functional
tests, the correlation between measurements over time is weak. Thus, in clinical practice it is
very unlikely that VF changes can be corroborated by OD changes and vice versa. In (Hood
and Kardon, 2007), a linear model relating glaucomatous loss in RNFL thickness to the loss
of sensitivity is proposed. Excellent agreement with the (Garway-Heath et al., 2000) map
was found. The authors also found that initial large RNFL thickness measurements were
associated with eventual abnormal RNFL, explaining the difficulty in understanding whether
ON or VF damage occurs earlier. Other studies found strong correlations between inferior
RNFL thickness measurements and the superior VF (Bowd et al., 2006; Sanchez-Galeana et
al., 2001). Furthermore, in (Gardiner et al., 2005), a topographical map of sectors of the optic
nerve and corresponding areas of the VF was found to support the map in (Garway-Heath
et al., 2000). Although some areas (inferior and inferotemporal) presented good correlation
with predicted VF locations, other areas obtained weaker or unexpected correlations. The
authors argue that the regional structure-function relationships may vary between individuals
more than previously assumed (Mackenzie and Cioffi, 2008). In (Sommer et al., 1991a), VF
defects were found in corresponding RNFL sectors, amongst 1344 patients that were followed
for 6 years; in many cases, structural change occurred before functional change. In (Kass
et al., 2002), 55% of glaucoma patients presented with OD changes first, 35% presented with
VF damage before OD change, while 10% presented with simultaneous structure-function
change. However, different results were obtained when using different onset criteria. An
interesting paper relevant to this issue is (Vesti et al., 2003), where 7 different methods of
determining VF change were compared, obtaining very different results. In (Heijl et al.,
2002), 86% of 255 patients observed presented with VF change alone, while 13% presented
with simultaneous changes in the VF and OD. Only 1 patient of 136 presented with isolated
OD change. Conversely, in (Johnson et al., 2003), 479 eyes were followed for 4 or more years,
and the authors found that structural changes generally occurred in the absence of VF abnor-
mality. Another longitudinal study (Chauhan et al., 2001) found that only 4% of the patients
progressed in VFs only, and most of the cases progressed on OD only or on both OD and
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VF. Histological studies have also been conducted to investigate the structure-function rela-
tionship looking at post-mortem retinal ganglion cell counts in glaucoma patients (Quigley
et al., 1989; Harwerth et al., 1999). These studies found support for OD changes occurring
before VF changes and for a linear relationship between VF sensitivity and cell count.
2.3 Screening for Glaucoma
Early screening for glaucoma provides a method to promptly intervene and possibly slow
the glaucoma disease process (Heijl et al., 2002; Kass et al., 2002). To this purpose, several
techniques have been proposed over the years, using several instruments with different results.
In this section we will review the properties of different screening instruments, with particular
focus on the most recent state-of-the-art technologies that have been adapted for glaucoma.
To compare performances of different techniques, the proportion of positive subjects
identified by each test is usually evaluated. This is known as the sensitivity, which is not to
be confused with VF sensitivity, which refers to the level of vision at each point in the VF.
The specificity, on the other hand, is the proportion of healthy subjects correctly excluded
by a test. Sensitivity and specificity are also known respectively as the True Positive rate
and the True Negative rate, and can be combined for performance comparison, as will be
discussed in the section 2.4.3.
2.3.1 Visual Field Assessment
The most commonly used instruments for assessing a patient’s VF are the Octopus Perimeter
and the Humphrey VF Analyzer (HFA). These instruments perform the ”Standard Auto-
mated Perimetry” (SAP), where illuminated targets are projected onto an illuminated back-
ground. The brightness of the target is varied and the patient is asked to respond when
the target is seen. By presenting targets of different luminosity, the average brightness of
the dimmest test object that can be seen is determined. This is called the threshold and is
determined for different locations in the VF. The standard test-program used in glaucoma
patients is the 24-2, in which the target is randomly presented to 54 locations spanning 24◦
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from the fixation point, i.e. the central focus of our vision. The time needed to perform
the 24-2 test, depending on the test algorithm employed, is about 5 to 15 minutes. In VF
testing, it is unlikely that a patient with a significant VF defect would have a normal result;
however, it is common that individuals with healthy vision record abnormal VF test results.
Many factors can contribute to an abnormal VF result, so the specificity of SAP is not as
high as clinicians would like (Artes and Chauhan, 2005). At present, VF data must be com-
bined with the ability of experienced clinicians to identify if there is a true abnormality due
to glaucoma. The HFA provides reliability indexes (false negatives and false positives) and
global indices, such as the mean deviation (MD) and the pattern standard deviation (PSD)
to summarise VF test results. The MD is an index based on the size of a VF defect, and
is sensitive to generalised loss of sensitivity. The PSD, instead, is sensitive only to localised
VF defects. The Loss Variance (LV) index of the Octopus perimeter provides similar infor-
mation. If indices are significantly different (P <0.05) from normal, this information is also
provided by the instrument. The HFA also provides a map of the total deviation of each test
point, which represents the difference between the measured threshold and the age-corrected
normal value expected for that location. This map is accompanied with a probability plot
indicating whether a total deviation value, at a particular test location, is likely to be found
in a population of health individuals (four symbols indicate: P <5%, P <2%, P <1% and P
<0.5%). Another index provided by the HFA is the Glaucoma Hemifield Test (Asman and
Heijl, 1992), which evaluates VF sensitivity differences in either side of the horizontal mid-
line, above or below the point of fixation (referred to as the superior and inferior hemifields).
The absolute sensitivities of the VF is also presented as a grey scale interpolated map. A
typical printout of VF test results from the HFA is presented in Figure 2.4.
2.3.2 Optic Disc and Retinal Assessment
Optic disc analysis has been used for 150 years as an indicator of glaucomatous damage.
OD appearance is included in the current definition of glaucoma and, as already discussed,
constitutes the definition of early glaucoma for the American Academy of Ophthalmology
(American Academy of Ophthalmology, 2010). To determine structural loss, imaging of the
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Figure 2.4: Humphrey VF Analyzer output. Source: Zeiss Inc.
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ONH is used. Stereoscopic ONH Photography is currently the most used method of ONH
analysis, according to (Mardin and Ju¨nemann, 2001). This study found that stereoscopic
ONH photography is also the most sensitive single detection method for early glaucoma,
although the comparison did not take account different definitions of glaucoma across studies.
Clinicians are generally very experienced with evaluating such photographs, however any
such assessment is clearly subjective. From ONH photographs, it is possible to extract
ONH parameters, such as cup-to-disc ratio, disc and cup area and volume, neuro-retinal
rim width and area. In the past, these were obtained by plotting the outline margins of
the OD, optic cup and other features by hand, and then calculating areas according to
their coordinates using a planimetry computer. In a prospective longitudinal study (Caprioli
et al., 1996) on 193 eyes, detection rates of structural glaucomatous change was 15% using
qualitative evaluation of ONH stereophotographs, and 3.6% using manual stereoplanimetry of
the disc rim area. Computerised systems have emerged lately, sharing several basic features,
such as Par Is 2000, Rodenstock ONH Analyzer and the Glaucoma Scope. In the latter,
a lamp using near-infrared light is used to obtain a three-dimensional (3D) map of the
ONH and a series of related parameters. The experience of the operator and pupil size are
significant limitations of this test. Confocal Scanning Laser Ophthalmology (CSLO) offers
real-time, 3D imaging of the ONH and RNFL, using the intensity of light reflected off the
retinal surface. The Heidelberg Retina Tomograph (HRT) is the only commercially available
confocal scanning laser ophthalmoscope. In the HRT, the final topography image is obtained
by averaging 3 scans, and contours are traced automatically and presented to easily view the
depth of the cup and other tissues, together with ONH stereographic parameters. Among
its output, a reflectivity image showing the classification of the different sectors of the ONH
(e.g. normal, borderline, etc.) is provided. The HRT also provides the Moorfield Regression
Analysis (MRA) score, first proposed in (Garway-Heath, 2005). This is based on the 95%
confidence interval of age-corrected differences in the optic disc and the neuro-retinal rim
area. However, the method requires the operator to identify the optic disc. Several studies
have investigated the performance of CSLO in detecting OD changes (Zangwill et al., 1995;
Zangwill et al., 1996), finding that there was good agreement between HRT and clinicians
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in detecting early glaucomatous disc changes. Sensitivity for detecting patients with early
glaucomatous VF loss was equal to approximately 88% at 78% specificity (Mikelberg et al.,
1995). A longitudinal study collecting data with HRT II by (Chauhan et al., 2000; Chauhan
et al., 2001), found that glaucomatous disc changes determined with the instrument occurred
more frequently than VF changes. Most patients with field changes also had disc changes but
less than half of those with disc changes had field changes. Similarly, (Kamal et al., 1999)
found that sequential optic disc images on the HRT allowed the detection of glaucomatous
change before confirmed VF change in a group of OHT patients converting to early glaucoma.
Optical Coherence Tomography (OCT) is a recent technology that uses light in the near
infrared range to achieve high-resolution cross-sectional imaging of the eye (Huang et al.,
1998). OCT, like CLSO, measures OD areas and RNFL thickness, but with higher accuracy
and precision than CLSO. There is high correlation between OCT and HRT measurements
and disease status (Schuman et al., 2003).
Retinal Nerve fibre Layer status (RNFL) can be indicative of early glaucoma that is
undetected with OD imaging and VF testing (Tuulonen et al., 1993). The RNFL is composed
of millions of retinal ganglion cells (fibres), which converge at the OD, and lie in the inner
retina. The measurement of the height of the retinal surface can be obtained by tomographic
scans using CSLO. This method has been found to have 73% sensitivity for the detection of
glaucomatous ON damage (O’Connor et al., 1993), where diagnostic precision was defined
as the total proportion of correct diagnoses for the presence or absence of VF loss. However,
the low axial resolution and the fact that superior techniques exist make this technique less
than optimal for RNFL analysis. OCT can obtain high resolution images of the fundus, from
which thickness measurements can be determined by computer analysis. Good correlation
of thickness has been found with structural and functional parameters (Schuman et al.,
1995). Scanning Laser Polarimetry (SLP) is also used to investigate the RNFL, obtaining
thickness measurements in a short time by measuring the summed retardation of a polarised
scanning laser beam. The GDx is a scanning laser polarimeter that incorporates a database
of normative data. A sensitivity of 58% at a given specificity of 80% was found for pre-
perimetric RNFL defects (Horn et al., 1999), and a sensitivity of 89% and 87% for early to
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moderate glaucoma (Greaney et al., 2002), where glaucoma was defined as an open anterior
chamber with an early to moderate reproducible glaucomatous VF defect. Sensitivity and
specificity of 90% and 100% were found using expert operators’ classification of VF defects
as the gold standard in (Munkwitz et al., 2004) and of 96% and 93% in (Tjon-Fo-Sang
and Lemij, 1997). Histological examinations on monkeys found good correlation between
SLP retardation values and histological RNFL thickness measurements (Munkwitz et al.,
2004). Assessment of the RNFL appears to be more sensitive and specific than estimations of
parameters of the ONH. As measurement techniques become more refined and characteristics
of the RNFL become better understood, this kind of structural measure may prove to be
better than VF testing for diagnosis and follow up in glaucomatous patients and patients at
risk of glaucoma (Yanoff and Duker, 2008).
The presented imaging techniques can be used in conjunction with information from
clinical examination and functional tests. However, a comparative study concluded that,
when used alone, imaging techniques do not provide sensitivities and specificities that justify
implementing them as a primary population screening tool for early to moderate glaucoma
(Sanchez-Galeana et al., 2001). In (Mardin et al., 1999), HRT sensitivity was just 42% at
a specificity of 95% for early glaucoma, rising to 84% for moderate glaucoma. Moderate
glaucoma was defined as changes in the OD (on clinical examination) and VF, while early
glaucoma was defined as increased IOP, normal VFs, and glaucomatous appearance of the
OD as evaluated by photographs. OCT has been shown to have sensitivity of 82% at a
specificity of 84% for moderate glaucoma (Greaney et al., 2002), defined by VF testing
showing reproducible defects. As observed by (Michelson and Groh, 2001), conventional
photographic imaging of the OD by an experienced examiner remains the most sensitive
method for detecting early glaucoma. However, experts have also been shown to frequently
fail to diagnose early to moderate glaucoma among patients with pertinent risk factors, VF
changes, and ON damage (Wong et al., 2003). In (Stein et al., 2005), the use of multiple
imaging devices together improved the specificity of the diagnosis. The use of these new
technologies arguably hold potential for glaucoma screening, especially in combination with
functional testing.
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2.4 Classification Techniques for Glaucoma
In clinical settings, the techniques most used to assess the onset of glaucoma are strictly re-
lated to clinical knowledge, and they mainly subjectively assess VF testing according to OD
examinations. Other factors are also taken into account by the clinician, such as IOP and
other ocular, systemic and demographic factors. However, the interpretation of quantitative
imaging and functional test measurements is problematic, especially regarding early detec-
tion of glaucoma (Chauhan et al., 1999). The Glaucoma Advisory Committee of Prevent
Blindness America states that devices used in screening for glaucoma should attain at least
85% sensitivity at 95% specificity (preferably 98%) for moderate to severe VF defects (Com-
mittee, 1996). In a study conducted in 1994 among 120 people, a sensitivity of 67% and 51%
at specificities of 65% and 83% was found by 2 trained glaucoma specialists who categorised
VFs based on sensitivity, patient information and other indices (Goldbaum et al., 1994). The
reference was based on OD examination. Other experiments obtained different results: in
(Chauhan et al., 1990), perimetry indices obtained a sensitivity of 64% at 74% specificity,
using the VF inspection by three investigators as a reference. For OD assessment, as already
described, sensitivities are generally higher. However, variability in measurements and pop-
ulations must always be kept in mind when comparing different studies. The next section
gives an overview of the ML approaches that have been used for glaucoma and provides a
comparison of such techniques across the literature.
2.4.1 Machine Learning Approaches
Many studies have been conducted in order to find automated techniques to help clinicians
in the classification of glaucoma. In particular, statistical and ML approaches have been
explored in this context. Among the former there is the STATPAC package, which is in-
tegrated with the HFA and provides simple deviation from average ”normal” values. The
HFA also computes the AGIS score metric. Regarding the OD assessment, the HRT pro-
vides MRA and other deviation scores. These metrics, described in the previous sections,
are universally used to help clinicians in the interpretation of the VF and OD, but are still
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insufficient for diagnosis of early glaucoma. The ML approaches use sophisticated algorithms
to obtain a classification output given an a set of measures from the patient (input). The
algorithm learns the classification rules using training data to be able to map the input to
the output correctly. The learning process can be supervised or unsupervised. In the first
case the training data is previously associated with a state (healthy or glaucomatous eye),
and the classifier tries to minimise mistakes. Then it can be used to classify a new set of
measures in a different dataset, or even to predict outcomes. Unsupervised learning instead
uses unlabelled data, thus the classifier tries to set the rules to discriminate between different
subsets of the training data. It can be used to find data clusters and patterns, which can be
compared to expert-knowledge or even explored in more depth. Unsupervised learning can
be used for classification and prediction too. It must be noted that an important difference
between these two approaches lies in the labelling process. Supervised classifiers are in fact
dependent on the process of pre-classification of the training data, which can be biased. In
particular, as already described, glaucoma data is often difficult to classify because no gold
standard is available, thus the impact of the labelling process should be taken into account.
Another important difference in Machine Learning Classifiers (MLC) concerns how to solve
decision problems. In one case, the algorithm finds a function to map the input x directly to
a class label. In this case, probability plays no role. Another approach is to first determine
the posterior class probability p(Ck | x) and then use decision theory to assign each new x
to one of the classes. Approaches that model the posterior probability directly are called
discriminative models. A more complex approach is to first determine the class-conditional
densities p(x | Ck) individually for each class Ck and also infer the prior class probabilities
p(Ck). Then, using the Bayes theorem, the posterior class probabilities p(Ck | x) can be
found:
p(Ck | x) = p(x | Ck)p(Ck)
p(x)
(2.1)
Approaches that explicitly or implicitly model the distribution of inputs and outputs are
known as generative models, because by sampling from them it is possible to obtain synthetic
data points in the input space (Bishop, 2006). Discriminative approaches are focused on
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classification accuracy but provide less insight into the structure of the data space, while
generative approaches, by allowing the marginal density of data p(x) to be estimated, focus
on modelling the data completely and allow more insights to be gained. However, it can be
wasteful of computational resources and excessively demanding to find the joint distribution
p(x, Ck). Thus the debate is still open, and there has been much interest in exploring the
merits of generative and discriminative approaches to machine learning, and in finding ways
to combine them (Jaakkola and Haussler, 1999). Following the rationale of exploring the
nature of glaucoma through data, this thesis focuses on probabilistic graphical models, which
belong to the generative approach and allow both supervised and unsupervised learning.
However, in the remainder of this chapter the main ML models that have been applied in
the glaucoma context and their performances will be presented.
2.4.2 Machine Learning Techniques for Glaucoma
Several Machine Learning algorithms have been used with glaucoma data. The techniques
will be briefly discussed here and their performances on published works will follow.
The Classification and Regression Trees (CART) algorithm (Breiman et al., 1984) is a
widely used statistical technique for producing classification and regression models with a
tree-based structure. For classification, CART uses a tree structure, consisting of a hierarchy
of univariate binary decisions. Each internal node specifies a binary test on a variable which
splits the data into two disjointed branches, and each leaf node specifies the class label.
The structure of the tree is derived from the data in a complicated pruning process, using
the misclassification loss function as a score function. The misclassification loss function is
minimised using a cross-validation technique, which is a method that partitions the training
data into a subset for building the tree (i.e. learning data) and then estimates the misclas-
sification rate on the remaining validation set. CART uses a greedy local search method
to identify good candidate tree structures, recursively expanding the tree and then pruning
branches. Even if the CART technique can handle a large number of variables and contains
mixed data types, its decision boundaries are constrained to be parallel to the input variable
axes (Hand et al., 2001). Other data mining algorithms based on tree models exist, and a
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widely used alternative to CART is the C4.5 algorithm (Quinlan, 1993). Instead of using
a cross-validated score function, it adjusts the estimated error rate on the training data to
approximate the test error rate.
Multilayer Perceptron (MLP), also termed a feed-forward neural network, is a common
supervised learning classifier applied to a wide class of problems such as face recognition
(Samal and Iyengar, 1992) and optical character recognition (Baird, 1993). It is a particular
class of neural networks (NNs), which in general constitute an approach to classification that
fixes the number of the basis functions (i.e. classification functions on the input to obtain
the output) but allows them to be adaptive during training, in an attempt to avoid the curse
of dimensionality (Bellman, 1961). In particular, MLP architecture is a feed-forward network
with input and output layers separated by hidden layers of nodes. The links between nodes
represent weight parameters, which are calculated on the data and connections between
layers. Learning involves multiple bidirectional passes through the layers of the network,
and the error signal is passed backward (i.e. error-backpropagation) in order to reinforce or
inhibit each weight assigned by the hidden layer. The cycle is repeated until the error rate
is low compared with the labelled examples in the training set (Bowd and Goldbaum, 2008).
The output value is obtained with non-linear transformation (activation function) on the
inner products in the internal layers and, because of the non-linear nature of the model, the
decision boundaries between classes produced can also be non-linear (Hand et al., 2001). The
MLP is the most popular architecture in neural networks and have proven to be of greatest
practical value (Bishop, 2006) even if it requires repeated training from different random
initial conditions and convergence to a global solution is not guaranteed (Chan et al., 2002).
Self-Organizing Maps (SOMs) (Kohonen, 2001) is another type of NN used with unsu-
pervised learning, which clusters high dimensional data thus decreasing its complexity. The
SOM forms a nonlinear projection of a high-dimensional data manifold on a regular, low-
dimensional (usually 2D) grid, in which the clustering of the data space is clearly visible.
The variables investigated can be displayed separately using grey-level or pseudocolor coding
on the SOM grid, so that it is possible to understand the mutual dependencies between them
and the structures of the data set (Kohonen et al., 2004).
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Support Vector Machine (SVM) algorithms (Vapnik, 2000) are used with success for
solving a variety of classification and regression problems in different fields (Furey et al.,
2000; Dumais et al., 1998). These models non-linearly map training data (i.e. labelled cases)
to high-dimensional space where an optimal hyperplane (a linear boundary) can be found
to minimise the separation error with lower computational burden. Further, just a subset
of the training data containing the samples which are the most difficult to classify is used
to find the hyperplane, instead of using all the samples as in the linear learning classifiers.
Reflected back to the input space, the decision surface is not constrained to linear separation
anymore, obtaining a curve which is well tuned to the samples in the teaching set (Bowd
and Goldbaum, 2008).
The Relevance Vector Machine (RVM) classifier is also based on fewer sample vectors,
and typically results in much sparser models (Chan et al., 2002). The benefit of the latter
property is that its results are more generalisable, decreasing the chances of over-fitting.
Further, the output of the RVM is the probability of class membership, in contrast to the
non-probabilistic value obtained with SVM (Bowd et al., 2008), although this is at the
expense of non-convex optimisation during training. A probability output allows a more
intuitive expression of uncertainty in the prediction. Methods have been developed to obtain
SVM probabilistic outputs (Chan et al., 2002).
The Linear Discriminant Analysis (LDA) and Quadratic Discriminant Analysis (QDA)
classifiers use supervised learning in order to classify data into categorical values (e.g. healthy
or glaucomatous). They divide the input space into decision regions whose boundaries are
called decision surfaces (Bishop, 2006). In both LDA and QDA, Gaussian class-conditional
densities p(x | Ck) are assumed. However, in the LDA these densities share the same
covariance matrix, so the discriminant function obtained is a linear function of input x,
while in the QDA these assumptions are relaxed, obtaining a quadratic discriminant.
Mixture of Gaussians (MoG) and Mixture of Generalized Gaussian (MGG) are mix-
ture of ”expert” networks (in this case Gaussian estimators) that provide a Bayesian-based
probabilistic output based on labelled input (Tresp, 2001; Bowd et al., 2008). As for the
generative approach, we need to model the individual class-conditional densities p(x | Ck)
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to obtain the posterior probability and build the classifier. Since the input of the glaucoma
data contains continuous variables, we can model each p(x | Ck) by a normal multivariable
density: this would result in a classical LDA or QDA. However, often the distributions of
these variables are not well represented by a single Gaussian distribution, and a more flexi-
ble solution would be useful in this case. Using simple nonparametric methods such as the
histogram method (Hand et al., 2001) is not the best choice, since it subjects the classifier to
the curse of dimensionality, even if, according to (Bishop, 2006), the nonparametric Bayesian
methods are attracting increasing interest. Instead, the Mixture of Gaussians approach is
a semi-parametric model that uses mixtures of normal densities to describe more complex
distributions, i.e. for each variable we will have
p(x) =
M∑
m
p(x | m)P (m) (2.2)
where for each cluster m, p(x | m) is a Gaussian distribution with parameters P (m).
The clusters could be thought as each modelling (i.e. fitting) different regions of the input
space, with the goal of improving generalisation (Bowd et al., 2008). The MGG regards the
case when two Gaussians are not the best choice to fit a density. It uses the same mixture
model as in 2.2, but this time each distribution is now described by a linear combination of
non-Gaussian random variables. The parameters are adapted during training, which is done
by gradient ascent on the data likelihood (Lee and Lewicki, 2000). The Subspace Mixture
of Gaussians (SSMoG) is a dimension-reducing MoG method that iteratively samples, with
replacement, multiple random subsets of the full-dimensional dataset, allowing the use of
MoG classifiers on high dimensional data (Bowd et al., 2008).
The Parzen Window is a kernel-based nonparametric approach to density estimation
(Parzen, 1962), which has been used with a particular isotropic Gaussian Parzen Window
function, in analogy with MoG, in order to classify glaucomatous and healthy data (Chan
et al., 2002).
Another nonparametric method, which is widely used, is the K-nearest-neighbour method
(KNN), which uses a smoothed Gaussian function with an optimal SD as a kernel function.
To estimate the distribution on a point, a small sphere centered on the point is considered to
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grow until it contains a certain amount of data points K, which actually governs the degree
of smoothing. To use KNN for classification, the density estimation is applied to each class
separately and then the Bayes’ theorem is used. The so called nearest-neighbour rule is the
particular case of K=1, meaning that a test point is simply assigned to the same class as the
nearest point from the training set.
An interesting and useful task in ML techniques for classification is the so called feature
selection, i.e. the search for the subset of input variables that contribute most in the clas-
sification. Since exhaustive search with the combination of all possible subsets of variables
is prohibitively expensive, other approaches are used. For example, in (Chan et al., 2002),
forward selection and backward elimination are used to rank the variables; in the former
variables are added one at a time, choosing the next variable that most increases classifi-
cation. Feature selection may be a valuable way to speed up and enhance test procedures
for different ML techniques, as well as improving classification accuracy and physiological
understanding.
Another class of models that has been used in the glaucoma context is the probabilistic
graphical models. Instead of just using purely algebraic manipulation to solve probabilistic
models, probabilistic graphical models are useful to augment the analysis using diagrammatic
representations of probability distributions. They offer several useful properties: first, they
provide a simple visualisation of the structure that can be used to design and motivate
new models. Second, many insights into the properties of the model, such as conditional
independence properties, can be seen in the graph. Third, complex computations required
can be expressed in terms of graphical manipulations, in which underlying mathematical
expressions are carried along implicitly (Bishop, 2006). Among these models, the Bayesian
Networks (BNs) are directed graphical models in which each node represents a variable, and
a lack of arcs between nodes represents a conditional independence assumption. Once the
structure and the parameters describing the variables in the model are set using a training
dataset or arbitrarily, it is possible to infer about any value of any node. For classification,
BNs can be used to infer the group of the patient by taking into account the value of
the observed variables. Missing data and unobserved variables can also be included in BN
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models.
2.4.3 Performance of Machine Learning Classifiers
There have been many studies comparing the performances of different ML techniques ap-
plied to glaucoma. Most of them rely upon VF measurements, while some of them rely upon
OD measurements or a combination of structural and function data. Comparisons are usu-
ally obtained by considering Receiver Operator Characteristic (ROC) curves (Bradley, 1997).
The ROC curve consists in plotting the sensitivity of the test (in our case the proportion of
correctly classified glaucomatous cases, or ”True Positives”) versus 1-specificity (in our case
the proportion of normal eyes misclassified as glaucomatous, or ”False Positives”). The plot
shows these values for different choices of threshold, increasing from 0 to 1. The threshold
is the value to which the estimated probability p(C | x) is compared to when classification
is made. To compare different ROC curves, the area under the ROC curve (AUROC) and
its variance can be calculated, summarising the quality of classification over a wide range of
misclassification costs (Bradley, 1997).
Regarding VF data, Table 2.1 reports the main studies on classification using ML tech-
niques. Despite the different absolute performance results, which depend on several factors
such as inclusion criteria or gold standard assumptions, ML techniques perform better than
state-of-the-art solutions in all studies. MLPs, QDAs and MoGs perform particularly well
with SAP data. Clustering was also assessed using SOM and more flexible models, obtaining
interesting insights and promising results. MLCs have also been applied to imaging mea-
surements of glaucoma. Imaging techniques and tomographies can provide enormous arrays
of data and the use of MLC is then an obvious approach. The results of such studies on
cross-sectional datasets are presented in Table 2.2. Again, the potential of ML techniques
are shown in these studies. However, in this case, MLP, SVM and RVM techniques perform
similarly. Note that the variability in glaucoma definition and number of subjects included
in the studies make it difficult to directly compare classifiers across the studies. When OD
and VF data are combined, the studies in Table 2.3 indicate that classification performances
further increase. BNs have had relatively limited application to glaucoma data, despite their
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Table 2.1: ML studies on cross-sectional SAP data (Supervised and Unsupervised).
Reference ML Technique Subjects Criteria for Results (sensitivity and
glaucoma and specificity)
(Goldbaum
et al., 1994)
MLP, Experts 60 G,
60 H
IOP > 22 mmHg
and GON (cup-disk
ratio > 0.7 and ex-
perts’ evaluation)
MLP obtained 60%/72%,
which was similar to experts
results.
(Lietman et
al., 1999)
MLP, STATPAC,
AGIS, NTG score
106 G,
249 H
IOP > 21 mmHg,
reproducible VF
defect
MLP better at higher speci-
ficities but worse at lower
specificities.
(Chan et
al., 2002)
MLP, SVM, LDA,
QDA, STATPAC,
Parzen Window,
MoG, MoGG
156 G,
189 H
Analysis of OD
photographs and
ocular history
Best QDA (78%/76%). Gen-
erative better than discrimi-
native. All ML better than
STATPAC.
(Goldbaum
et al., 2002)
MoG, MoGG,
MLP, SVM, Hu-
man
156 G,
189 H
Consensus masked
evaluations of OD
photographs
MoG highest, better than
STATPAC. All ML better
than human.
(Bizios
et al., 2007)
MLP, PSD, STAT-
PAC
100 G,
116 H
Expert evaluation
of OD photographs
MLP accuracy of 93.5%,
against 85.6% to 91.7% for
global indexes.
(Henson et
al., 1996)
SOM 560 G VF deviation < -6
dB
Found 50 clusters with 7 typ-
ically observed patterns.
(Sample et
al., 2004)
Bayesian Mixture
of Factors
189 H,
156 G
Consensus masked
evaluations of OD
photographs
Found 5 clusters, 98% of
healthy eyes were assigned to
one cluster.
(Goldbaum
et al., 2005)
Variational
Bayesian-
independent com-
ponent analysis
mixture model
189 H,
156 G
Consensus masked
evaluations of OD
photographs
31% of healthy eyes were as-
signed to one cluster.
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Table 2.2: ML studies on cross-sectional OD data (Supervised and Unsupervised).
Reference ML Technique Subjects Criteria for Results (sensitivity
glaucoma and specificity)
(Uchida et
al., 1996)
MLP, Linear analy-
sis (CSLO data)
53 G,
43 H
OD appearance
consistent with
early VF defects
MLP AUROC of 0.94, better
than the others.
(Bowd et
al., 2002)
MLP, SVM, LDA
(CSLO data)
108 G,
189 H
VF defects (based
on PSD and GHT)
Comparable (85% -
91%/90%), AUROC 0.94
- 0.97.
(Bowd et
al., 2005)
SVM, RVM (SLP
data)
92 G,
72 H
VF defects (based
on PSD and GHT)
Same AUROC (0.94), better
than standard SLP parame-
ters (AUROC 0.51 - 0.87).
(Huang
and Chen,
2005)
MLP (OCT data) 89 G,
100 H
IOP > 22 mmHg
and early VF defect
MLP (82%/90%), AUROC of
0.82.
(Burgansky-
Eliash et
al., 2005)
SVM (OCT data) 47 G,
42 H
VF defects (based
on PSD and GHT)
and GON (cup-disk
ratio > 0.6 and ex-
perts’ evaluation)
SVM (92%/95%), AUROC of
0.98.
(Huang et
al., 2007)
SOMs, decision
trees (OCT data)
71 H,
64 G
IOP > 22 mmHg
and reproducible
VF defect
SOM identified the two of
five most informative clus-
ters, derived decision tree
(92%/83%).
characteristics that make them well-suited to glaucoma diagnosis. In (Tucker et al., 2005),
a BN classifier was built in an attempt to give a deeper understanding of glaucoma, and it
was then compared to traditional black-box MLCs. The network was learned using every
point of the VF data as a variable, and applying a quasi-greedy searching technique, called
Simulated Annealing (SA), to explore the space of structures. For every iteration of the
algorithm, three spatial operators (add a link to a near node, change the parent of a link
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Table 2.3: ML studies on cross-sectional OD and VF data.
Reference ML Subjects Criteria for Results (sensitivity and
Technique glaucoma specificity)
(Brigatti et
al., 1996)
MLP (CSLO
data)
185 G, 54
H
Early VF defects MLP obtained 87%/56% when
trained only on OD data and
90%/84% when trained also on
VF data.
(Goldbaum
et al., 2004)
RVM, differ-
ent types
SAP: 156
G, 189 H;
HRT: 95
G, 135 H
SAP: evaluation of
OD photographs,
HRT: repeatable
VF damage
SAP with HRT criteria
(76%/90%) better than HRT
with SAP criteria (83%/90%).
(Mardin et
al., 2006)
LDA, classi-
fication tree
88 G, 88
H
VF defect (MD >
2.8 dB) and evalua-
tion of OD appear-
ance
Combination of HRT and VF
data overall better (95%/91%).
(Bowd et
al., 2008)
RVM, SS-
MoG, STAT-
PAC
156 G, 69
H
Repeatable VF de-
fects or GON
RVM and SSMog (75%/90%),
better when OCT and SAP data
combined (AUROC 0.84 and
0.86) than OCT alone (0.80 and
0.81) and SAP alone (0.81 and
0.84).
(Racette et
al., 2010)
RVM, LDA GON:
144 G, 68
H
VF defects or GON RVM on combined HRT and
SWAP data, better (AUROC
0.93) than LDA and than RVM
on HRT (0.88) and SWAP (0.76)
alone.
and swap the relative position of two nodes’ parents) were applied to the existing structure.
Subjects included 78 subjects with early VF loss (based on AGIS score) and 102 normal
volunteers (AGIS score of 0) known not to be sufferers. After categorisation of the VF
data into four states, 10-fold cross-validation was applied to the BN classifier learned and
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to a Naive Bayes classifier, a Tree Augmented Network (TAN), a linear regression classifier
and a KNN classifier (where K was chosen using 10-fold cross validation). Results between
Bayesian Classifiers found that the BN performed best with an AUROC of 0.94 (sensitivity
was around 85% at 90% specificity), while the next best was the Naive Classifier with an
AUROC of 0.9. The TAN performed worst (AUROC of 0.8). Compared to more traditional
classifiers, the BN classifier performed better than the KNN method (AUROC of 0.91) and
was comparable to linear regression (AUROC of 0.94). However, the great advantage given
by the BN is the transparency of the model, which allowed an explicit modelling of rela-
tionships between variables. In order to assess the reliability of such learned relationships
between points, expert knowledge concerning the anatomy of the eye was used: mean optic
nerve-head angle distance between linked nodes, which is supposed to be low, was 15.28
degrees (over 180). Further, VF points linked directly to the class node were analysed, as a
form of feature selection, and these reflected a common feature of the early stages of glau-
coma (the nasal step VF defect, Figure 2.3). Other unexpected patterns were discovered,
showing the potential of BN models in learning links that can teach interesting patterns in
clinical data. In (Tucker et al., 2003), 623 VFs from 24 converters patients (i.e. changing
from healthy to glaucomatous state, according to AGIS score) were analysed similarly to the
above discussed work. The BN classifier obtained a sensitivity of 63 % at a specificity of
80%, the Naive Bayes classifier obtained 60% sensitivity at 81% specificity the TAN yielded
60% sensitivity at 79% specificity.
To our knowledge, MLCs have been used to detect glaucomatous progression using mostly
SAP data. Results are reported in Table 2.4.
A predictive approach with MLCs has been also implemented. In (Bowd et al., 2004) an
SVM classifier was used to predict future conversion to a glaucomatous VF in suspect eyes.
Data used for baseline cut-off were CSLO measurements from a previous study, subsequently
followed longitudinally. Suspected eyes classified as abnormal by SVM were 1.7 times more
likely to develop three consecutive VF defects than eyes classified as normal, which was
similar to predictive values of expert assessment of OD photographs and MRA in CSLO
(Garway-Heath, 2005). In a recent study (Demirel et al., 2009), a classification tree (CART)
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Table 2.4: ML studies on glaucoma progression.
Reference ML Subjects Criteria for Results (sensitivity and
Technique glaucoma specificity)
(Brigatti et
al., 1997)
NN 233 G VFs evaluated by
experts
Sensitivity of 73% at 88%
specificity.
(Sample et
al., 2002)
SVM, MoG,
STATPAC
114 G, trained
on 156 G (Gold-
baum et al.,
2002)
IOP > 23 mmHg,
trained on GON
36 converters based on STAT-
PAC. Agreement STATPAC-
MLC 88% to 95%, but MLCs
predicted abnormalities ear-
lier.
(Lin et al.,
2003)
NN 80 G over 7
years
AGIS AUROC 0.92, (86%/80%)
and (91%/90%).
(Sample et
al., 2005)
VB-ICA-mm
model
191 G over 6
year
OD appearance
(GON) and VF
defects
31% converters, better than
AGIS.
was applied to VF age-adjusted data of 100 healthy individuals and 168 patients with high
IOP or early glaucoma, in order to predict progressive glaucoma optic neuropathy, i.e. glau-
comatous RNFL appearance. Classification tree models suggested that patterns of baseline
VF findings were predictive of progressive glaucoma optic neuropathy with sensitivity of
65% at specificity of 87%, which may indicate that spatial MLCs can be used to determine
which VF locations are more predictive of poorer prognosis of progressive glaucoma optic
neuropathy.
2.4.4 Modelling Glaucoma Progression
Temporal relationships in progressive glaucoma data are seldom modelled. Although several
studies (Heijl et al., 1990; Hood and Kardon, 2007) have used statistical models to explore
and predict the temporal aspects of VF data, MLC classifiers have been applied in very few
studies. In (Ibanez et al., 2007) a statistical spatio-temporal model of healthy eyes was built
for forecasting and simulation of healthy VFs. In (Swift and Liu, 2002), multivariate time
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series were modelled with a novel algorithm for large variable datasets to predict and model
VF deterioration. Regarding longitudinal data, the use of BNs has only been partially
explored, although graphical models have been assessed. In (Fitzke et al., 1996), a new
method of analysis using a graphical display of longitudinal field data is presented. In this
method, linear regression models of sensitivity at different locations in the VF over time
are coloured to illustrate the changes and aid the interpretation of field loss. The model
was compared with STATPAC 2, obtaining a good level of agreement. In (Anderssen and
Jeppesen, 1998), VF data were investigated with State Space Models (SSMs). SSMs are
models where latent variables are introduced to obtain a more general framework, while still
retaining tractability with sequential data. In fact, temporal sequences must be ”limited” to
ensure that the amount of data produced is manageable, as the sequence increases, and to
take into account the correlation between subsequent values. This leads to the consideration
of the Markov Models (MM), in which it is assumed that future predictions are independent of
all but the most recent observations. However, while MMs are severely limited, SSMs provide
more general models, and can be readily characterised using the framework of probabilistic
graphical models. Examples of such State Space Models are the Hidden Markov Model
(HMM), in which the latent variables are discrete, and Linear Dynamical Systems (LDS),
in which the latent variables are Gaussian (Chan et al., 2002). In this context, Dynamic
Bayesian Network (DBN) is an extension of BNs that can model sequential data (Friedman
et al., 1998). Inference is very similar to standard inference in BN (Dagum et al., 1992),
and different methods for learning from data have been proposed. DBN can be seen as a
generalisation of HMM and LDS, by representing the hidden (and observed) state in terms
of state variables, which can have complex interdependencies (Murphy, 1998). SSMs and in
particular DBNs are likely to be valuable techniques for modelling glaucoma data, because
of their spatial and temporal nature. In (Tucker et al., 2005), a BN classifier, already partly
presented in this chapter, is combined with temporal data to produce a DBN classifier,
which is able to model and classify data with spatial and temporal relationships. In this
case, in addition to three spatial operators, three temporal operators were applied iteratively
to find the best scored structure for the classifier. The three non-spatial operators were:
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adding a link, removing one and changing the parent of an existing link. The learned
spatio-temporal classifier (STC) was then compared with other BN classifiers (TAN and
Naive Bayes), KNN and linear regression. Among BN classifiers, the worst performers were
TAN and Naive Bayes (AUROC of 0.79 and 0.77), while STC with 3 parents was the best
(AUROC of 0.88). ROC curves show that linear regression performs similar to STC and
KNN when the misclassification cost is higher than 0.6. Generally, for diseases that have
a low frequency and a slow progression, the misclassification cost lies on the higher values
(Goldbaum et al., 2002); this is also the case for glaucoma. It must be noted that VF
clinical classification requires three consecutive abnormal fields, but MLC do not use such
conservative criteria. Further, VFs are not re-classified after conversion, as patients cannot
become healthy. However, external interventions (e.g. medication) may result in negative
output from MLCs, resulting in FNs. In this study, the graphical model of the STC is also
evaluated, showing that the effect of noise in the data is more present in the STC than in
the non-temporal BN. However, many autoregressive and some others temporal links were
found, justifying the better performances of the STC over the BN. Interesting insights are
also derived from the temporal structure, and the suggestion of data integration and metrics
definition is provided in the study.
2.5 Summary
This chapter has shown that glaucoma, an irreversible form of blindness, is a major public
health problem. This situation is likely to worsen in the future and further studies need to
be carried out to ensure that as few sufferers as possible succumb to visual disability from
this condition. As the American Optometric Association (American Optometric Association,
2010) highlights, the only risk factor that can be clinically modified is IOP. Although IOP
is a poor diagnostic tool for glaucoma, lowering it through medication has been proven to
be beneficial in preventing glaucoma progression (Collaborative Normal-Tension Glaucoma
Study Group, 1998; The AGIS Investigators, 2000; Heijl et al., 2002; Leske et al., 2003; Kass
et al., 2002). Early diagnosis is essential in this context.
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With regard to the available screening techniques, considerable discordance exists been
different results from structural and functional tests in glaucoma, especially in relation to its
progression over time. Whether ON damage or VF damage appears first seems to be unclear,
probably because it is a co-occurrence of both, and because many factors influence which is
perceived to occur first. These results once again point out the importance of using both
functional and structural techniques to monitor the onset of the disease and its progression
(Mackenzie and Cioffi, 2008). In fact, combining different screening techniques seems to hold
the potential to improve classification performances, as well as give insights into the disease.
In this context, ML approaches have shown excellent results with OD and SAP data in
cross-sectional studies for classification of glaucoma. Their characteristics and performance
with combined functional and structural cross-sectional data suggest that further studies
concentrating on MLCs should be carried out. However, little modelling has been done
on longitudinal data using ML techniques. Relevant to this, (Bowd and Goldbaum, 2008)
suggest that future exploration should include large longitudinal datasets, with techniques
able to generalise and combine structural and functional measurements. One approach that
seems to have this potential is definitely the BN model, which allows large datasets of
different data types and expertise knowledge to be combined. Its intuitive output and the
ability to model causal relationship between variables explicitly is highly useful to clinicians.
Extensions of BNs can be used to incorporate the temporal aspects of the data and improve
classification performance as well as help researchers to learn more about the mechanisms
behind glaucoma.
The rest of the thesis is focused on such models, which will be presented in more depth
in the next chapter. Cross-sectional and longitudinal datasets will then be used in Chapters
4 and 5 to explore and assess BN extensions for glaucoma. In particular, ad-hoc models will
be used to tackle data integration, variability, and biases in the data in order to improve
diagnostic performance and gain insights in the nature of the disease.
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Chapter 3
Exploring Glaucoma with Bayesian
Networks
Bayesian Networks (BNs) are probabilistic graphical models that provide intuitive data rep-
resentation and perform classification. As discussed in the previous chapter, they may be
particularly appropriate for investigating many questions related to glaucoma diagnosis and
monitoring. This chapter introduces the fundamentals of the BN framework and explores
the potential of these models in the context of glaucoma.
In Section 3.1, the datasets that are investigated in the thesis are presented. Section 3.2
illustrates the basics of inference and learning using a simple BN. In Section 3.3, two BNs
based on functional and anatomical data and one BN based on prior anatomical knowledge
are built and assessed. Finally, Section 3.4 summarises the results and introduces following
chapters of the thesis.
3.1 Data Investigated
For this research, three independent datasets were available (Table 3.1). Datasets A and B
both consist of 52-point VF raw sensitivity values (i.e. not age-corrected) obtained with the
Humphrey Field Analyser (HFA) II and retinal data from the Heidelberg Retinal Tomograph
(HRT) (Fig. 3.1).
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Table 3.1: Characteristics of the available datasets
Dataset A Dataset B Dataset C
Healthy Subjects (values) 102 (102) 19 (155) -
Converters (values) 78 (78) 43 (474) -
Total Subjects (values) 180 (180) 62 (629) 51 (912)
Mean Age (Healthy) 67.6 (57.5) 65.7 (66.7) 66.9
Figure 3.1: VF Test output for the right eye with VF Loss (left) and HRT output image showing six sectors
of the optic disc with possible defects in three sectors (right).
Retinal data from the HRT consists of a number of measurements in six sectors of the
Optic Disc (OD). Retinal data was pre-processed by applying the 95% prediction interval
Moorfield Regression Analysis (MRA) indicated in (Garway-Heath, 2005; Wollstein et al.,
1998). As described earlier, this regression equation is a linear combination of Age, Optic
Disc Area (ODA) and Retinal Rim Area (RRA) into one single parameter. MRA is grouped
into six sectors as suggested in (Garway-Heath et al., 2000) for computational and anatomical
reasons.
Dataset A is a cross-sectional dataset of 78 early glaucomatous patients and 102 healthy
control subjects. The definition of glaucoma was based on an Intraocular Pressure (IOP)
greater than 21 mmHg and clinically evident early VF defects repeatable over at least three
visits. Healthy people had IOP < 21 mmHg and a normal VF defined according to the
Advanced Glaucoma Intervention Study (AGIS) classification (Gaasterland et al., 1994).
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Early VF defects were defined as those with a score of 5 or less in the AGIS classification.
Patients included had visual acuity greater than 20/40, refraction less than 6D ametropia, no
recent ocular trauma or surgery or other posterior segment ocular pathology, and no history
of diabetes. Healthy patients also had to have no history of primary open-angle glaucoma
in a first-degree relative.
Figure 3.2: Flowcharts that illustrates how each sample was created from each cohort for Datasets A, B and
C.
Dataset B is a longitudinal dataset of 43 patients from an ocular hypertension treatment
trial (Kamal et al., 1999), who developed glaucoma in the time span observed (”converters”)
and 19 healthy subjects. Initial eligibility criteria for the ocular hypertensive subjects were
IOP > 21 mmHg on two or more occasions, and two normal consecutive VF test (AGIS
score of 0), absence of any other ocular disease and age higher than 35 years. Conversion
was defined as an AGIS > 1 on three consecutive tests, but with no stipulation for the AGIS
score in subsequent VFs. Healthy subjects had an AGIS score of 0 in two baseline tests and
IOP < 21 mmHg, no ocular disease, no family history of glaucoma or ocular hypertension
and age higher than 35 years; there was no stipulation for the AGIS score in subsequent
42
Exploring Glaucoma with Bayesian Networks Data Investigated
VFs. Mean length of the series is 10.14 VFs, ranging from 4 to 18.
As highlighted in the thesis, datasets A and B used similar AGIS criteria to indicate
glaucoma, and optic disc appearance was not a restriction criterion. IOP thresholds used
were the same for both datasets.
Dataset C is a longitudinal dataset of 51 patients selected from the MoreFlow Medical
Research Council 5-Fluorouracil (5-FU) study (Kotecha et al., 2009). This was an 80-month
prospective randomised controlled trial on the efficacy of pre-operative 5-FU treatment on
primary trabeculectomy. Patients who showed progressive glaucomatous disease despite max-
imally tolerated medical therapy were listed for trabeculectomy and randomized to receiving
either per-operative 5-FU or placebo. The study cohort consisted of 369 eyes of 369 patients.
As part of the study protocol, the patients had ONH imaging performed before surgery, at
3-months after surgery, and then at annual intervals for 3 years. At this point, a change in
the study protocol was introduced that allowed imaging every 6-months. VF examination
was performed before surgery and at 3-month intervals for the first year and at 4-month
intervals thereafter. Intraocular pressure measurement was performed before surgery and at
every trial visit (five visits in the first 3 months after surgery, then at 3-month intervals for
the first year and at 4-month intervals thereafter). The follow up period was 5 years. VF
test data was filtered by excluding series with less than 10 VFs and without corresponding
HRT data. The resulting data consisted of 912 VFs in total; the mean number of VFs per
patient was 17.88, ranging from 10 to 28. Raw VF sensitivity data was grouped into six
sectors according to the functional-structural map proposed in (Garway-Heath et al., 2000).
The selection of the functional and anatomical variables from the main datasets followed
mainly the availability of such variables across all datasets, as well as the indications from
consolidated knowledge in the field. VF sensitivity is the most used classification input data
across the literature, while for anatomical data the most used variables are OD area, Rim size
and Cup size, as described in sections 2.3 and 2.4. Regarding the anatomical measurements,
the MRA was chosen as it combines in a convenient parameter OD area, rim size and age.
Regarding the summarized sectorial VF variables, the sensitivity was averaged across the
six sectors indicated in (Garway-Heath et al., 2000). This is a widely accepted functional
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map based on the anatomical characteristics of the retina, as described in section 2.2.2.
The map is based on the anatomy of the retinal nerve fibre bundles, so that the points in
each sector lie on the same nerve fibre bundle and are more likely to be correlated between
each other. The values of each sectorial variable are obtained by averaging the pointwise
sensitivity values, so that only six values are obtained for each VF test. In this work, this
operation was performed to reduce complexity of the calculations needed in certain models.
The retinal sectorial variables were provided directly by the HRT instrument. While IOP
could also be included, as discussed in future work, it wasnt included in the analysis as this
work focuses on structural and functional measurements.
Figure 3.2 shows the flowcharts that illustrates how each sample was created from each
cohort. More details on the available data are reported in Appendix A.
A set of simulated datasets were also used for validation purposes. These were obtained
using ad-hoc models that will be described in the relevant sections.
3.2 Introducing Bayesian Networks
This research aims to explore and extend the use of BNs for glaucoma modelling. As demon-
strated in the previous chapter, BNs have excellent properties relevant to glaucoma mod-
elling, and offer many advantages over other AI and graphical models (Heckerman, 1995;
Friedman et al., 1997): first, they can readily handle incomplete datasets because they offer
a natural way to encode correlations between input variables. Second, BNs allow one to learn
about causal relationships, which is extremely useful in clinical research, such as glaucoma,
when we are trying to gain an understanding about a problem domain. They also allow us
to make predictions in the presence of interventions. Third, BNs combined with Bayesian
statistical techniques facilitate the combination of domain knowledge and data, having causal
semantics that makes the encoding of causal prior knowledge particularly straightforward.
Fourth, BNs offer an efficient and principled approach for avoiding the over-fitting of data.
The BN is a graphical model of the probabilistic relationship between variables, which
encodes the joint probability distribution for a large set of variables (Heckerman, 1995). BNs
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for a set of variables X consist of a network structure S that encodes a set of conditional
independence assertions about variables in X, and a set of local probability distributions
associated with each variable. The network S is a graph with nodes and directed links
(known as arcs), and must be a directed acyclic graph (DAG). In a DAG, there are no closed
paths within the graph; thus we cannot move from node to node along links following the
direction of the arrows and end up back at the starting node (i.e. there are no directed
cycles). The nodes in S are in one-to-one correspondence with the variables X. The links
are connected from a parent node to a child node, and the lack of possible arcs in S encode
conditional independences. Conditional independence between the random variables X and
Y given Z is defined as
p(X | Y,Z) = p(X | Z) (3.1)
Therefore, once the value of Z is known, X and Y are independent.
3.2.1 A Simple Bayesian Network for Glaucoma
A simple BN for glaucoma data is shown in Figure 3.3. This network includes a Subject
Condition node that represents whether a patient is a glaucoma sufferer or not, and a set of
leaf nodes that represent the output of three different tests.
Figure 3.3: BN for Glaucoma with 3 binary leaf nodes representing tests’ outputs and a binary Subject
Condition class node, representing the patients’ glaucoma condition.
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The network assumes conditional independence between VF and ONH tests, given the
underlying condition of the patient. In general, a BN can encode a set of conditional in-
dependence relationships between variables, and it can be demonstrated that a node is
conditionally independent of its non-descendants given its parents (Pearl and Shafer, 1988).
Also, in a BN a node is conditionally independent of all the other nodes in the graph given
its Markov blanket, which is defined as the node’s parents, children and children’s parents.
The CPD associated with each variable X encodes the probability of observing its values
given the values of its parents, and can be described by a continuous or a discrete distribution.
In this case, the CPD is called a Conditional Probability Table (CPT). For example, in the
above graph the CPTs are as reported in Tables 3.2-3.5.
Table 3.2: Subject Condition (SC)
CPT.
Value Probability
Healthy 0.6
Glaucoma 0.4
Table 3.3: VF Test CPT.
Sensitivity Probability Probability
(PD = Healthy) (PD = Glaucoma)
Low 0.1 0.7
Medium 0.2 0.2
High 0.7 0.1
Table 3.4: RNFL status CPT
Outcome Probability Probability
(SC = Healthy) (SC = Glaucoma)
Healthy 0.6 0.3
Impaired 0.4 0.7
The CPT in Table 3.2 indicates the prior probability of having glaucoma, as the Subject
Condition node has no parents. All the CPTs together provide an efficient factorisation of
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Table 3.5: ONH Test CPT (G = Glaucoma, H = Healthy).
RNFL status = Healthy
Outcome Probability Probability
(SC = H) (SC = G)
Positive 0.3 0.8
Negative 0.7 0.2
RNFL status = Impaired
Outcome Probability Probability
(SC = H) (SC = G)
Positive 0.2 0.95
Negative 0.8 0.05
the joint probability
p(x) =
n∏
i=1
p(xi | pai) (3.2)
where pai are the parents of the node xi (which denotes both node and variable). For
the network shown in Figure 3.3, the joint probability of all nodes is:
p(SC, V F,ONH,RNFL) = p(SC)p(V F | SC)p(ONH | V F, SC)p(RNFL | ONH,SC, V F )
using the Chain Rule of probability. Fortunately, we can exploit the conditional indepen-
dences encoded in the BN, obtaining a more compact representation of the joint probability:
p(SC, V F,ONH,RNFL) = p(SC)p(V F | SC)p(ONH | SC)p(RNFL | ONH,SC)
In general, for n binary nodes, the number of parameters to be estimated is O(2n), but
the factored form needs O(n2k), where k is the maximum number of parents of a node.
3.2.2 BN Inference
Once the CPTs are defined, it is possible to make inference about the value of any target
variable in a BN. For instance, if we observe a Positive (P) ONH test, the probability of the
patient being Glaucomatous (G) can be calculated using Bayes’ Theorem:
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p(SC = G | ONH = P ) = p(SC = G,ONH = P )
p(ONH = P )
=
∑
V F,RNFL p(SC = G,V F,RNFL,ONH = P )
p(ONH = P )
=
∑
V F,RNFL p(SC = G,V F,RNFL,ONH = P )∑
V F,RNFL,ONH p(SC, V F,RNFL,ONH = P )
The calculations are carried out using the Chain Rule of Probability and applying
marginalisation, i.e. summing out all the irrelevant variables. The sums can be ”grouped”
while marginalising according to the conditional independences between the variables, in a
process called variable elimination:
=
∑
V F
∑
RNFL p(SC = G)p(V F | SC = G)p(RNFL | SC = G)p(ONH = P | SC = G,RNFL)∑
V F,RNFL,ONH p(SC, V F,RNFL,ONH = P )
=
p(SC = G)
∑
RNFL p(RNFL | SC = G)p(ONH = P | SC = G,RNFL)
∑
V F p(V F | SC = G)∑
V F,RNFL,ONH p(SC, V F,RNFL,ONH = P )
=
p(SC = G)p(RNFL = H | SC = G)p(ONH = P | SC = G,RNFL = H)∑
V F,RNFL,ONH p(SC, V F,RNFL,ONH = P )
+
+
p(SC = G)p(RNFL = I | SC = G)p(ONH = P | SC = G,RNFL = I)∑
V F,RNFL,ONH p(SC, V F,RNFL,ONH = P )
=
0.4 · 0.3 · 0.8
K
+
0.4 · 0.7 · 0.95
K
=
0.096 + 0.266
K
=
0.362
K
= 0.7137
where K is a normalising constant corresponding to the likelihood of the data. Note that
when RNFL is also observed to be Impaired, the probability of glaucoma becomes 0.8471,
but when it is observed alone the probability is just 0.5385. This allows assessment of the
impact of different tests and, even if in a small exemplificative context, shows the potential
of using BNs.
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A similar approach is used to perform classification, i.e. finding the posterior probability
given observations of the other variables:
p(Ck | x) = p(Ck | x1, x2, x3, ...) = p(Ck, x1, x2, x3, ...)p(x1, x2, x3, ...) (3.3)
Exact inference in BNs can become a very demanding task; therefore approximated
methods are often used in practice. These include methods based on Monte-Carlo sampling
and variational methods. In this thesis, the junction tree engine was used (Murphy, 1998).
This is an exact inference method that uses a greedy search procedure to find a good ordering
for variable elimination.
3.2.3 Parameter Learning
The process of building a BN involves learning the structure and estimating the conditional
probabilities of the nodes. Given the structure, the latter objective is to determine the
parameters of a distribution (or a set of distributions, in relation to the dimension of the
variables) for a node for every configuration of its parents. For a full Bayesian approach,
the posterior distribution of the parameters p(θ | D) should be computed. However, often
the calculation of the full posterior is intractable, and approximate methods are used. For
example, the parameters θ can be estimated by maximising the posterior probability of the
parameters given the data D:
θˆ = arg max
θ
p(θ |D) = arg max
θ
p(D | θ)p(θ) (3.4)
This can be done only under the assumptions that there are no missing data and that
parameters are mutually independent. Note that, with a uniform prior distribution of the
parameters, the latter equation is simplified by maximising the marginal likelihood function,
i.e. arg maxθ p(D | θ). In this case, the estimates are called Maximum Likelihood estimates,
as opposed to Maximum A Posteriori (MAP) estimates. Often, the log-likelihood is consid-
ered, so that the log-likelihood of the dataset Di, i = 1..M , is a sum of terms, one for each
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node k:
Lk =
1
M
M∑
i=1
log p(xk|pa(xk), Di) (3.5)
The log-likelihood contribution can be calculated for each node independently and, for
discrete nodes, the CPD estimation is reduced to simple counting. For example, for the BN
in Figure 3.3, the conditional probability parameter of the node VF test is obtained with:
p(V F = k | PD = j) = n(V F = k, PD = j)
n(PD = j)
=
n(V F = k, PD = j)∑M
m=1 n(V F = m,PD = j)
(3.6)
where n is the number of samples in the dataset and m = 1..M is the set of values taken
by the variable VF test.
When the learning data is incomplete or there are unobserved variables, the posterior
distribution becomes intractable as the log-likelihood is not decomposable. Thus, approxima-
tion techniques such as Monte-Carlo methods, Gaussian approximation and the Expectation
Maximisation (EM) Algorithm can be used to solve the problem (Dempster et al., 1977). EM
is an iterative procedure in two steps that aims to estimate the parameters. In the first step,
the hidden values for the unobserved data are inferred using the present model, while in the
second step the estimated likelihood function is maximised. When the algorithm converges
to a local maximum, the parameters are estimated. The ability to learn from incomplete or
missing data is referred to as clustering or unsupervised learning, which were introduced in
the previous chapter. In a BN, this extends to including unobserved or hidden variables, i.e.
variables for which no instances of the dataset are specified.
3.2.4 Structure Learning
The structure of the network can be imposed or learned from the data. The first case
is useful when external knowledge is available, such as from known causal relationships or
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expert advice. Learning the structure from data, on the other hand, often leads to interesting
insights and performance improvements. Structure learning is a NP-hard problem, since the
number of DAGs on N variables is super-exponential in N . Therefore, techniques to search
for local optima in the structure space are typically employed, such as a search-and-score
approaches. In this case, the neighbourhood of an initial guessed network is iteratively
searched until a local optimum is reached. A widely used search technique is the Simulated
Annealing (SA) algorithm (Kirkpatric et al., 1983), which performs a quasi-greedy search by
allowing non-optimal solutions to be explored to escape local minima.
Algorithm 3.1 Simulated Annealing algorithm.
Input: Temperature, Cooling_Factor, Model, Data, Max_Iterations
Score Model and store in Best_Score
Loop on iterations until Max_Iterations is reached
Apply OPERATION to Model
Score Model and store in New_Score
Diff_Score is New_Score - Score
if (New_Score is higher than Score)
Update Score and Model
if (New_Score is higher than Best_Score)
Store Model for Output
Best_Score is New_Score
end if
elseif Random_Number is less than exp(Diff_Score / Temperature)
Update Score and Model
end if
Temperature is Temperature · Cooling_Factor
end Loop
Output: Model stored for Output
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The procedure is described in Algorithm 3.1. The input parameters Temperature, Cool-
ing Factor and Max Iterations regulate the convergence of the algorithm, Model is the start-
ing model and Data is the training dataset in use. Best Score is used to store the current
best model score, while Score and New Score hold respectively the score of the current model
and the new model at each iteration. The latter is evaluated after operations are carried out
on the current model. If the new score is higher than the current score, the parameters of
the current model and the current score are updated. If the new solution is the best among
the explored ones, the results are also stored in Best Score and for the final output. If
the new solution is worse than the current one, a temperature factor Temperature regulates
whether to accept it as a new current solution. Note that Random Number represents a
random number between 0 and 1. The acceptance of solutions which are not the best allows
the algorithm to escape local minima, which are a common issue in structure learning of
BNs. The temperature factor is lowered at each iteration proportionally to a cooling factor
Cooling Factor. After a specified number of iterations Max Iterations, the algorithm returns
the best explored model.
To evaluate the models, the full posterior distribution of the parameters for a structure
can be estimated. As explained before, point estimates are usually considered, so that the
task is to maximise the posterior distribution, which can be decomposed as in Equation 3.7:
p(M |D) = p(D |M)p(M)
p(D)
(3.7)
where p(D | M) is called the marginal likelihood of the model M and p(M) is the prior
probability of the model. Note that the same task can be solved by maximising the logarithm
of these two functions, which can be approximated for efficient computation. For example,
the Bayesian Information Criterion (BIC) score (Schwarz, 1978) for the model M can be
calculated as follows:
BIC = log p(M) + log p(θ) + logL(θˆ,M |D)− k
2
log n (3.8)
Where p(θ) is the prior probability of the parameters θ, n is the number of cases in D,
k is the number of parameters in the model and L is the Maximum Likelihood configuration
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of θ, i.e. L(θˆ,M | D) = p(D | θˆ,M) with fully observed D. Often, a non-informative
uniform prior is assumed for both the models and the parameters, obtaining a likelihood-
based score adjusted for the model complexity. Since the likelihood function monotonically
increases with the number of parameters, overfitting and estimation problems may arise if
no correction factor was present to take into account the complexity of the model. Other
approaches, such as the Akaike score (Akaike, 1974), penalise differently the dimension of
the model but have the same rationale. Since the number of parameters in the model is the
sum of the number of parameters in each node, the BIC score also decomposes.
Missing data, or unobserved variables, make the structure search problem more compli-
cated as the computation of the score becomes very inefficient. Therefore, few solutions are
available for this task. One solution, called Structural EM (SEM), extends the EM algorithm
in order to search the joint space of parameters and structure (Friedman et al., 1997). At
each iteration the algorithm can either find better parameters for the current structure or
select a new structure.
3.2.5 Model Averaging
When learning BNs, resampling techniques can be used in order to reduce noise and obtain
more robust results. Bootstrapping (Friedman et al., 1999), for example, involves iterative
random sampling from the dataset (with replacement). The technique permits to obtain an
unknown characteristic of an unspecified distribution by drawing subsets from the observed
data iteratively, and computing a statistic for each subset. For a great number of iterations,
the bootstrap distribution approximates the actual distribution. This technique has been
applied in many fields (Zoubir and Boashash, 1998), and it can also be applied in searching
the space of BN models using subsets of training data. Bayesian Model Averaging can be
used on the set of learned structures to calculate the posterior probability for each arc as
proposed in (Friedman and Koller, 2003), i.e. by weighting each arc f on the network score in
which it is present. Since calculation of the posterior probability on the whole set of possible
structures is feasible only for tiny domains, an approximation is made by enumerating only
over the learned set of structures (i.e. a set of optimal structures), as proposed by (Madigan
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and Raftery, 1994). Thus, the formula used to estimate the relative mass of the structures
in G that contains arc f given the data D is:
P (f |D) ≈
∑
G∈G P (G|D)f(G)∑
G∈G P (G|D)
(3.9)
where f(G) is a binary function equal to 1 when the arc is present in the structure G,
and P (G|D) represents the posterior probability of each structure given the data D. The
latter function can be calculated as the product of the likelihood of the data and a prior over
the structures. The arcs with the highest posterior probability are then selected to obtain
the final structure.
3.3 Bayesian Networks for Glaucoma
This section presents a set of experiments using BNs for glaucoma to assess the impact of the
technique and the characteristics of the datasets, as well as highlighting some key concepts
in BN inference and prediction. The BN models were implemented using ad-hoc functions
and the Bayes Net Toolbox for Matlab (Murphy, 2001).
3.3.1 Na¨ıve Bayesian Network
A first set of experiments was carried out by training a Na¨ıve BN using Dataset A and testing
it on Dataset B (Table 3.1). In a Na¨ıve BN all variables are assumed to be conditionally
independent, given the class. This model therefore easily allows the approximation of the
full conditional distribution, being linear in the number of variables N rather than exponen-
tial. The assumption of independence is very limiting and almost always incorrect in real
applications; nevertheless Na¨ıve BNs have been shown to perform well in many classification
applications (Tucker et al., 2005). The structure of the chosen Na¨ıve BN is shown in Figure
3.4.
VF pointwise data was grouped into six variables corresponding to the nerve fibre layer
structure, following (Garway-Heath et al., 2000) and Figure 2.3. Therefore, it was possible
to obtain anatomically concordant HRT and VF measurements for the six sectors of the OD,
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Figure 3.4: Na¨ıve Sectorial Bayesian Network
i.e. temporal superior (Ts), nasal superior (Ns), temporal (T), nasal (N), temporal inferior
(Ti) and nasal inferior (Ni) sectors.
The CPD of each variable was assumed to be a continuous Gaussian distribution with
unknown mean and standard deviation. The training of the parameters was performed using
ML estimation as already described for the discrete case. The AGIS metric was not used as
an indicator of glaucoma in the testing dataset (Dataset B). The BN classifier was compared
to a C4.5 Tree classifier, a KNN classifier, a Multilayer Perceptron and a Logistic Regression
classifier. These classifiers are described in the previous chapter and were built using Weka
software (“The WEKA Data Mining Software : An Update”). The ROC curves of the assessed
classifiers are shown in Figure 3.5. The sensitivity of AGIS and MRA metrics is lower than
other ML classifiers. Although at high specificity the BN does not perform better than the
other ML classifiers; for specificities below 88%, the BN model outperforms all the other
models. This is reflected in the overall AUROC values, which are shown in Table 3.6.
3.3.2 Anatomy-Based Bayesian Network
The independency between the variables that is imposed by the Na¨ıve BN does not incorpo-
rate any external anatomical knowledge about glaucoma. To include such information, the
structure presented in Figure 3.6 was considered. s Instead of the MRA linear combination
of Age, Optic Disc Area (ODA) and Retinal Rim Area (RRA), raw ODA and RRA were
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Figure 3.5: ROC curves for a set of ML classifiers tested on Dataset B.
Table 3.6: AUROC values for ML and traditional classifiers
Classifier AUROC
KNN 0.70
C 4.5 0.72
Linear Log 0.78
Multilayer 0.79
BN 0.82
considered. This allows the inclusion of anatomical knowledge in the model, by imposing
dependency between ODA and RRA and between nerve fibre bundles and VF sectors. The
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Figure 3.6: Anatomy-based BN
direct dependence between ODA and glaucoma has been proposed in the literature as an
explanation for African-Caribbean subjects being at increased risk of developing glaucoma
(Sommer and Doyne, 1996). The performance of this classifier was compared to the Na¨ıve
BN built using both raw and pre-processed HRT values, obtaining the AUROC reported in
Table 3.7.
Table 3.7: AUROC values for ML techniques
Classifier AUROC
Na¨ıve BN 0.823
Raw Na¨ıve BN 0.830
Anatomy-based BN 0.835
The overall performance of the anatomy-based BN is higher than the others. However,
a better analysis can be obtained by looking at the full ROC curve, which shows the perfor-
mance at different specificities (Figure 3.7). At high specificities, no classifier outperforms
the others. However, the anatomy-based classifier outperforms the others for specificities
lower than 80%, while the Na¨ıve BN is the best classifier for specificities between 90% and
80%. The MRA pre-processing affects the performance of the classifier at higher specifici-
ties, but has a positive impact for lower specificities. Thus, each network has a particular
utility at different specificities. The output provided by the three classifiers for two subjects
is shown in Figure 3.8. The differences in the outputs can be explained by analysing how
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Figure 3.7: ROC curves for anatomy-based and Na¨ıve BNs
conditional dependencies act on each BN. The Na¨ıve BN, in fact, is composed of diverging
arcs only, i.e. arcs from the class node to the leaf nodes. In this case, information may be
transmitted through a diverging connection if the state of the parent variable in the connec-
tion is not known, e.g. in classification. Once the parent variable is observed, the two leaf
nodes become independent. By introducing VF-RT arcs, converging connections are added
to the model. In converging connections, information passes from one parent to the other
if either information about the state of the variable in the connection or one of its descen-
dants is available. In other words, the parents are conditionally dependent given the value of
their common child, even if they are marginally independent. This effect is called explaining
away, because the parent nodes compete to explain the observed value of the common child.
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Figure 3.8: Probability of having glaucoma for a converter and a healthy subject. The colors are chosen
according to Figure 3.7 and the green vertical line represents the AGIS onset of glaucoma.
For instance, having observed that VF (NS) is low (e.g. 15 dB), the probability of having
Glaucoma is:
P (Class = Glaucoma | V F (NS) = 15)
However, if we also observe a thin neuroretinal rim RT (NI) (e.g. 5), the posterior
probability of glaucoma becomes lower, as the rim size is ”explaining away” the observed
low VF sensitivity:
P (Class = Glaucoma | V F (NS) = 15, RT (NI) = 5) < P (Class = Glaucoma | V F (NS) = 15)
Indeed, a thinner rim is indicative of glaucoma, therefore in this case a direct arc between
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the two parents RT (NI) and Class was included. Modelling causality is a debated subject
and (Pearl, 2000) offers a wide discussion about the matter. From a general point of view,
causality can be extracted from data in conformity with the Causal Markov Condition. The
latter implies that if a causal relation is present, then there is a BN that correctly captures
it. However, understanding whether the correct BN is found is often not feasible, considering
the number of possible networks and the nature of the tests that should be carried out to
assess causality between variables, as discussed in (Heckerman, 1995).
3.3.3 Data-Driven Bayesian Network
Among the techniques used to learn conditional independence between variables, BN struc-
tures can be learned from data using a search-and-score approach. SA, described in Algo-
rithm 3.1, was carried out using a particular set of operational functions on VF and HRT
sectorial variables. In particular, three structural operations were considered:
• Adding an arc: a random node among the non-connected nodes is chosen and connected
to another node, with the maximum number of parents of a node set to 2.
• Deleting an arc: a random arc in the BN is chosen and removed.
• Moving an arc: the other two operations are called in sequence, so that a random arc
is deleted and a new arc is added.
The following Figure shows possible effects of the operations on a simple BN.
Figure 3.9: Operations on the structure of a BN. a to b: Deleting an arc, b to c: Moving an arc, b to a:
Adding an arc.
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The learning algorithm was run 100 times using bootstrapped data from Dataset A.
In particular, 100 sets of records were randomly sampled with replacement from dataset
A and used as training datasets for the algorithm. The resulting 100 networks were then
weighted based on their likelihood score, according to (Friedman and Koller, 2003) methodol-
ogy presented in Section 3.2.5. Typical parameters were 2100 iterations per run, temperature
starting at 5 and a cooling factor equal to 0.99. These parameters were obtained by tuning
and observing the score curves obtained during the learning. Parameters were accepted when
curves consistently ended in a plateau, as illustrated in Figure 3.10. The figure shows how
the number of iterations is chosen: the likelihood-based score typically improves dramati-
cally during the first 500 iterations, therefore about 2000 iterations are set before stopping
the algorithm. The figure also shows the amount of score variability obtained across the 100
runs, in terms of standard deviations from the mean.
Figure 3.10: Likelihood-based mean score plus and minus Standard Deviation (dashed) for 100 runs of the
SA algorithm on Dataset A.
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As in the other experiments, each variable was modelled as a continuous Gaussian distri-
bution. The resulting networks were combined using Bayes Model Averaging, as explained
earlier. The resulting relationships are shown in Figure 3.11.
Figure 3.11: Relationships learned on Dataset A using Simulated Annealing. Lighter arcs represent lower
probabilities (black: P>0.8, grey: 0.6<P<0.8).
By looking at the data-driven structure, several insights can be obtained. Most of the
discovered arcs connect adjacent sectors in relation to the structure-function map. This is
due to the pre-processing of the data and can be seen as a proof of the reliability of the
BN and the implemented learning algorithm. Many arcs involve the inferior part of the
OD, which is confirmed by several studies in which early damage in glaucoma is shown to
occur earlier at the inferior segment of the OD in arcuate sectors of the VF (Yanoff and
Duker, 2003; Johnson et al., 2003), although this hypothesis is not fully accepted (Artes and
Chauhan, 2005). From this set of arcs, a BN was built by avoiding cycles while preserving
conditional dependencies, obtaining the network in Figure 3.12.
The model obtained was then used for classification on Dataset B and compared to
the previous investigated BNs (Figure 3.13). The new data-driven classifier obtained the
highest AUROC among the models (0.853), with consistently higher sensitivities, especially
at high specificity values. High specificities are more of interest for diseases such as glaucoma,
because it is a relatively low frequency disease. This reflects the higher weight put to minimise
the occurrence of false positives (FPs).
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Figure 3.12: BN learned on Dataset A using Simulated Annealing.
Figure 3.13: Comparison of ROC curves for SA derived BN, anatomy-based BN and Na¨ıve BN.
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Another test was also performed to take into consideration the different nature of the two
datasets. Dataset A is a cross sectional dataset, while dataset B is a longitudinal dataset.
Therefore, a test between the models explored was carried out by selecting only one visit
from dataset B to obtain a cross-sectional testing dataset. The sampling was based on the
AGIS score, consistently with the inclusion criteria for dataset A, so that the first positive
visit for each patient was selected for testing. A random visit was sampled from each patient
in the controls group. The training dataset was randomly split into 3 groups. Of these,
2 parts were used to train the model. The process was repeated three times, one for each
combination of training subsets. This procedure was carried out to guarantee a ratio of
training and testing datasets size of roughly 2:1. The results showed that, as in the full
dataset tests, the SA data-driven BN classifier outperformed the other two, which behaved
similarly. Average AUROC was 0.909 for the SA classifier, while the Na¨ıve BN and the
Anatomy-based classifier obtained 0.852 and 0.856 respectively. The ROC curves for each
test are showed in Figure 3.14
Figure 3.14: Test results of ROC curves for SA derived BN, anatomy-based BN and Na¨ıve BN. The
classifiers were tested on a cross-sectional dataset extracted from dataset B and with three different subsets
of dataset A as training datasets.
3.4 Summary
This chapter has introduced the specific datasets used in this research and the basics of
BN models. A small set of simplistic BNs were introduced to demonstrate the usefulness
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of these models in glaucoma. Early investigations on combined functional and anatomical
data have shown that BNs obtain better performances over other ML techniques and classic
metrics. The results of data- and anatomy-driven BNs also suggest that such models are
effective and informative. In particular, the anatomy-based BN seems to perform well at
lower specificities, but it is outperformed by the data-driven BN at higher specificities.
The utility of data integration and the potential of BNs will be further explored in
following chapters, where more advanced models will be presented. The next chapter will
look deeper into BNs for cross-sectional data and will also propose new techniques for tackling
bias associated with metrics and inter-subject variability, while Chapter 5 will present BN
models for application in longitudinal data.
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Chapter 4
Bayesian Networks for
Cross-Sectional Data
Supervised ML classifiers, such as the BNs presented in previous chapters, require a training
dataset to model the relationships between inputs (observed variables) and outputs (outcome
variables, e.g. diagnoses). Such training data needs to be labelled; in the case of diagnoses,
labels would be having a disease or not having a disease. However, in glaucoma, the true
condition is not assessable, since there is no gold standard test for the condition and because
there is no univocal definition of glaucoma. Using a particular metric to label subjects in
the training dataset introduces biases that should be taken into consideration.
The first section of this chapter aims to tackle this issue and explore the impact of
different metrics. Section 4.2 is focused on combining different BNs. In particular, an un-
supervised anatomy-based BN and a data-driven BN supervised on the AGIS metric are
combined using a BN-based ensemble of classifiers, with the purpose of enhancing classifi-
cation performance and better understanding their interaction. Section 4.3 presents a novel
clustering algorithm that aims to tackle inter-subject variability in the data, and at the same
time obtain more insights into glaucoma and the AGIS metric. The last section summarises
the main conclusions of the previous sections and introduces the next chapter.
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4.1 Supervised, Semi-Supervised and Unsupervised BNs
This section explores supervised and unsupervised BNs in conjunction with the metrics
AGIS, MRA and a combination of the two. A semi-supervised approach, which is based
on healthy subjects’ data, is also described and assessed. The last part of the section com-
pares and discusses the results obtained with the different approaches and summarises their
characteristics.
4.1.1 AGIS and MRA based Bayesian Networks
In Datasets A and B, the AGIS functional metric was used to classify patients as having
glaucoma, de facto introducing a bias towards this metric. The parameters of the models
presented in the previous chapter were trained on VF AGIS-labelled data and ignored the
condition of the OD of the subjects. MRA can be used as an OD diagnosis metric for
glaucoma, with a significant negative deviation from the mean in MRA suggesting glaucoma.
By re-labelling patients using this MRA classification metric, a new set of relationships,
SMRA, can be learned (Figure 4.1) using the SA algorithm and Bayesian Model Averaging,
as was performed in the previous chapter for AGIS-labelled training data.
Figure 4.1: Relationships learned using MRA-labelled data. Lighter arcs represent lower probabilities
(black: P>0.8, grey: 0.6<P<0.8).
From this, a BN structure can be extracted and used to make inference (Figure 4.2).
The notation SMRA indicates that the structure (S) of the BN is obtained using MRA-
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labelled data. The notation P indicates the data used to train the parameters of the BN.
For example, a BN described by SMRA,PMRA is a network trained using MRA-labelled data
both for structure and parameters.
Figure 4.2: BN structure learned using MRA-labelled data (SMRA).
The classification performance on the longitudinal dataset (Dataset B) for the BN fully-
trained on MRA-labelled data is lower than the AGIS-based network, as shown in Table
4.1.
Table 4.1: Performance of AGIS and MRA combined BN classifiers. Subscripts S and P indicate the
metrics used for structure learning and parameters training, respectively.
Classifier Sensitivity at Sensitivity at AUROC
90% specificity 80% specificity
SAGIS , PAGIS 0.66 0.80 0.853
SMRA, PMRA 0.59 0.74 0.818
SMRA+AGIS , PMRA+AGIS 0.64 0.78 0.838
This table shows the AUROC values and the sensitivity values at 90% specificity and
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80% specificity for the classifiers. The table also reports the performance of a BN learned
and trained on MRA- or AGIS-labelled data, SMRA+AGIS , PMRA+AGIS , so that a point was
considered positive in the dataset used for its training if either the MRA or AGIS metric was
positive. Different metrics can be combined differently. For instance, the structure SMRA
can be trained using AGIS-labelled data, obtaining SMRA, PAGIS , which can be seen as a
BN that combines the different metrics. The classification performance of the two possible
combinations of structure learning and parameters training are compared in Figure 4.3.
Figure 4.3: Performance of BNs learned using data labelled according to a metric and trained using data
labelled according to another metric.
The classifiers perform differently at different specificities, with frequent crossings be-
tween the ROC curves but overall similar performance.
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4.1.2 Semi-Supervised Bayesian Network
Ideally, it would be best to extract the structure of a BN from the data while being indepen-
dent from a positive MRA or AGIS clinical metric. One solution is to isolate healthy data
and use it to train a classifier. This leads to semi-supervised classification, i.e. using only
labels belonging to a subset of the data. The control group is assumed to be glaucoma-free,
which is likely given the low incidence of the condition and the inclusion criteria applied
for control subjects. Thus, considering these subjects as healthy, it is possible to obtain
higher specificity and make use of all the structural and functional information without the
application of imperfect metrics or subjective clinical interpretation. In the BN framework,
a semi-supervised model can be learned using only control-labelled data and then trained on
labelled control and unlabelled glaucomatous data. In other words, the new label CNewi for
patient i is assumed to be equal to
CNewi =
 COldi if COldi = ControlH if COldi = Glaucomatous (4.1)
where C indicates controls and H is the unobserved value. The set of relationships
obtained using only Control labelled data can be seen in Figure 4.4, followed by the derived
BN SCONTROLS .
Figure 4.4: Relationships learned using only healthy subjects labelled data (SCONTROLS). Lighter arcs
represent lower probabilities (black: P>0.8, grey: 0.6<P<0.8).
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Figure 4.5: BN structure learned using Controls labelled data.
The combination of this structure with the AGIS metric, i.e. SCONTROLS , PAGIS , was
tested on Dataset B, and obtained the best results observed among the classifiers introduced
so far. In particular, it achieved 71% sensitivity at 90% specificity, and 80% sensitivity at
80% specificity, with an AUROC equal to 0.856.
4.1.3 Unsupervised Bayesian Network
As already introduced, the use of unlabelled data is referred to as clustering. In BNs,
unknown labels are treated as missing values and algorithms such as the EM can be used to
estimate the parameters of the model.
Unsupervised BNs performances on Dataset B are reported in Table 4.2. The SCONTROLS ,
PCONTROLS network is indeed a semi-supervised network, as it makes use of the healthy pa-
tients’ labels (Controls) both for the structure (S) and the parameters (P). The performances
of unsupervised models were generally lower than supervised or semi-supervised techniques.
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Table 4.2: Performance of AGIS and MRA unsupervised BN classifiers. The subscript of S and P indicate
the metrics used for structure learning and parameters training, respectively.
Classifier Sensitivity at Sensitivity at AUROC
90% specificity 80% specificity
SCONTROLS , PCONTROLS 0.66 0.80 0.851
SAGIS , PUNSUPERV ISED 0.58 0.78 0.841
SMRA, PUNSUPERV ISED 0.55 0.72 0.818
4.1.4 Discussion
Figure 4.6 shows the three structures obtained with AGIS-, MRA- and Healthy subjects
labelled data. The best performing networks (i.e. AGIS-labelled and semi-supervised net-
works) have similar structures but are different to the MRA-based model, especially with
regards to strengths and across-types relationships. This leads to the conclusion that being
more conservative is more effective in this dataset in terms of classification. In fact, a triple
out-of-range VF test is a conservative metric, whilst MRA at 95% P.I. is more prone to False
Positives. However, from a qualitative point of view, the OD-based network more reliably
captures different characteristics of glaucomatous eyes, as it is guided by OD appearance in-
stead of VF results. For instance, the structure-function relationship may be overlooked by
the SAGIS because of the exclusion criteria of patients with impaired OD. The controls-based
network captures more relationships between sectors compared to the AGIS-based network,
because of the learning process: the presence of a defined class node in the AGIS-based
network ”explains away” the relationships between sectors by selecting the most informative
relationships for classification in the feature selection process.
Parameters appear to play a large role in the learning process. When the controls-based
BN was trained using AGIS-labelled data it obtained the best results observed among all
the classifiers, i.e. 71% and 80% sensitivity at 90% and 80% specificity, respectively, and
an AUROC of 0.856. The results obtained with the combined networks, SAGIS , PMRA and
SMRA, PAGIS , also highlight the impact of the metric chosen; however, when compared with
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Figure 4.6: BN structures learned using SA approach. Lighter arcs represent lower probabilities (black:
P>0.8, grey: 0.6<P<0.8).
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the other networks, their performance was worse at higher specificities. The full unsupervised
models performed least well, and the semi-supervised model performed best.
There are several possible reasons for these results. Firstly, the EM algorithm needs
sufficient data to compute the probabilities iteratively. Another plausible reason is that the
SMRA and SAGIS structures are learnt on a supervised dataset, introducing a bias that can
lead to poor results if combined with unlabelled data for training. The use of metrics in the
inclusion criteria should also be considered while looking at the performances of the models.
In fact, glaucoma patients in Dataset A were defined on the basis of the AGIS score and for
Dataset B the conversion was also based on three positive AGIS scores. Even if the effect
of AGIS on the testing dataset was minimised by considering a series of visits as positive
from the first visit, it may be argued that the subjects in this group are more likely to show
AGIS score-related defects, and therefore be captured earlier by methods trained on the
same metric. The results presented in this section suggest that further investigations in how
to combine different metrics could lead to better performing classifiers.
To further compare the models introduced, performances are assessed at 90% specificity
in Table 4.3. Errors are broken down into pre- and post- glaucoma diagnosis, where the cut-
off was the AGIS-based diagnosis of glaucoma, after which medication was given in many
cases.
Table 4.3: Errors of BN classifiers at 90% specificity. The subscripts of S and P indicate the metrics used
for structure learning and parameters training, respectively.
Classifier Total Pre-Diagnosis Post-Diagnosis
SCONTROLS , PAGIS 133 102 31
SAGIS , PAGIS 157 113 44
SAGIS+MRA, PAGIS+MRA 170 119 51
SMRA, PAGIS 176 124 52
SAGIS , PMRA 183 126 57
SMRA, PMRA 191 126 65
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At 90% specificity, it is clear that using the semi-supervised structure leads to fewer
errors in the post-treatment data, especially when combined with AGIS-labelled data. This
is an unsurprising result, because all the networks are learned and trained on glaucomatous
cases and so the controls-based network is the only one with an unbiased structure. This
leads to more precision in discriminating healthy and non-healthy subjects, as the learning
process is not biased by any imperfect metric.
Note that each variable in the BNs so far has been modelled with a continuous Gaus-
sian distribution, but mixtures of Gaussians (MoGs) can also be used. MoGs, introduced in
Chapter 2, can be easily implemented in BNs by linking a discrete node of size K to a contin-
uous node. Given that a continuous Gaussian distribution is defined by two parameters, the
resulting mixture of Gaussians will have size 2K. These parameters need to be estimated,
for instance using the EM algorithm, in a process that is not guaranteed to reach global
optima. Therefore, performance improvement and ease of convergence should be taken into
consideration when deciding which model to use to describe the data locally. For Dataset B,
similar results are obtained with MoG distributions (Ceccon et al., 2010b).
4.2 Ensembles of Bayesian Networks
As shown in the previous chapter, data-driven networks appear to be better at excluding
negative patients than anatomy-based BNs, whilst the latter seem to produce higher sensi-
tivities at low specificities. This highlights the need of a classifier which is able to integrate
different datasets follows the indication from consolidated knowledge in the field, as described
in Chapter 2 and in the previous chapter. Among the available techniques, the ensembles of
classifiers, and in particular the stacked ensembles, seems to fit the problem. Their ability to
exploit the single classifiers outputs through a BN framework allows to retain the convenient
characteristics and performances of BN base models and combine them selectively to build
a single output. Therefore, this combining method was chosen. Non-generative ensemble
methods try to combine existing base classifiers, without acting on the base classifiers struc-
ture. There is a broad literature on ensembles of classifiers (Kittler, 1998; Sharkey, 1996), and
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given the input available (i.e. probabilistic outputs from base BNs), a non-generative stacked
structure ensemble is chosen (Duin and Tax, 2000). Stacked ensembles use Machine Learning
techniques on the top of the base learners, using their output as a set of input data for the
final combiner. This type of model has been shown to be an effective combiner in (Garg et al.,
2002), especially if the individual classifiers disagree with each other (Hansen and Salamon,
1990). In particular, since the aim here was not just to increase the performance, but also
to understand how data and anatomy-driven networks interact, a Combining BN model was
chosen. This model combines the outputs of two BNs in one node, as shown in Figure 4.7. In
order to use different classifiers, we selected the data-driven BN (SCONTROLS , PAGIS) and
the anatomy-driven unsupervised BN (SANATOMY , PUNSUPERV ISED).
Figure 4.7: Ensemble Bayesian Network.
Each base classifier output was discretised into 8 states and then linked to a 2-states class
node. The discretisation was performed using an equal frequency approach in order to make
the examination of the CPT of the class node easy to assess. In fact, the CPT results in a
8x8 matrix showing the interactions between the two networks. As will be further discussed
later in this section, the CPT is also optimised with a smoothing filter window of size 3. The
procedure is presented in Algorithm 4.1.
Where OutputBN1 and OutputBN2 represent the two base classifiers’ outputs and Out-
put CPD is the Conditional Probability Distribution of the node associated with the final
output. The Output CPD can be easily extracted after training the BN Model, and used
to replace the non-smoothed CPD in the Update operation. An optimised BN was also set
up by weighting its output on the accuracy of the base classifiers on the training dataset.
The probabilistic outputs are, in this way, biased towards the output provided by the most
76
BNs for Cross-Sectional Data Ensembles of Bayesian Networks
Algorithm 4.1 BN-based Combining Algorithm.
Input: Data, OutputBN1, OutputBN2
Discretise OutputBN1 and OutputBN2
Build and Train Model
Smooth Output_CPD
Update Model
Output: Model
accurate base classifier. Algorithm 4.2 was thus applied to the final output of the combining
BN.
Algorithm 4.2 Accuracy Weighted Algorithm.
Input: Data, OutputBN1, OutputBN2, AccuracyBN1, AccuracyBN2
Align accuracyBN1 and accuracyBN2
Weighted_output = (outputBN1 · accuracyBN1 + outputBN2 · accuracyBN2) /
/ (accuracyBN1 + accuracyBN2)
Final_output = (output + Weighted_output) / 2
Output: Final_output
Where the prefix Output is the output of the raw combining BN and the suffixes BN1 and
BN2 represent the two base classifiers’ outputs and accuracies. For example, OutputBN1
represents the raw output of the first network BN1. The align function aligns the base clas-
sifiers accuracies using the threshold values, in order to weight each base classifier’s output on
the corresponding accuracy for each threshold value on the testing dataset. Weighted output
is the new output weighted on the accuracies of the base classiifers, while Final output is
the final output of the classifier. For validation purposes, a combination of the outputs was
also performed using a weighted voting approach (Woods et al., 1996). The weights were
adjusted in relation to the accuracy of the base networks.
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4.2.1 Experimental Results
Results were evaluated using 3-fold CV on Dataset A and 6-fold cross validation (CV) on
Dataset B. K-fold CV randomly splits the data into K groups. Of these, K−1 parts are used
to train the model and the remaining part is used to test model performance. The results
from each K testing set are then arranged together to calculate the overall performance of
the classifier. Different folds for the two datasets reflect the different sizes of the datasets, so
that a consistent amount of data points was guaranteed to be tested at each iteration. The
performances of the single and the Combining Networks are shown in Table 4.4 and Figures
4.8 - 4.9. The specificity cut-off of 90% was chosen for consistency with other tests and in
relation to glaucoma clinical management. False positives in glaucoma lead to overtreatment
and cost in clinical management, so methods with high false positive rates, over 15%, are
generally considered as not clinically useful.
Table 4.4: Performances of base and combined BNs in terms of mean AUROC and total errors at maximum
accuracy and at 90% specificity.
Dataset A Dataset B
AUROC Errors Errors at AUROC Errors Errors at
90% spec 90% spec
Semi-Supervised BN 0.98 6 13 0.87 84 206
Anatomy-Driven BN 0.98 7 13 0.75 110 326
Weighted Vote Combined 0.98 5 13 0.84 90 252
BN-based Combined 0.98 8 12 0.87 93 186
Accuracy Weighted BN 0.98 5 12 0.85 93 118
Considering the overall performances on Datasets A and B, the semi-supervised data-
driven BN performs better than the anatomy-driven BN, and is at least comparable to
the combined ones. On Dataset A, however, the performances of all the classifiers are
comparable. Among the combined classifiers, the Weighted Vote is outperformed only at
high specificities, but in Dataset B it is outperformed by both the other combined networks.
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The BN combined networks perform well in both datasets, and were the best classifiers at
high specificities.
Figure 4.8: ROC curves of base and combined classifiers tested with 6-fold CV test on Dataset B.
Looking at the ROC curves in a particular test on Dataset B (Figure 4.8) it can be seen
that the performances of the base semi-supervised data-driven BN are highest at mid-range
specificities. However, at higher specificities, the BN combined networks are comparable or
outperform it, as shown in Table 4.4. On Dataset A, the performance of the two base BNs
are more similar and often the anatomy-driven BN outperforms the others (Figure 4.9). The
Weighted Vote classifier performs better at low specificities, as pointed out considering the
total errors.
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Figure 4.9: ROC curves of base and combined classifiers tested with 3-fold CV test on Dataset A.
4.2.2 Discussion
The semi-supervised network based on controls and AGIS is clearly performing very well at
all specificities, confirming that using the conservative nature of AGIS metric score and the
idea of modelling healthy subjects is effective for classification in glaucoma. However, the bias
introduced by using the AGIS score in the inclusion criteria and its unreliability must be kept
in mind. On the other hand, as already seen in independent dataset testing, the anatomy-
driven network does not perform very well. However, the different results obtained with this
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model suggest that improvements in performance can be obtained by using as a base classifier
in combination with others. In fact, diversity and accuracy of base classifiers are key factors
for obtaining better performing ensembles of classifiers. Diversity was obtained by using
an unsupervised approach on the anatomy-based network. This consequently decreased the
performance of the base classifier but increased performance for the combined one, especially
at higher specificities. The performance of the accuracy Weighted Vote classifier decreased,
in relative terms, when the specificity increased. This is also the case in the BN combining
network weighted on the accuracy, as expected. Nevertheless, the simple BN combining
classifier is not biased towards high accuracy and this allows it to outperform all the other
classifiers at high specificities. In fact, looking at the ROC curves it can be seen that, with an
increase of accuracy of the anatomy-based network, there is a decrease in performance of the
accuracy weighted ones; in this particular case this is due to the anatomy-driven network that
does not outperform the other models at any specificity. However, on Dataset A, the opposite
was observed (Figure 4.9), i.e. the BN Accuracy-Weighted classifier outperformed the non-
weighted one. The higher number of total errors observed in Dataset A may be explained
by the differences between this dataset and Dataset B: in Dataset A the diversity between
the results of the base classifiers is lower than in Dataset B, leading to worse combined
performance. This highlights the importance of choosing the most efficient base classifiers,
and further studies on generative ensembles of classifiers (i.e. active learning of base classifiers
to improve diversity and accuracy of base classifiers) (Jacobs et al., 1991) is required. It must
also be pointed out that the structures of the base classifiers were learned and trained on
Dataset A, introducing a bias with respect to the performance. It is worth reiterating that
the AGIS score was used in the inclusion criteria for both datasets, making it difficult to
compare performances of classifiers supervised on AGIS itself or unsupervised. The difference
in performances obtained with the two base classifiers and the two datasets highlights the
potential of combining data. The data of interest is very ”noisy” due to the absence of a gold
standard and the high variability of the measurements, therefore a generalised algorithm that
accords itself to the best performing network independently from the given data is desirable.
This was not possible using accuracy weight, as the training dataset and the testing dataset
81
BNs for Cross-Sectional Data Ensembles of Bayesian Networks
were different in nature: when using Dataset A to train an accuracy-based network and
Dataset B to test it, results will be biased by the different accuracies for the same networks
in each dataset. A solution would be to use an independent dataset of the same type
(cross- sectional or longitudinal) for training and testing; using cross-sectional data to build
models designed for longitudinal data is not advisable for glaucoma (Artes and Chauhan,
2005). Further, a broader search on both datasets for a network that shows more accurate
and diverse performances than the other could lead in this case to better results for both
datasets.
Figure 4.10: Instance of a raw CPD of the class node. Each value represents the probability of positive
output for each combination of base classifiers inputs (i.e. the final output of the combining network).
An interesting advantage offered by the BN combining classifiers is the possibility to
observe the CPD for the class node. This gives interesting insights about how the network
works and how the two outputs combine to obtain better results. In Figure 4.10 an instance
of a CPD is shown; for each combination of discretised outputs of the base classifiers, a prob-
ability is reported in the table. This reflects the output of the final classifier; in particular, it
is the probability of diagnosis of glaucoma for each combination of inputs. For example, the
probability of observing an output of 7 and 4 for the anatomy-based BN and the data-driven
BN, respectively, is 0.73. Note that an output of 7 corresponds to a very high probability of
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glaucoma for the base classifiers, as the outputs were discretised in 8 states. Some 0 values
are obtained in the corners of the matrix, due to the lack of data for these combinations of
outputs: these cells are smoothed with the mean-filter application. By observing the prob-
ability values in relation to their position, it can be noted that if any of the base classifiers
observe a low probability of glaucoma then the combined output will be low. Also, if any
of the two observe a high probability, the output is likely to be high. However, the higher
values in the matrix are skewed towards the bottom-left, so that the AGIS semi-supervised
network is more reliable at high specificities. Looking at lower values of the semi-supervised
network (e.g. value 3), the output of the anatomy network increases the probability of glau-
coma sensibly, adding its knowledge to the result. Several different instances of this matrix
have been found in this study, again indicating high variability between different datasets
used. Thus, exploration of the CPD of the combined network confirms higher performances
of semi-supervised networks at high specificities, and it also gives a quantitative measure of
the improvement that each single base classifier brings to the final output.
4.3 Clustering Bayesian Networks
Clustering is another technique that can be used to improve the performance of BNs and
gain insights into data. When performed with BNs, it represents a model-based clustering
technique that inherits all the qualities of BNs, including efficient computations, high perfor-
mances in classification, the intrinsic ability to deal with noisy data and the clear graphical
representation of the model. In this section, pointwise functional data from Datasets A and
B were used, i.e. 52-point VF raw sensitivity values (i.e. not age-corrected) obtained with
the HFA II.
In glaucoma, the standard approach is to perform clustering on glaucomatous subjects
only or to discard class information and perform clustering on the whole dataset (Goldbaum
et al., 2002). However, clustering only on glaucoma patients is not useful for classification
because it does not take into account healthy subjects. On the other hand, clustering on the
whole dataset may result in discovering the artificial differences between healthy and glauco-
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matous subjects, reflecting the inclusion criteria for the dataset. Our approach, instead, aims
to gain performance and insights by applying clustering and classification simultaneously. In
BNs this can be obtained by including an unobserved variable in the model that is related
to the classification variable. Figure 4.11 shows the network used for this task. A class node
(C) is linked to all variables, which are in turn dependent on the clustering node (i.e. H
hidden variable).
Figure 4.11: Clustering Naive Bayes Network. Squares represent Class (C) and Hidden (H) nodes, while
ellipses represent VF sensitivity nodes (V).
Considering the dependencies between the variables in the model, the clustering and the
class nodes are marginally independent. However, it can be demonstrated that they are
conditionally dependent on the observed variables V (Wellman and Henrion, 1993). This
effect has been described in Chapter 3 where one or more variables (i.e. parents) converge
to an observed one (i.e. child). Given the observed child, observing the value of one parent
will act on the parameters of the other parents. Intuitively, it can be explained by the fact
that the parents are competing to explain the observed value. In other words, knowing that
a variable belongs to a cluster acts on the probabilistic output for the classification node.
In the same way, knowing the class value of the data changes the clustering as well. Since,
in the training dataset, the class node represents the AGIS-dependent glaucoma label, the
variance associated with the AGIS label is explained away by the class node. The clustering
uses the remaining variance to separate the data without regards to the AGIS score, which
in turn has an impact when the classification is performed on new data. The rationale here
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is based on the fact that there might be other factors, either shared, or not, by healthy
and glaucomatous subjects, competing to explain the observed values. The hidden variable
describes these factors and uses them to perform a better classification. For example, there
may be particular VF patterns that are shared by certain people which are particularly
helpful to indicate glaucoma in that group. Capturing and using this difference to calculate
the classification probabilistic output could lead to better classification performance. To
summarise, this model is able to characterise the different clusters of people who share
patterns and relationships not directly dependent on the scoring metric in use, while at the
same time exploiting this information in the classification process. Moreover, it is possible to
quantify the added utility by building a ”confidence” index for each of the clusters of data,
which can be directly used in clinical practice.
4.3.1 Clustering Simulated Annealing
Regarding the structure learning process, the Structural Expectation-Maximization (SEM)
algorithm can be used. This extends the Expectation-Maximization (EM) algorithm to
structure searching, as introduced in Chapter 3. The algorithm iterates over two steps:
in the first step, the model that maximises the score with the present instantiation of the
parameters is chosen, while in the second step the parameters that maximise the score with
the present model are selected. In analogy with the EM algorithm, SEM uses the expected
values for the unobserved parameters while performing the model search. This allows one
to learn a set of relationships, and the parameters of the model, without using any clinical
metric. SEM is one of the most commonly used techniques to deal with missing data and
structure learning for BNs, although it is not the only method that can be used. This
section introduces a technique which performs clustering and structure learning using a SA
framework (CSA). As already shown, SA has been shown to perform particularly well with
BNs. The differences of CSA with respect to SEM lie in the single-stepwise nature of the SA
algorithm and in its convergence qualities. In particular, the unobserved data are treated as
observed, starting with a random grouping of the data. At each further iteration, the cluster
of one randomly picked patient is changed, until convergence is found. It should be noted
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that the EM step is skipped in favour of a traditional scoring of the present complete data.
This leads to a faster model evaluation, although more iterations are needed to stabilise
the groups of patients. While the application of such a technique to BN-based clustering is
novel, to our knowledge, the rationale has been investigated in (Selim and Alsultan, 1991)
and it has been shown that clustering benefits from the annealing algorithm, obtaining many
advantages with respect to other methods, e.g. to K-means clustering. The pseudocode of
the algorithm is described in Algorithm 4.3. Where the input parameters Temperature,
Cooling Factor and Max Iterations regulate the convergence of the algorithm, Model is the
starting model and Data is the training dataset in use. Best Score is used to store the current
best model score, while Score and New Score hold respectively the score of the current and
the model explored at each iteration. The latter is evaluated after either an operation on the
model structure (adding an arc, deleting an arc and moving an arc) or a random reassignment
of a data point to a cluster. Only arcs between leaf nodes are permitted when peforming
operations. The probability of carrying out one operation or the other is regulated by the
Selection Factor. Note that Random Number represents a random number between 0 and
1. If the new score is higher than the current score, the parameters of the current model
and the current score are updated. If the new solution is the best among the explored
ones, the results are also stored in Best Score and for final output. If the new solution is
worse than the current one, a temperature factor Temperature regulates whether to accept
it as a new current solution. The temperature factor is lowered at each iteration through
a cooling factor Cooling Factor. After a number of iteration Max Iterations, the algorithm
returns the best explored network and clusters configuration. Typical parameters used in
the experiments were 15000 Max Iterations, a starting temperature of 15, a cooling factor of
0.99 and Selection Factor equal to 0.15.
4.3.2 Experimental Results
The ROC curves of the clustering BNs implemented are presented in Figure 4.12. As sug-
gested by (McNeil and Hanley, 1984), in cases where ROC curves cross, global AUROC
comparisons may not be indicative. The partial AUROC values can instead be considered
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Algorithm 4.3 Clustering Simulated Annealing.
Input: Temperature, Selection_Factor, Cooling_Factor, Model, Data, Max_Iterations
Score Model and store in Best_Score
Loop on iterations until Max_Iterations is reached
if (Random_Number is lower than Selection_Factor)
Apply OPERATION to Model
else
Apply CLUSTER to Data
end if
Score Model and store in New_Score
Diff_Score is New_Score - Score
if (New_Score is higher than Score)
Update Score, Data and Model
if (New_Score is higher than Best_Score)
Store Model and Data for Output
Best_Score is New_Score
end if
elseif Random_Number is less than exp(Diff_Score / Temperature)
Update Score, Data and Model
end if
Temperature is Temperature · Cooling Factor
end Loop
Output: Model, Data
by using the more clinically meaningful part of the ROC curve (McClish, 1989). Table 4.5
presents the partial AUROC values for specificities above 80%. The table shows a consistent
improvement in performances at high specificities with the inclusion of the clustering process
and structural learning when compared to the Naive Bayes classifier. Even if no significant
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difference was found over the entire ROC curve, the left part of Figure 4.12 seems to confirm
the higher
Figure 4.12: ROC curves for clustering BNs on pre-, post- and full testing dataset. The models included are
Clustering Naive Bayes (CNB), Structural Expectation-Maximization (SEM), Naive Bayes (NB) and
Clustering Structural Annealing (CSA). Pre- and post- diagnosis curves (thin lines) are above and below the
correspondent overall performance curves (thick lines), respectively.
performances at high specificities of CSA, SEM, and CNB over NB. Among all, the best
classifiers are SEM and CSA, which perform similarly to each other.
Regarding the structures learned using SEM and CSA, the respective results are shown
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Table 4.5: Normalised partial AUROC Curve for Specificity > 80% for Bayesian classifiers. The models
included are Clustering Naive Bayes (CNB), Structural Expectation-Maximization (SEM), Naive Bayes and
Clustering Structural Annealing (CSA).
Classifier Overall Pre-Diagnosis Post-Diagnosis
Naive Bayes 0.53 0.39 0.66
CNB 0.57 0.43 0.72
SEM 0.56 0.44 0.67
CSA 0.59 0.45 0.74
in Figure 4.13. The networks present several similarities, such as dense first order (adjacent
location) spatial relationships and fewer distant relationships. However, CSA obtained a
sparser network structure with arcuate, or partial arcuate, patterns in the central and pe-
ripheral VF, with a similar distribution to the known anatomical distribution of the retinal
nerve fibre layer.
Figure 4.13: Structure learned with CSA (left) and SEM (right) superimposed to the VF map. Different
colours help to highlight different spatial order relationships (red: < 2, blue: < 5, black: ≥ 5).
4.3.3 Clusters Analysis
The number of clusters in the analysis was chosen arbitrarily after a discussion with clinicians.
Higher number of clusters may give more insightful results, although the lower number of
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elements in each cluster may affect the robustness of the results. To quantitatively measure
the quality of the clusters, the silhouette mean index is used. This measure was first proposed
by (Rousseeuw, 1987), and is based on the comparison of clusters tightness and separation.
The mean silhouette index is obtained by averaging over the silhouette index of each element
i, which is calculated as follows:
s(i) =
b(i)− a(i)
max(a(i), b(i))
(4.2)
In the above formula, a(i) is the dissimilarity between the element i and the elements
in the same clusters and b(i) is the dissimilarity from the elements in the other clusters. A
silhouette mean value is close to 1 when elements are appropriately clustered and close to −1
when they are assigned to the less appropriate clusters. The difference between sensitivity
values is used to measure dissimilarity between elements, and results for the assessed classi-
fiers can be found in Appendix A (Table A.4). The table is not reported because silhouette
values were moderate and similar for all BN models, but higher for the K-Means clustering.
This result reflects the fact that since the silhouette score measures the distance between
clusters, a technique that only separates healthy subjects from glaucomatous subjects would
be expected to obtain a higher value. Therefore, the K-Means clustering performed similarly
to a simple discrimination task, being unable to separate the data into groups based on
variance other than that carried by the inclusion criteria used in the data collection, i.e. the
AGIS metric.
The similarity between different clustering techniques was assessed using the Cohens
Kappa index (Carletta, 1996). This index can be used to measure the agreement between
two clustering techniques using the following formula:
Kappa =
P (a)− P (e)
1− P (e) (4.3)
Where P (a) is the observed agreement between two techniques (i.e. elements assigned
to the same cluster) and P (e) is the probability of chance agreement. Kappa value is 1 if
there is complete agreement and 0 if there is no agreement. It must be noted that such a
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measure does not take into account the qualitative similarity between the clusters obtained.
The Kappa values for the investigated models are reported in Table 4.6.
Table 4.6: K-Values for Bayesian classifiers. The models included are Clustering Naive Bayes (CNB),
Structural Expectation-Maximization (SEM) and Clustering Structural Annealing (CSA).
CNB SEM CSA
CNB - 0.29 0.30
SEM - - 0.34
CSA - - -
The clusters obtained with different BN clustering techniques are rather similar, showing
good robustness in the data. This is reflected in a fairly high kappa value and in a relatively
smooth distribution of the data across clusters, as will be shown later. K-Means clustering
obtained qualitatively different clusters, therefore it was not included in Table 4.6.
A qualitative representation of the clusters obtained with CSA is shown in Figure 4.14.
The upper section shows the VF maps learnt for each cluster. These were obtained by
sampling from the conditional distribution p(X|Ci), where Ci is the observed cluster label
(i = 1..4) and X is a vector of variables representing each point in the VF map. In the lower
section, the distribution of glaucomatous and healthy subjects over clusters in the training
dataset is shown for each technique. The clusters are aligned to maximise the Kappa value
of SEM, CNB and K-Means with respect to the clusters obtained with the CSA technique.
While relatively uniform distributions were obtained using BN clustering techniques, K-
Means obtained sparse clusters effectively separating glaucomatous and healthy subjects.
Figure 4.15 shows the results of the CSA algorithm on the testing dataset. The VF maps
for each cluster are shown on the left side of the figure. Each point value in the VF map
was obtained by averaging over the tested patients assigned to each cluster by the algorithm,
separately for glaucomatous and healthy subjects. Age distributions are also included in
the graphic, together with histograms above VF maps that converted, showing the age
distribution for patients in that group. The red vertical lines in the histograms are the
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Figure 4.14: Models obtained from the training dataset. Above: Clusters obtained with CSA. Below:
Distribution of data points for each cluster obtained with Clustering Naive Bayes (CNB), Structural
Expectation- Maximization (SEM), K-Means (K-M) and Clustering Structural Annealing (CSA). For each
histogram, left bar (blue) represents the number of healthy data points and right bar (red) represents the
number of glaucomatous data points in a given cluster.
AGIS classifications, so that it is possible to compare the ability of CSA to capture late or
early glaucoma with respect to this metric. For example, distributions skewed to the right
indicate presence of late glaucoma in the cluster, which were mostly correctly captured by
the AGIS metric. The right section of the figure shows the number of VFs assigned to each
cluster, separately for healthy subjects, pre-diagnosis and post-diagnosis. Cluster 1, on which
the highest discrimination power was found, shows a strong difference in sensitivity in VF
hemifields (i.e. the difference in VF sensitivity between the upper and lower half of the VF).
This is a characteristic pattern of glaucoma, and it is the rationale behind the Glaucoma
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Figure 4.15: Results of CSA algorithm on the testing dataset. The four clusters are presented in four rows.
The left section of the figure shows the VF maps for each cluster for Glaucomatous (red) and Healthy
subjects (blue). The x-axis in the graph is the mean age for each group. The deviation from the mean age is
also reported with whiskers for each VF map. Above each glaucomatous VF map, a histogram showing the
distribution of the data points relative to the AGIS diagnosis is shown. The diagnosis is represented with a
vertical red line in the centre of the histogram. The right section of the figure shows the number of data
points assigned to each cluster for healthy subjects (Controls), pre-diagnosis (Pre) and post-diagnosis (Post).
Hemifield Test (Asman and Heijl, 1992), currently implemented in several VF screening
machines. Cluster 4, which also performed well in classification, presents a nasal defect
pattern, which is often described in literature as an early indicator of glaucoma (Drance, 1969;
Spry and Johnson, 2002). Cluster 3 shows general functional impairment in the peripheral
VF, which is another early sign of glaucoma development. Cluster 2 performed rather poorly
as a discriminator between converters and healthy subjects, and included healthy subjects
with ”bad” (unreliable) VF tests and glaucomatous patients with a non-uniform pattern of
depressed points.
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4.3.4 Discussion
By considering the clusters presented in Figures 4.14 and 4.15, several insights into glaucoma
can be obtained that are of interest for clinical practice. The best discriminating cluster
(Cluster 1) shows the greatest age difference between healthy and glaucomatous subjects,
as well as the largest proportion of cases in the post-diagnosis group. This indicates that
a strong hemifield difference is typical of later stages of glaucoma, and when occurring at
a younger age likely indicates glaucoma. The higher proportion of post-diagnosis patients
in a cluster means that the AGIS score is able to capture these cases too. This is also
reflected in a right- skewed histogram above the VF map in Figure 4.15. The second best
performing cluster (Cluster 4) characterises an early nasal defect, and it is also placed on
the left side of the figure, meaning that if this pattern is observed in younger subjects also
suggests glaucoma. In this case, AGIS seems to perform less well than the proposed model,
with a high proportion of pre-diagnosis patients falling in this group. This may be due to the
inclusion criteria (conversion defined as three successive positive AGIS scores) but also due to
the nature of AGIS scoring. The AGIS score reflects the pointwise VF sensitivity deviation
relatively to age-corrected healthy individuals and labels points showing a depression below a
certain threshold. For example, in the nasal area, the threshold is an 8 dB loss. The threshold
criterion and the reference model may contribute to the overlooked cases, i.e. false negatives,
obtained by AGIS classification of cases in Cluster 4. Our technique, instead, uses absolute
pointwise values with different parameterisation for each cluster and was able to capture the
defect earlier. Cluster 3 obtained acceptable classification performance, modelling mainly
post-diagnosis glaucoma developing peripheral VF glaucomatous damage at an older age.
Cluster 2, instead, is difficult to characterise because of the small number of cases allocated
and because of its inhomogeneous appearance, which is probably due to unreliable VF tests.
In comparison to SEM, CSA obtained a sparser and ”cleaner” structure. This is probably
due to the broader search space that the algorithm explores in comparison with SEM. The
CSA network structure learned on the training data shows strong agreement with typical
progression paths in the VF and stronger similarity to the distribution of the RNFL. Similar
dependencies were found in (Gardiner et al., 2004), in which a VF filter was found to be in
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accordance with the accepted physiological shape of the RNFL. In (Strouthidis et al., 2006),
higher correlations between VF and ONH measures were found in peripheral VF areas, which
is confirmed by the higher density of the CSA structure on corresponding sectors.
4.4 Summary
This chapter explored the impact of metrics on BNs and combinations of BN models to
improve classification performance and gain new insights. With regards to metric bias and
data integration, the positive impact of combinations of anatomy and traditional metrics
was measured, showing that even if the use of classic metrics alone is not sufficiently pre-
cise in early glaucoma classification, BNs built using both metrics obtain good results. In
particular, if combined with semi-supervised unbiased structures, the AGIS score performed
the best for high specificities. If combined with MRA, it obtained among the best results
at lower specificities. A new combining algorithm, using a BN-based ensemble of classifiers,
demonstrated that the performance of the combined classifier is better where results for the
base classifiers are different. It was also possible to investigate the nature of anatomy and
data-driven interactions, obtaining interesting insights and some performance improvements.
Further investigations into glaucoma mechanisms and variability of VF data were carried out
using clustering approaches, and in particular a novel clustering technique. This allowed us
to understand inter- and intra-subject variability, and the impact of metrics on diagnosis.
Several patterns of relationhips between the variables were found to be supported by previous
clinical research, while others represent new interesting insights for clinicians.
The incorporation of time-dependent relationships in the model represents the next nat-
ural step to explore glaucoma classification and understand its progression. To this aim, the
next chapter will propose several BN-based models that deal with longitudinal datasets.
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Chapter 5
Bayesian Networks for Longitudinal
Data
The BN models presented in the previous chapters explicitly take into account relationships
between variables but not changes in the variables over time. In other words, time-dependent
relationships are not modelled, even though progression is a key aspect of glaucomatous dis-
ease. We have already seen that functional and structural measurements are related in
glaucoma, as indicated by the cross-sectional BNs constructed and discussed so far. Fur-
thermore, evidence in clinical literature shows that the RNFL deteriorates simultaneously
as the VF is impaired with the progression of the disease. In this context, assessing how
relationships between variables in BNs change over time is of great interest for understanding
glaucoma progression.
This chapter presents three BN models for longitudinal datasets, with the purpose of im-
proving classification performance and exploring the mechanisms of glaucoma progression. In
Section 5.1, the widely used Dynamic Bayesian Network model is presented. The limitations
of this model in glaucoma are discussed and addressed using novel techniques proposed in
Section 5.2, called the Dynamic Stages Bayesian Network. This BN model allows key stages
to be extracted from the data and exploited for classification. Section 5.3 presents a novel
BN for longitudinal data, called the Non-Stationary Clustering Bayesian Network, which
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allows clustering of temporal processes. Finally, Section 5.4 discusses the overall conclusions
from this chapter.
5.1 Dynamic Bayesian Networks
To model time-dependent relationships in the BN framework, an extension called Dynamic
BNs (DBNs) (Dean and Kanazawa, 1989) was presented in Chapter 2. Intuitively, DBNs are
BNs in which directed arcs flow forward in time. Nodes are used to represent variables at
different time points; therefore arcs can occur at the same time point and between different
time points. In DBNs, learning and inference methods are very similar to those described
for BNs (Dagum et al., 1992). A simple univariate example is shown in Figure 5.1.
Figure 5.1: Simple Dynamic Bayesian Network.
Red arcs in the figure flow from left to right through the chain, i.e. from t = 1, .., N .
The model does not represent dependencies between variables over more than one step so it
is called a first-order Markov Process. In these models, each variable is directly influenced
only by the last variable, i.e. P (Y1, Y2, .., YN ) = P (Y1)P (Y 2 | Y1)...P (YN | YN−1). In the BN
framework, once the CPD of the nodes in the first two time points and the relationships within
and between them are defined, the model is fully parameterised and it can be replicated
for the remaining time points. An extension of these models is to make the observations
dependent on a hidden variable, called state (H) so that the sequence of states is a Markov
Process. This defines the so-called State Space Models (SSMs), shown in Figure 5.2. If the
state variable assumes a set of discrete values, the model is called a Hidden Markov Model
(HMM). HMMs were introduced in Chapter 2 and are one of the most commonly used
DBNs. In general, DBNs represent a general framework that include several configurations
of variables with continuous and discrete distributions, such as Factorial HMM, Kalmann
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Figure 5.2: State Space Model.
Filters, and many other widely used models.
Although DBNs can capture the time-dependent nature of relationships in the data,
they are models for stationary processes, therefore parameters and relationships between
variables are not allowed to change over time. Once the relationships are set for two time
points, the model is replicated over time. In many medical contexts, however, dependency
between variables can change over time. The results reported in the previous chapters have
shown that relationships between variables in glaucoma vary at different disease severities,
suggesting that an approach based on stages of disease is necessary.
5.2 Dynamic Stages Bayesian Networks
This section presents a novel BN model, called a Dynamic Stages Bayesian Network (DSBN)
that can extract the key stages of glaucoma progression, and can be generalised to any
temporal process. In the DSBN, time points are aligned and the pattern is extracted. For
diseases such as glaucoma, where there is high variability in terms of rate and onset of
progression, the idea of stretching and shrinking the time dimension of the individual time
series to align them and identify common stages of disease may be useful for classification
and gaining insights about the temporal process of progression.
It must be noted that the term time series typically refers to sets of data samples collected
in time spaced at uniform time intervals (Chatfield, 1996; Brillinger, 1981). Instead, real-
world glaucoma observations are irregularly sampled, being therefore irregular time series.
For the remaining Chapters, however, the term irregular was dropped for simplicity and time
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series was used to refer also to series of samples collected at not-uniform time intervals.
5.2.1 Stages of Disease
In the DSBN, a stage represents a phase in the disease progression defined by a particular set
of values of the variables observed. For example, a healthy VF may be considered the first
stage of glaucoma, while a deep depression in the sensitivity of all sectors of the VF may be
considered the last stage. In between the two extremes, VF disease stages are characterised
by patterns and relationships between variables, such as early superior hemifield defects or
general mild depression. In the DSBN, the stages are obtained from the data. Sequences of
stages can also be considered, for instance by identifying common sets of consecutive stages.
Sequences of stages are independent of time, but have only one direction of flow. The
sequences of stages are also referred to as temporal patterns, which are not to be confused
with spatial patterns in VF tests. A model that is able to extract and identify patients’ sets
of stages across time would address the issue of speed of glaucomatous progression. The
irregular sampling of the data, the bias and noise in the data are also tackled in the DSBN
by selecting certain data points in the learning process.
Modelling the stages of glaucoma in a BN framework can be obtained by explicitly
assigning each stage to a variable in a static BN model. The idea is to link a set of stage-
nodes to a classification node, as shown in Figure 5.3. The number of leaf nodes is arbitrarily
chosen.
Figure 5.3: Dynamic Stages Bayesian Network.
Intuitively, each time series contributes to the model with a number of data points equal
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to the number of leaf nodes, so that for a dataset of K time series and a model with N leaf
nodes, the size of the training data used is KxN . Time series with less time points than leaf
nodes will be excluded from the process. N data points are sampled from each series so that
only the most informative data points are used.
5.2.2 Learning Dynamic Stages Bayesian Networks
For a model with N leaf nodes, the pseudocode for the learning algorithm is reported in
Algorithm 5.1. This is based upon the SA search described in Chapter 3 (Algorithm 3.1), so
that several variables correspond to those described previously. In particular, Temperature,
Cooling Factor and Max Iterations are parameters that regulate the SA search.
The algorithm starts with a random DSBN model Model, which undergoes a set of
operations at each search iteration. The first of these is the WARPING operation on one
randomly selected time series. This operation samples N random data points from the full
time series, so that there is one point from each time series at each stage. The operation
UPDATE then updates the data matrix with the new sampled N points for the selected
time series. Note that in the selected subset of data points from each time series the ordering
of the data is preserved, i.e. the order of the data points in a time series is a constraint as
subsequent events cannot cross each other going backwards in time. The rest of the algorithm
procedure is similar to the SA algorithm already described in Algorithm 3.1, which compares
the explored solution with the current solution and the best solution explored so far. If a
better solution is found, the model is updated, i.e. reparameterised using the data matrix
updated in the UPDATE operation. Intuitively, sampling N data points from each time
series leads to an ’alignment’ of the time series, because the marginal likelihood of each node
is higher for more similar data points. In other words, from each time series the subset of
points that gives a better total likelihood of the model is chosen, i.e. the N most similar
stages through which all time series pass will be identified by the model. An example of
the alignment process can be seen in Figure 5.4. When convergence is reached, the best
alignment of either the glaucoma or controls data is obtained. The points that are left out
from the time series are those that are worse at discriminating between the two classes and at
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Algorithm 5.1 Learning the DSBN Algorithm.
Input: Temperature, Cooling_Factor, Model, Data,
Max_Iterations
Score Model and store in Best_Score
Loop on iterations until Max_Iterations is reached
Select Random Time_Series
Apply WARPING to Time_Series
UPDATE Data
Score Model and store in New_Score
Diff _Score is New_Score - Score
if (New_Score is higher than Score)
Update Score, Data and Model
if (New_Score is higher than Best_Score)
Store Model and Data for Output
Best_Score is New Score
end if
elseif Random_Number is less than exp(Diff_Score / Temperature)
Update Score, Data and Model
end if
Temperature is Temperature · Cooling_Factor
end Loop
Output: Model, Data
characterising the patterns of progression. This set of discarded points is likely to constitute
deviations due to noise or variability.
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Figure 5.4: Scheme of the warping algorithm in two steps (from top to bottom). Data points are
represented with incrementing numbers indicating their cardinal position in the time series. Red and blue
circles represent glaucomatous and controls parameter distributions for each stage, i.e. continuous Gaussian
distributions, respectively. Data points 1 to 5 (top) are all fitted in the best set of parameter distributions of
DSBN (up), in this case controls. When data point number 6 is considered (bottom), data point number 4
is left out because a higher likelihood is obtained with this new alignment of the data. Notice that the order
of subsequent visits is kept.
5.2.2.1 Experimental Results
The DSBN model was tested on Dataset B using only one global sensitivity value, obtained
by averaging sensitivity over all VF points. SA was run 10 times with 3000 iterations
(initial temperature of 7 and cooling factor of 0.95) and the best scoring solution was chosen.
Random restart was used at each run. The results obtained are shown in Figure 5.5. A
clear descending pattern in sensitivity values can be seen for glaucomatous patients, which
shows their progressive loss of functionality. The key stages are meaningful as part of this
pattern. On the other hand, healthy subjects seem to keep stationary high functionality, even
though fluctuation is present throughout the pattern. As observed in literature, even healthy
subjects are subject to a physiological loss of functionality and high variability. However,
patients can worsen suddenly, and lose their vision at different rates (Haas et al., 1986; Spry
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Figure 5.5: Key stages identified using DSBN for glaucoma (red) and control (blue) subjects, in terms of
sensitivity (dB) mean and standard deviation (areas) values for each stage.
and Johnson, 2002). The key stages identified confirm this, as time points are aligned and the
pure temporal pattern is left. The physiological deterioration of visual function was taken out
of the model, because it was not a useful discriminator between controls and glaucomatous
patients. This explains why no progression was observed for control subjects, but there
was mild fluctuation and a slight increase in sensitivity at Stage 4. The standard deviation
(SD) for different stages is also of interest, being different for the controls and glaucomatous
patterns. For controls it reduces over the stages, while for glaucomatous subjects it increases.
Higher variability for glaucomatous subjects is also confirmed in literature (Flammer et al.,
1984; Russell et al., 2012). For controls, the SD decreases over the stages, so that a subject
with a good test performance is more likely to be correctly diagnosed as healthy at later
stages than at early ones, most likely due to learning effects (Heijl and Bengtsson, 1996).
For glaucoma patients, the mean values are also more variable in later stages. This is due to
the nature of glaucoma and the fact that the model ”learns” that at later stages it is easier
to discriminate between controls and glaucoma patients, i.e. it exploits time dependent
information. However, for the glaucomatous group, the distributions have longer tails and
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this reflects the higher variability of VF measurements in the later stage of the disease.
5.2.3 Dynamic Stages Bayesian Networks for Classification
While the learning algorithm uses a SA-like approach to sample from the original full dataset,
in the testing phase an exhaustive search can be used, as the search space is limited to one
time series. Also, during the testing phase, as in clinical practice, the whole time series was
not made available in full from the beginning. In fact, it may be needed to investigate if a
patient has glaucoma at his first appointment, then at the second, and so on. Therefore, in
the testing phase the exhaustive search is carried out by adding one data point at a time. At
each iteration, the complexity of an exhaustive search follows the combination complexity of
C(n,N), where C is the combination of n data points taken N at a time without repetition.
N is the number of stages and n the number of data points in the series. The complexity of
the combination search is O(n), but since this search is performed at each new point available,
the complexity of the full search is O(n2). The complexity in calculating the model score
at each iteration is not included in the calculation, and can make the algorithm particularly
slow when increasing the number of variables included in the model.
5.2.3.1 Experimental Results
The performances and robustness of the algorithm were tested on Dataset B using CV,
described earlier. Results for the DSBN, DBN (simple HMM model) and BN are shown in
Figure 5.6 for 2-, 3-, 5-, 10- and 15- fold CV. K-fold CV randomly splits the data into K
groups and then uses K 1 parts to train the model and 1 part to test model performance
iteratively. The results from each K testing set are then arranged together to calculate the
overall performance of the classifier. In the testing phase, for each node, the SD was set at
the value obtained on the whole dataset (i.e. 25), in order to take into account the variability
of the points discarded by the model during the learning phase.
The DSBN outperforms the other models for every K-fold CV tested, while the DBN
and BN perform similarly to each other. Note that different Ks correspond to different
number of elements in the training and testing datasets. For the experiments reported with
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Figure 5.6: ROC curves obtained on different K-fold CV for the DSBN, DBN and BN.
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increasing K, the sizes of the training datasets were 31, 41, 49, 55, and 56, respectively. The
average AUROC values for the CV tests were 0.73 for the BN, 0.71 for the DBN and 0.78
for the DSBN. An ANOVA test confirmed the difference in AUROC values (p = 0.03). To
assess normality of the AUROCs, the Shapiro-Wilk normality test was carried out (Shapiro
and Wilk, 1965). This test, which is appropriate for small sample sizes, did not reject the
null hypothesis of normality for all sets of AUROC (p > 0.05). Therefore, DSBN models
discriminate between glaucomatous patients and controls better than the other approaches
implemented. Figure 5.7 shows an example of how the algorithm can be used to characterise
different patients by looking at their disease progression in terms of stages. For instance,
in the top of Case 1, it is possible to observe that a patient’s visual function decreases
smoothly over time, and this corresponds to an increased probability of having glaucoma
(bottom of Case 1). However, a different patient shown in the top of Case 2, remains at
the same stage of glaucoma for a long time, and then quickly deteriorates to stages 3-5. It
is also very interesting to look at the discarded data, i.e. the noise component of the time
series; we see that this patient’s VF sensitivity dramatically improves from the last time
point on two occasions. This noise, due to short term variability, is appropriately discarded
by the algorithm, and the corresponding glaucoma probability value (bottom of Case 2 5.7)
remains at 100%. This differs from static BNs, where each visit is treated independently
from previous visits.
5.2.4 Discussion
There are several advantages of the DSBN model over static BNs and DBNs. Even if con-
structed with a single average variable, the results shown above suggest that the DSBN
identified meaningful stages of disease and obtained better classification performances than
DBNs and static BNs. The data can be combined further by exploiting the ability of BNs
to model underlying relationships in the data when multiple variables are observed. The
pattern obtained with one variable can be compared to multiple variables and other data
types can easily be added to the model. In this context, post-processing of aligned data can
show interesting insights. For example, mapping the aligned data back to the VF sensitivity
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Figure 5.7: Sensitivity values in dB over time in months (top) and probability of having glaucoma according
to DSBN over time in months (bottom) for two patients (left and right). Red circled data represent the
selected data for each stage after the last visit.
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in the original data produces sectorial pattern profiles as shown in Figure 5.8. The numbers
Figure 5.8: Key stages on sectorial data post-processed from the DSBN results obtained on one average
variable. Sectorial variables are Temporal-Superior (TS), Nasal-Superior (NS), Nasal (N) , Temporal (T),
Temporal-Inferior (TI) and Nasal-Inferior (NI).
represent the actual rate of decrease in terms of dB difference between states. Note that
these results come entirely from the glaucomatous data without any external conversion in-
dicator or metric. The progression between the first and second stages shows a decrease in
functionality mainly in the arcuate sectors (TS, NS and TI), while the next disease step is
mainly related with a decrease in the temporal sector. The last stage seems to occur when
all the sectors decrease, which corresponds to the final stage of the disease.
The relationship between discarded and aligned data can also be used to gain insights.
When N points are selected from each series, the remaining points can be analysed. The
histograms of the discarded glaucomatous data between each stage are shown on the right
hand side of Figure 5.9, while the data kept in the model for glaucomatous patients is
presented on the left hand side. Note the distribution of noise, showing long tails towards
the final stages.
Among the possible extensions of DSBNs, adding variables to each stage and accounting
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Figure 5.9: Histograms for informative and non-informative sectorial data after DSBN learning on one
variable.
for relationships between variables in separate stages can be used to capture non-stationary
relationships, although a structure-learning framework must be put in place in this case. This
has only partially been investigated thus far, so represents its natural extension. Another
natural extension of the model is to use a hidden class variable. In this case the model can
be used to perform clustering of the time series. As with static BNs, the EM algorithm can
be used to assign each time series to a group while maximizing the likelihood of the data
in an iterative process. Such a configuration was tested using a simple off-the-shelf dataset,
provided by Transport for London. The experiment is reported in Section A.2 of Appendix
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A. The results show meaningful clusters and interesting insights into the data.
Another limitation with the DSBN that should be addressed in future work is the ability
of time series to skip stages. In the DSBN, all time series must provide N data points to
fill all stages, which implies that all time series progress through all the stages. However,
in practice, it is very likely that patients present with the disease at a later stage or are
not observed in middle stages. Another limitation lies in the fact that it uses only a small
minority of the total data points, and it may be better to use all information available, even
noise, in the decision process. The need to set beforehand the number of stages of the model
may also represent a limitation of the DSBN.
5.3 Non-Stationary Clustering Bayesian Networks
This section presents a novel algorithm, called the Non-Stationary Clustering Bayesian Net-
work (NSCBN). This is based on the Non-Stationary Dynamic Bayesian Network (NSDBN)
framework, and resolves key limitations of the DSBN model. In particular, no data is omit-
ted from the NSCBN model and stages can be skipped. Furthermore, the number of stages
is learned from the data. After introducing the NSDBN, this section presents the NSCBN
and discusses some experimental results.
5.3.1 Non-Stationary Dynamic Bayesian Networks
The Non-Stationary Dynamic Bayesian Network (NSDBN) is a class of models that shares
several features with DSBN models, including the concept of stages. However, unlike DSBN
models and many other temporal models, NSDBNs do not assume that the underlying process
originating the data is a stationary process. Furthermore, in DSBNs, each stage is modelled
using one data point from each time series, while each stage in the NSDBN consists of a
subset of the data.
Intuitively, in the NSDBN learning process both model parameterisation and segmenta-
tion are performed. Figure 5.10 shows a NSDBN with 4 stages, G1, .., G4. In NSDBNs, a
stage is represented as a unique BN with independent parameters and conditional dependen-
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Figure 5.10: Non-Stationary Dynamic Bayesian Networks.
cies. Each stage models a subset of the data points available, i.e. a segment of data from each
time series. This is different from DSBNs, where one data point is selected from each time
series for each stage. In both models, each stage has the same number of variables. In the
example shown in Figure 5.10, each stage has 5 variables. The learning process for NSDBN
models typically corresponds to sampling over the posterior distribution of the model. How-
ever, the search space is usually limited by constraints on one or more degrees of freedom; in
particular, the segmentation points of the time series, the parameters of the variables, the de-
pendencies between the variables and the number of segments. To our knowledge, no studies
have attempted to resolve all of these problems simultaneously, perhaps because of the size of
the search space. Among the most recent and complete work, (Talih and Hengartner, 2005)
used a Markov chain Monte Carlo approach to estimate the variance structure of the data,
but the search space was limited to a fixed number of segments and undirected edges only.
(Xuan and Murphy, 2007) proposed an approach to model changing dependency structures
from multivariate time series, but the search was also limited to undirected edges. (Robinson
and Hartemink, 2008) formalised the concept and proposed a solution for dealing with the
aforementioned degrees of freedom bar the parameters. (Grzegorczyk and Husmeier, 2009)
instead retained the stationarity of the structure in favour of parameter flexibility, arguing
that structure changes lead almost certainly to over-flexibility of the model in short time
series. While the first approach may only capture parameter changes that are strong enough
to give rise to a structural change, the latter may not correctly model underlying conditional
dependencies over the stages. The ability to both assess weak and strong changes in variable
distributions and explicitly model the evolution of their relationships would be extremely
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informative, especially in unknown processes such as glaucoma.
5.3.2 Degrees of Freedom in Non-Stationary Clustering Bayesian Net-
works
The NSCBN is a novel algorithm that tackles all elements of the degree of freedoms simul-
taneously. In particular, the number of segments and the segmentation points of the time
series are allowed to vary. Also, the parameters of the variables and the dependencies be-
tween them are not set beforehand. Moreover, the NSCBN adds a further degree of freedom
for the clustering of patterns. Each cluster can be defined as a sequence of stages, i.e. a
temporal pattern as defined in Section 5.2.1. As in DSBNs, temporal patterns do not reflect
the time dimension of the data, but have only one direction of flow. The clustering of the
temporal patterns is obtained by allowing an unconstrained segmentation of the data. In
fact, when performing segmentation in the NSCBN, time series are allowed to skip stages,
which translate into an automatic separation of the data into different temporal clusters.
The ability to separate data into temporal clusters can be an extremely useful tool when
exploring temporal processes and is a novelty of NSCBNs over NSDBNs.
5.3.3 Learning Non-Stationary Clustering Bayesian Networks
The algorithm used to obtain a NSCBN is a two-step SA technique that switches between
WARPING operations on the data and STRUCTURAL operations on the model. This is
analogous to the SA and the DSBN algorithm previously described (Algorithms 3.1 and 5.1).
The pseudocode for the learning algorithm is shown in Algorithm 5.2. The input parameters
Temperature, Cooling Factor, Model, Data and Max Iterations were described in Algorithm
3.1 and 5.1 and have the same functions in learning a NSCBN. The new inputs are the
following: Structural Iterations, Warping Iterations and Operation. The first two regulate
the number of STRUCTURAL and WARPING operations carried out, while the Operation
is a binary variable that defines which of the two operations is being carried out. This
is typically set to perform warping operations at the start of the algorithm, but switches
to structural operations after a number of iterations. As with DSBNs, the WARPING
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Algorithm 5.2 Learning NSCBN Algorithm.
Input: Temperature, Cooling_Factor, Model, Data, Max_Iterations,
Structural_Iterations, Warping_Iterations, Operation
Score Model and store in Best_Score
Loop on iterations until Max_Iterations is reached
if (Operation is Warping)
if iterations < Warping_Iterations
With Probability P
Select Random Time_Series
Apply WARPING to Time_Series
UPDATE Data
With Probability 1-P
Apply STAGE to Model
else
Switch Operation from Warping to Structural
end if
end if
if (Operation is Structural)
if iterations < Structural_Iterations
Apply STRUCTURAL to Model
else
Switch Operation from Structural to Warping
end if
end if
Score Model and store in New_Score
Diff_Score is New_Score - Score
if (New_Score is higher than Score)
Update Score, Data and Model
if (New_Score is higher than Best_Score)
Reset iterations
Store Model and Data for Output
Best Score is New Score
end if
elseif Random_Number is less than exp(Diff_Score / Temperature)
Update Score, Data and Model
end if
Temperature is Temperature · Cooling_Factor
end Loop
Output: Model, Data
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operation performs the segmentation of the time series. This corresponds to (i) randomly
selecting a time series and (ii) randomly picking a set of segmentation points. Unlike in
the DSBN, the function may segment the selected time series over a subset of the total
set of stages so that time series are allowed to skip stages. With a lower probability, in
this configuration the STAGE function is carried out. This corresponds to (i) randomly
picking a stage and (ii) removing it from the model or (iii) adding a new stage after having
selected one. Note that in the former case the data is rearranged in the remaining stages.
As in the other SA approaches, after each iteration the model is scored and the solution is
accepted according to the current Temperature and the difference between the new and the
old score. When a solution is accepted, the structure and the parameters of the model are
updated and the old data segmentation is replaced. Once a better solution is not found for
a certain number of Warping Iterations, the algorithm switches to the structural operations
by changing the Operation binary variable. The structural operation is performed by the
STRUCTURAL function. After randomly selecting a stage, this function carries out one
of the following operations on the selected stage: (i) adding an arc between two randomly
selected nodes, (ii) removing a randomly selected arc or (iii) rearranging the arcs by removing
a randomly selected subset of arcs and adding them back at a randomly selected position.
This is analogous to the structural operations described in the previous chapters. When
no more improvements are obtained with structural operations for Structural Iterations, the
algorithm switches back to the warping operations and so forth until the best score does
not improve for a given number Max Iterations. Note that convergence of the algorithm was
found typically after about 10000 total iterations, with an initial temperature of 10 and a
cooling factor of 0.9. kbic was set to 0.9, P to 0.05. In all the experiments, the best scoring
solution among 5 to 10 runs was selected.
Intuitively, since the parameters depend on the segmentation of the data and the score of
a new segmentation depends on the current parameters and the structure of the model, the
algorithm tends to converge by grouping together similar data. Given that data is not forced
to pass through all the stages, if clusters of data are present they will tend to aggregate into
separate stages, forming the temporal clusters described above. The process is illustrated in
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Figure 5.11. In part A of the figure, a new time series Dk is to be allocated in the model.
Figure 5.11: A. New time series Dk to be allocated in the model. B. The time series is allocated and a new
stage is added to the model. C. The clusters are highlighted by observing the distribution of the model and
the allocation of the data in each stage.
The exemplificative model shown in the figure has two stages, represented by a continuous
line that shows two peaks in the CPD. Time series are represented by sets of dots of the
same color, i.e. D1 in purple and D2 in cyan. Data is segmented in two segments to fit the
two stages. When a third time series Dk (red dots) is considered, a third stage is added to
the model to collocate the new points. The stage is added if the increase of the likelihood of
the data p(D | θ) is higher than the increase of the complexity factor of the model, which is
regulated by the complexity parameter in the BIC score. Part C of Figure 5.11 illustrates
the clustering of the temporal patterns for the same example. Although all three time series
share Stage 1, the D2 progression oath spans Stage 2 while Dk skips this stage and progresses
to stage 3. In the figure, the different characteristics of Stages 2 and 3 are highlighted by
the direction of the arrows, so that it is clear that the selective allocation of the data points
into certain stages divide the data into different paths of progression, performing in fact a
clustering of the temporal patterns in the data.
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5.3.4 Experimental Results
The NSCBN algorithm was tested using three simulated datasets and two real-world datasets
(Datasets B and C, Table 3.1). The real data experiments elicit interesting insights from
a clinical perspective, but a systematic testing of the algorithm using simulated datasets
enables assessment of the performance and the robustness of the algorithm. This section
presents and discusses the results obtained from these experiments.
5.3.4.1 Simulated Data
The simulated datasets were generated using four BNs with 5 variables, shown in Figure
5.10. After a random initialisation of the parameters, the four BNs (i.e G1, G2, G3 and G4)
were repeatedly sampled and the obtained data was concatenated to build three different
datasets to assess performance of the algorithm with different degrees of freedom. The first
dataset consisted of 800 data points distributed in three time series with only one cluster,
i.e. all time series were obtained using G1, G2 and G3. The second simulated set was made
up from 650 data points in four time series. Of these, two were obtained by sampling from
G1 and G2 and the other two by sampling from G3 and G4, i.e. two separate clusters were
simulated. The third dataset was obtained by sampling 650 points distributed in 40 time
series. Of these, 20 were obtained using only G1 and G4 and 20 using G2 and G3. For the
real-world datasets analysed (Datasets B and C), the variables were grouped into six sectors
as described in Section 3.1. The datasets were categorised into five values using a frequency
based approach to ensure that an equal number of discrete states were observed.
The simulated datasets were used to analyse how the algorithm performed when increas-
ing the degrees of freedom. Thus, four experiments were carried out. The first (see Figure
5.12, UTKNKC) was carried out using the first simulated dataset and imposing Unknown
segmentation Timepoints, Known Number of segments (i.e. three segments) and Known
Clusters (i.e. one cluster). The second (see Figure 5.12, UTUNKC) was obtained using the
same dataset, but Unknown segmentation Timepoints, Unknown Number of segments and
Known Clusters (i.e. one cluster) were imposed. The third experiment (see Figure 5.12,
UTUNUC) was carried out using the second simulated dataset made of two clusters of two
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time series each. All degrees of freedom were allowed in the experiment, i.e. Unknown seg-
mentation Timepoints, Unknown Number of segments and Unknown Clusters. The fourth
experiment (see Figure 5.12, UTUSUK, bottom right) was carried out on the third simulated
dataset, made of two clusters of 20 time series each. All degrees of freedom were allowed in
this experiment. For all experiments, the best scoring solution over five runs was selected.
The results for each class of experiments follow:
Figure 5.12: Results on the three simulated datasets. For each experiment, Section A shows the distribution
of the data points across the stages (dashed: true distribution) and Section B presents the structure learned
at each stage.
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UTKNKC The results for this experiment are presented in Figure 5.12 (top left). In section
A, the segmentation obtained by the model is compared with the true one for each time
series. The difference between the two is minimal. The structural dependencies present
in G1, G2 and G3 (Figure 5.10) were captured by the algorithm, although a further
relationships was also obtained.
UTUNKC Results when the number of stages was allowed to vary during the learning
are presented on the top right of Figure 5.12. The number of stages learned by the
algorithm is correct. While the learned segmentation of the time series almost matches
the true one, the structural relationships learned by the algorithm are less precise in
comparison with the first experiment. Stage 1 captures all the relevant dependencies
in G1 (and more), but Stage 2 and Stage 3 capture only 50% of the direct relationships
in G2 and G3. However, considering the Markov Blankets at Stages 2 and 3 of the
original model (Figure 5.10), conditional dependency should be considered between
nodes 2 and 3 through node 5, while in Stage 1 the same applies for nodes 1 and 2
through node 5. Both of these relationships were captured by the algorithm, which
increases the number of conditional dependencies captured by the algorithm.
UTUNUC Two experiments were carried out with full degrees of freedom. In the first
such experiment four time series were correctly clustered into two groups, as shown
on the bottom left section of Figure 5.12. The learned number of stages was correct.
All the relationships were captured by the algorithm, except for Stage 3 (i.e. G3,
the first stage of the second cluster). The segmentation obtained is very close to the
original. The second experiment was carried out with a simulated set of 40 short time
series distributed in two clusters. The results are shown on the bottom right section
of Figure 5.12. The algorithm correctly identified four stages and found most of the
conditional dependencies present in the original model when we consider the Markov
Blankets described above. Notice that a different alignment of the stages into the
clusters was found, i.e. Stages 2 and 3 are assigned to Cluster 1 and Stages 1 and 4
are assigned to Cluster 2. The stages were remapped by the algorithm because there
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is no constraint on which stages each cluster has to take up. This rearrangement does
not affect the final result and can be seen as a proof of the flexibility of the model. In
fact, as shown in Section A, data was aligned correctly to each stage in most of the
cases. In Section B, the corresponding structures in relationships with Figure 5.10 are
reported in brackets for each stage.
The results obtained in the simulated dataset are acceptable in terms of segmentation
and modelling of the data. Even though minimal segmentation error was present in all ex-
periments, the number of stages and clusters were correctly identified. The separation into
clusters was obtained by considering the distribution of the patients and the data points, in
particular in relationships to peculiar starting and ending stages. Conditional independence
relationships in the original model were captured by the algorithm, although several spurious
relationships were also found. However, data were generated after random parameterisation,
so that parameter distributions may have acted on the conditional independence manifesta-
tion. In addition, structures were chosen to be partially shared by stages, as expected in real
world problems. In particular, 50% of the conditional dependencies in G1 and G2 are the
same (Figure 5.10). G3 also shares 66% of its arcs with G2, and 33% with G1. In fact, in
the clustering experiment shown in the bottom right of Figure 5.12, a small amount of data
belonging to G1 was placed also in Stages 2 and 3. However, the total number of misplaced
time points between Stages 1, 2 and 3 in Cluster 2 comprised 13% of the data. This has a
relatively low impact on trends, clusters extraction and analysis, but it shows that to obtain
an exact model in these conditions is difficult. As for the practicality of these models from a
clinical standpoint, our view is pragmatic and aims to find a trade-off between informative
power (e.g. variables trends, dependencies between variables and clusters of time series),
acceptable precision and processing time. The algorithm has been shown to be quite robust
and fast on both simulated and real-world datasets. Among different runs, in fact, several
models were found to be similar and the highest score was a fair indicator for the most
similar model with respect to the original one. The running time of the algorithm was less
than two hours on a modern desktop machine (dual-core, 2.8 GHz, 4GB RAM) for all the
datasets. The impact of the dataset size and type was only partially investigated, although
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the algorithm obtained acceptable results for both using a few long time series and many
short ones.
5.3.4.2 Glaucoma Progression Data
Results of using the NSCBN algorithm on Dataset B are presented in Figure 5.13. The
distribution of the time points over the stages is shown, grouped into clusters. Each cluster
presents different distribution over the stages, in particular regarding starting and ending
stages. At each stage, a VF sensitivity map is presented. The map was obtained through
Figure 5.13: Results on the real Dataset B: distribution of data across the stages for the four clusters
identified. The VF map associated with each stage is also shown.
averaging the original sensitivity values for each stage and variable and mapping them in
greyscale onto their corresponding spatial locations. This view conforms with traditional VF
visualisation, where darker values represent lower sensitivities. The conditional relationships
found at each stage (red arrows) are superimposed on the sectorial VF map. Considering
all clusters, the first four stages and Stages 8 and 9 hold the higher number of visits, while
the middle stages hold less data. In the first analysis there seemed to be one main group
progressing from Stages 1, 2, 3 and 4 and ending in Stages 8, 9 and 10, and another relatively
”stable” group starting in Stage 5 and ending in Stage 6. However, extra care should be taken
when drawing conclusions from this visualisation, since it is dependent on the sampling of the
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patients. For example, a patient who is in a stable condition for a long time or who is tested
more frequently will contribute many points to a number of stages and many fewer points to
other stages. Still, the histogram can be used in conjunction with the distinct patients graph
(see Figure 5.14) to explore the temporal clusters obtained. Patient transitions for each
cluster is shown in this graph. The groups can be further characterised through inspection
Figure 5.14: Results on Dataset B: patients transition across stages for the four clusters identified. Stages
are again represented as VF maps. Vertical arrows represent the number of distinct patients ”entering” each
stage, as well as describing the distinct transitions across stages. Solid lines represent strong transitions
between stages in terms of the number of patients, while dashed lines represent lines which carry three or
fewer patients. This threshold was chosen arbitrarily for clear visualisation purposes. The percentages of
patients at each transition are expressed in percentages relative to the data present at the previous level.
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of this figure. Cluster D, starting at Stage 5 and ending in Stage 6, seems to model a rather
stable condition, which can be described as an asymmetric upper hemifield defect. In the
other clusters, instead, glaucomatous progression occurs. Stage 1 seems to be a key stage
for patients ending at Stage 10. Both these stages show early defects and are characteristic
of Cluster A. Therefore we could associate this group (Cluster A) of patients with stable
mild glaucoma. Note that data in this cluster may have been misplaced in Stage 2 because
of its similarity with Stage 1, as was seen in the clustering simulated experiment described
above. Stage 4 is a key stage for patients ending at Stage 8, which shows general depression
with a severe peripheral VF endpoint. Stage 9 is the end stage for most of the patients
(55% of the whole dataset) and can be reached from Stages 3 and 4. Its characteristics are
also severe, but in comparison with Stage 8 it shows a depression in the upper hemifield,
i.e. an asymmetric pattern. Cluster C is a small subset of three patients who were found
to cover all stages from 3 to 7, progressing from mild diffuse to strong upper hemifield
defects. Note that Stage 2 is strongly represented in another cluster (Cluster B), being the
starting stage for 60% of the patients. This stage represents mild glaucoma worsening to
Stage 3. Here the upper hemifield shows impairment and loses its dependency with adjacent
sectors. This is also a key stage for separation, as progression splits into two paths: most of
the patients continue to develop asymmetrical defects ending in Stage 9, while others also
develop peripheral defects in the lower hemifield, leading to the most severe state described
by Stage 8. Notice that Stage 8 is reached only through Stages 2, 3 and 4, which are thus key
stages for understanding progression. In particular, this shows that according to this dataset
glaucoma typically acts initially on the superior hemifield. Afterwards, while asymmetrical
VF progression is likely, Stage 9 and also Stages 5 and 6 show that as long as only upper
hemifield defects are present, they tend generally to be stable, especially in terms of spatial
localisation. Strikingly, if inferior hemifield VF defects occur, even in the presence of diffuse
loss, the progression to peripheral severe defects is reached in 20% of cases. Therefore, this
might be seen as an important indicator for clinicians that the patient should be carefully
monitored. As discussed, the appearance of functional defects in the peripheral sectors of
VF in early glaucomatous patients is strongly supported in literature, although it is not
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fully accepted. Typical other changes during progression are change in sensitivity across the
horizontal meridian and generalised loss of retinal sensitivity.
The structures learned at different stages are consistent in each cluster and often cover
adjacent sectors. While Stages 1 and 2 share same conditional independences between sectors
(i.e. TS with NS, TI with NI and TI with T), Stage 3 lacks relationships in the upper
hemifield. Its main successors, Stages 9 and 4, lose also the other arcs. Stages 8 and 5 present
relationships between sectors reflecting their absolute values: lower to upper hemifields for
Stage 5 and TS to NS for Stage 8. In general, arcs are most commonly found on arcuate
sectors and less arcs are found towards the end stages. Thus, structural relationships learned
by the model interestingly seem to relate with the cluster and severity of progression. This
finding is supported by the real underlying structural impairment that occurs in the retina.
In fact, while VF progression takes place, relationships between different sectors of the RNFL
decay, and this may lead to a ”flatness” in the relationships between the variables that is
well captured by the model. Late stages sensibly have fewer dependencies. This observation
can be useful for characterizing patients and could be used as an indicator for the level of
health of patients’ retinas. Also, it confirms the utility of VF metrics, such as the Glaucoma
Hemifield Test, which evaluates the relative sensitivity between hemifields. Clustering in
this sense acts as a filter for variance, because it enables investigation of separate ”paths”
of progression. A small group of three patients was found to cover Stages 3, 4, 5, 6, 7
and 8, confirming that Stage 3 is pluripotent as it can lead to both severe peripheral or
asymmetrical defects. Out of three patients starting at Stage 3, one progressed to Stage
8, while two developed strong asymmetrical defects (Stage 7). Given the low proportion of
patients belonging to this cluster, the time series were visually inspected. As shown in Figure
5.15, both cases present strong sensitivity fluctuations. In the case presented in section A, a
progression on the temporal (T) and superior sectors is interrupted by a deep negative peak
in several sectors, which acts as a trigger for a switch from Stage 3 to Stage 4. Once in Stage
4, however, the patient’s condition unexpectedly improves for all sectors, including T, which
triggers, in turn, a switch to Stage 5. The rest of the seris follow a more common pattern
between Stages 5-6-7, so in this case the series seem to be affected by large fluctuations early
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Figure 5.15: Case studies from Dataset B. Sensitivity sectorial values are shown for each visit. Vertical
black lines represent changes in stages, represented by the corresponding VF maps in the lower section.
on, which may be due to other conditions of the patient or another type of test-dependent
error. Section B shows a patient who presented with great depression in the TS sector at the
beginning of the series and subsequently stabilised with high sensitivity levels. This appears
to have affected their starting positioning, which was Stage 3, instead of Stage 1. This may
be due to the introduction of medication after Stage 4, although this data was not available
to us and so cannot be assimilated by the model. As it is impossible to know the underlying
truth for this dataset, extra care should be taken when interpreting information from a small
groups of patients as they may belong to other groups or represent large measurements error.
5.3.4.3 Post-Trabeculectomy Data
The algorithm was also tested on Dataset C, which consists of a series of patients who
underwent glaucoma surgery (trabeculectomy). The clusters found are presented in Figure
5.16. Four temporal clusters were found in the analysis (A, B C and D). Clusters B and
C share two stages, highlighted by arrows crossing the boundaries of the two clusters, but
have different start and end stage characteristics; the other clusters show weak overlap.
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Figure 5.16: Results on the Dataset C: patients’ transition across stages for the four clusters. The thickness
of the arrows is proportional to the number of patients transitioning. For the start and end stages, the
number of patients is reported. Borders are added to stages to highlight when surgery was carried out.
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Figure 5.17: Results on Dataset C: distribution of data across the stages for the four clusters identified. The
VF map associated with each stage is also shown.
This is confirmed in Figure 5.17, which shows the time point distribution over all stages
for each cluster. While Clusters A and D do not present time points in the same stages,
there is overlap between data from Clusters B and C on Stages 4 and 5. This confirms the
higher diversity of Clusters A and D with respect to the others. Notice that Stage 6 is not
characteristic of any cluster and therefore it is not included in Figure 5.16. One patient was
also excluded from the analysis, having uncommon start and end stages.
The structures learned using the algorithm are consistent within the clusters and do not
differ strongly across clusters. Arcs are concentrated in the nasal sector (N) for Cluster A
and in the peripheral sectors (TS, TI, T) in the other clusters. VF sensitivity values seem
characteristic of each cluster, showing consistent and different progression paths over clusters.
Cluster A shows early damage and progression only in N, T, TS and NI sectors. Cluster B
presents severe damage in the superior hemifield in all stages, progressing mostly in NI, T
and TS sectors. Cluster C may be considered the only stable cluster, showing diffuse damage
across all sectors and strong TS damage. The patients in this cluster constitute roughly a
third of all the patients analysed. Cluster D shows mild diffuse damage in the first stages,
but progression in the T and TS sectors. Looking at the histograms in Figure 5.17, Cluster D
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presents most of the visits in its first stage, i.e. Stage 7, indicating high stability. Therefore,
observing a diffuse loss similar to Stage 7 may indicate a low rate of progression. Again, it
must be noticed that the histograms do not take into account those patients who are checked
less frequently after one year from the date of surgery, resulting in less time points towards
final stages. Clusters B and C present different characteristics. The former starts with strong
N, NI and TS damage and seems not to progress in the lower hemifield, while the latter has
diffuse loss but weak N and TI damage. Despite their differences, several patients are found
to pass from Cluster B to Cluster C, typically ending in Cluster C again. Even if several
patients follow this pattern, the amount of time points for Cluster B in Stages 4 and 5 is low,
as shown in Figure 5.17. Therefore, these VF tests are likely to represent errors, fluctuations
or temporal abrupt conditions due to surgery. One example of this kind is presented in Figure
5.18, in which the sensitivity values of the six sectors of the VF of a particular patient are
presented. The Figure shows five tests before surgery and ten tests after. Vertical lines on
Figure 5.18: Results on Dataset C: case study. Sectorial sensitivity values are shown for each visit. Vertical
blue lines represent changes in stages, which are represented by the corresponding VF maps in the lower
section.
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the graph separate different stages, which are represented as VF maps. Data before surgery
is consistent with the first two stages of Cluster B, i.e. weak or no damage in TI and NS
sectors, and progression in the other sectors. Following surgery, the patient performed two
VF tests showing general diffuse loss, typical of Cluster C. However, progression resumed
and the patient was placed again in Cluster B. In our analysis we found that many patients
followed this pattern, so this may be considered by clinicians when making decisions. Other
indications can be extracted from the model. For example, surgery on patients in Cluster C
was more effective because patients did not progress after surgery in the cluster. Therefore,
these patients may need less monitoring than patients in Cluster A or D, for which surgery
is still effective (considering the large amount of time points in the starting stage) but for
which a sudden onset of further VF progression is possible at anytime. In this case, key
sectors for that particular cluster should be monitored more carefully.
5.4 Summary
In this chapter longitudinal glaucoma data was explored and exploited to perform classi-
fication of glaucoma. DBNs were introduced and their limitations for modelling glaucoma
context were discussed. In particular, a lack of support for non-stationarities in the data
was tackled by introducing DSBNs, which are BN models based on stages of disease. The
new DSBN model outperformed DBN for classification and provided a framework capable of
identifying key stages of progression. Only averaged data was tested, obtaining a descend-
ing pattern with increasing variability towards later stages. Although promising, DSBNs
also have important limitations, such as the need to use data covering all stages of disease.
Another novel technique was proposed to address this and other issues: the NSCBN is a
non-stationary BN that models longitudinal data using all measurements available. The
algorithm automatically learns the number of stages, the parameters and the relationships
between variables. Moreover, it is able to extract and model temporal patterns in the data,
i.e. sets of stages in groups of patients. The NSCBN was first tested on simulated data
using incremental levels of complexity, which confirmed that the model provides robust and
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sufficiently reliable results with a number of variables and data points similar to those of the
real data available. The use of the NSCBN algorithm on Datasets B and C led to interesting
insights on the progression and treatment of glaucoma. In particular, early glaucoma defects
were found to most often occur in arcuate sectors of the VF, while the inferior hemifield was
generally found to be affected at later stages. Damage in the inferior hemifield was also as-
sociated with a key stage for future progression, suggesting close monitoring of the patient is
necessary when this occurs. When the NSCBN was employed on the trabeculectomy dataset,
the patterns obtained showed little new damage following surgery. Furthermore, for patients
showing superior VF defects at the time of intervention, trabeculectomy was found to be
more effective than for other groups. This finding has important implications on the actual
utility and effectiveness of this operation with regards to whether patients have damage in
their superior or inferior hemifield, as well as provide useful information for clinicians on
progression of glaucoma.
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Chapter 6
Conclusions
6.1 Contributions
Glaucoma is a major disease and its mechanisms are not fully understood. Early diagnosis
is key to preventing blindness but this is not fulfilled by current diagnosis techniques. In this
context, the thesis’ contributions can be grouped as follows.
6.1.1 Diagnosis Performance
In this thesis a set of BN classifiers were tested against current techniques (e.g. AGIS) and
other state-of-the-art ML techniques for glaucoma diagnosis. BNs were shown to perform well
on all datasets investigated. In the cross sectional data, performance was highest at higher
specificities using a semi-supervised BN (71% sensitivity at 90% specificity). The application
of semi-supervised BNs allowed us to avoid the biases associated with an imperfect diagnosis
metric. In longitudinal data, although tested on one average variable, DSBNs obtained
better performances than BNs, indicating the potential of considering non-stationarity for
classification of glaucoma progression. Across all the experiments, the use of Simulated
Annealing allowed us to learn meaningful relationships between the variables and to further
increase the classification performances of BN classifiers.
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6.1.2 Data Integration
Data integration was carried out by exploiting BNs’ flexibility and intuitive representation.
This allowed easy integration of anatomical and functional data into a single network, and
exploration of the relationships between the variables using different metrics. While the
combination of both AGIS and MRA metrics did not improve the overall results, the use of
ensemble of classifiers to combine anatomy-based and functional data-driven BNs led to fewer
errors than considering the base classifiers alone on both cross-sectional and longitudinal
datasets. By investigating the ensemble model, it was also possible to understand how the
base classifiers combine to reach better results, indicating that the impact of the AGIS-based
classifier is higher than the anatomy-based one on the final output.
6.1.3 Disease Exploration
BNs represent relationships between variables graphically, which allows clinicians to assess
the results and contribute to the modelling process. In this study, Simulated Annealing
learning algorithms obtained several interesting relationships between structural and func-
tional measurements, and these were confirmed in clinical literature, particularly regarding
VF defects occurring as arcuate patterns.
Pointwise clustering using BN models allowed us to confirm, and find new relationships,
in the glaucomatous VF, as well as identify and group patients based on their condition. For
example, subjects showing superior hemifield defects are more easily identified as glaucoma-
tous with respect to patients showing other patterns, especially when patients are younger
than average. Therefore, such patients should be followed more carefully and perhaps treated
more intensively than others. The idea of characterising groups of patients is an interesting
aspect of glaucoma treatment and is supported by results presented in this thesis.
Regarding longitudinal data, the exploration of patterns of disease by NSCBN models
also led to interesting insights being gained from the data. These models are able to identify
a number of key stages in glaucoma progression and characterise them, as well as extract
relationships between variables and expose paths of glaucoma progression across patients.
Although no post-processing implementation is presented in this work, NSCBNs proved
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useful for visually predicting glaucoma progression and identifying key stages. In particular,
lower hemifield VF defects were found to be a key risk factor for progression. Applying
NSCBNs to the trabeculectomy dataset suggests that surgery is effective in many cases.
Moreover, the model was able to suggest how to maximise the effect of trabeculectomy by
exposing different paths of disease.
6.2 Limitations
Structural data and functional data are hugely important for monitoring glaucoma; how-
ever, literature shows that interpreting these data is difficult. For instance, the inclusion
of IOP and RNFL thickness measurements in conjunction with VF data could improve the
performance of classifiers. In this context, BNs represent a good modelling choice given their
flexibility in combining data; however, the number of variables must be taken into consid-
eration. Including a relatively high number of variables may make inference and learning
computationally demanding. This issue is common to several ML techniques, and in many
cases a solution can be obtained by aggregating data or performing feature selection.
The use of Simulated Annealing in this thesis follows previous work on the field of glau-
coma research and BNs. Although other structure-learning algorithms could be used, litera-
ture on BNs is focused on gradient search algorithms and investigating the impact of other
searching techniques was not the aim of this work. In general, other techniques such as
evolutionary algorithms may in fact be efficient and provide good results.
Several models described in Chapter 4 use different criteria for parameters and structure
learning. However, the relationships learned with a certain dataset may not be well supported
in the training phase, or in the inference, using another dataset. This issue affects the
performance of any model, but also provides us with interesting insights on the nature of the
metrics. Other techniques may be used to better exploit different metrics for classification.
NSCBNs proved very useful to better understand glaucoma and the effects of treatment
on the progression of the disease. Although their intuitive representation allows one to
qualitatively assess progression and the efficacy of treatment, no quantitative robust method
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is proposed. This may be represented by an extension to classification in the form of DSBNs;
however, several differences make ad-hoc learning algorithms necessary. A proposed solution
is shown in the next section. However, full posterior sampling techniques to find the best
configuration of the model were not explored.
6.3 Further Work
Further work could extend the proposed modelling techniques in a number of ways. Re-
ferring to the limitations of the datasets presented, a breakthrough would be to include all
available data types in one model. The ability to relate results from different sources is a very
important aspect for clinicians, and the framework provided in this thesis would perfectly
suit such an extension. In this sense, the main issue is data availability; however, further
data collection is being carried out, in particular with regards to new imaging techniques to
measure the RNFL. Preliminary results of a DSBN with VF sensitivity, OD MRA-combined
parameters and RNFL thickness data are shown in Figure 6.1.
Figure 6.1: DSBN with 18 stages and 3 data types: VF sensitivity (VF), OD MRA-combined parameters
(RT) and RNFL thickness (RNFL). This model is a preliminary experiment of DSBN with no discarded
data and relationships allowed across data types and stages.
These results were obtained using severe discretisations, yet they represent potentially
very useful extensions of BN-like models for data combination and investigation of relation-
ships between data types and over different stages of disease. The model uses all data with
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one visit per node, so the number of nodes N = 1 + MK, where M is the length of the
longest time series in the dataset and K is the number of variables per slice. An example of
the insights that can be extracted by such multivariate models is shown in Figure 6.2, which
was obtained by looking at the transitions of the aligned time series in the model for each
of the three data types.
For VF data, controls seem less stable than converters, which may reflect the high vari-
ability in perimetry results caused by learning effects. More robust results are obtained for
OD data, although arguably this also means less flexibility. For RNFL measurements, con-
trols also seem more variable but the transitions are generally less interpretable. Perhaps
this is due to the data being measured from HRT and not OCT, i.e. with a low resolution
for such kind of analysis.
With regards to metrics and data combination, additional work on ensembles of clas-
sifiers could focus on the joined CPD and apply different prior knowledge to smooth the
parameters, as well as using different discretisation and base classifiers. This would allow
further understanding of the nature of the combination between networks and may improve
classification performances. Also, the use of ensembles of classifiers to combine the base
classifiers trained on different metrics presented in Section 4.1 was not assessed, although it
must be noted that the different results obtained at high specificity for the MRA and AGIS
based classifiers, showed in Section 4.1.1, may fit well the ensembles framework and may be
object of future analysis.
The identification of reliable data-driven standards to define conversion or diagnosis is
also a key aspect in the management of glaucoma, which in turn is the driving factor of
research into the disease. Future work could look at generalising and tuning the results
presented here, so that objective and comparative definitions of glaucoma may be extracted
from data.
With regards to the clustering of the patients, a refinement of the technique involving
both clinician expertise and other datasets with different number of clusters would allow one
to define and explore more groups and conditions, opening and expanding the paths indicated
by the present work. While some results will likely lead to well known patterns, new insights
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Figure 6.2: Main transitions in the data obtained from model in Figure 6.1.
135
Conclusions Further Work
could also be gained that could finally shed some light on inter-patient variability, and
ultimately glaucoma management.
The use of non-stationary models for longitudinal data analysis is a promising approach
that should be further investigated. In particular, testing DSBNs using multiple variables
for clustering and classification seems to hold good potential. NSCBNs represent a broad
platform for investigating glaucoma progression patterns. Their ability to automatically
identify the number of key stages and characterise these stages with regards to progression is
an important advantage over DSBNs. Limitations that should be addressed in future include
structural learning across stages and classification ability. Other algorithms to search the best
model configuration could also be implemented to allow faster and more robust clustering of
the patients using different data types. An example of a NSCBN for classification is shown
in Figure 6.3.
Figure 6.3: NSCBN with structural learning across stages and classification node.
The problem of calculating the score in such models, however, needs further investigation.
In the DSBN each time series has one point per node; however, in NSCBN each node may
have a different number of data points. This has to be taken into account when calculating
the likelihood of nodes with parents in other stages. A solution may be to calculate the score
by averaging the likelihood over all possible parent-child combinations.
It should be noted that all the models presented are easily generalisable to other fields
and data types. The methods provided in this thesis may be used to explore other datasets
without the need for many adjustments, apart from setting up the parameters in the learning
algorithms. Regarding glaucoma, which is the focus of this thesis, future work could look
at the integration of different data types and characterisation of the clusters of progression
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observed in the disease. Also, further datasets should be explored and compared to the
results presented in this work. NSDBNs could also be extended for prediction, a key issue
that relates with glaucoma management and can therefore be of great value. The ability
to identify glaucoma patients and give them the right treatment at the right moment to
minimise future progression is a target that can be pursued using the models presented in
this thesis.
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Additional Tables and Results
A.1 Additional Details on the Datasets
The listing of the variables and their basic distributional features is reported in this section.
Table A.1: Dataset A.
Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Patient ID Nominal 180 - -
Condition Nominal (Glau-
coma, Healthy)
180 - -
Gender Nominal (M, F) 180 - -
Eye Nominal (Left,
Right)
180 - -
Age Continuous
(Months)
180 248, 991 774, 743, 147
Disc Area (Total) Continuous 180 1.15, 3.01 1.95, 1.96, 0.34
Disc Area (Temporal) Continuous 180 0.25, 0.75 0.44, 0.46, 0.09
Disc Area (Temporal-Superior) Continuous 180 0.15, 0.38 0.26, 0.25, 0.04
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Disc Area (Temporal-Inferior) Continuous 180 0.16, 0.42 0.27, 0.27, 0.05
Disc Area (Nasal) Continuous 180 0.25, 0.76 0.45, 0.46, 0.09
Disc Area (Nasal-Superior) Continuous 180 0.15, 0.38 0.25, 0.25, 0.04
Disc Area (Nasal-Inferior) Continuous 180 0.14, 0.37 0.25, 0.24, 0.04
Rim Area (Total) Continuous 180 0.47, 2.53 1.29, 1.30, 0.39
Rim Area (Temporal) Continuous 180 0.02, 0.64 0.20, 0.21, 0.10
Rim Area (Temporal-Superior) Continuous 180 0.02, 0.33 0.15, 0.15, 0.06
Rim Area (Temporal-Inferior) Continuous 180 0.01, 0.36 0.17, 0.16, 0.07
Rim Area (Nasal) Continuous 180 0.06, 0.70 0.38, 0.37, 0.10
Rim Area (Nasal-Superior) Continuous 180 0.04, 0.33 0.20, 0.19, 0.05
Rim Area (Nasal-Inferior) Continuous 180 0.06, 0.33 0.20, 0.19, 0.05
MRA score (Total) Continuous 180 -0.38, 0.27 0.08, 0.06, 0.13
MRA score (Temporal) Continuous 180 -0.68, 0.64 0.26, 0.22, 0.22
MRA score (Temporal-Superior) Continuous 180 -0.75, 0.38 0.14, 0.11, 0.17
MRA score (Temporal-Inferior) Continuous 180 -0.85, 0.35 0.12, 0.05, 0.22
MRA score (Nasal) Continuous 180 -0.72, 0.20 0.11, 0.07, 0.13
MRA score (Nasal-Superior) Continuous 180 -0.51, 0.23 0.09, 0.07, 0.13
MRA score (Nasal-Inferior) Continuous 180 -0.44, 0.18 0.07, 0.03, 0.12
RNFL thickness (Total) Continuous 180 0.02, 0.40 0.20, 0.20, 0.06
RNFL thickness (Temporal) Continuous 180 -0.03, 0.13 0.07, 0.07, 0.02
RNFL thickness (Temporal-
Superior)
Continuous 180 0.03, 0.52 0.24, 0.23, 0.08
RNFL thickness (Temporal-
Inferior)
Continuous 180 -0.11, 0.45 0.20, 0.19, 0.09
RNFL thickness (Nasal) Continuous 180 0.04, 0.52 0.23, 0.24, 0.10
RNFL thickness (Nasal-
Superior)
Continuous 180 0.02, 0.60 0.27, 0.28, 0.09
RNFL thickness (Nasal-Inferior) Continuous 180 -0.04, 0.57 0.28, 0.28, 0.11
VF sensitivity (Temporal) Continuous 180 7.6, 30.1 25.1, 24.0, 4.5
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
VF sensitivity (Temporal-
Superior)
Continuous 180 12.2, 33.1 27.3, 26.2, 3.9
VF sensitivity (Temporal-
Inferior)
Continuous 180 7.0, 33.0 27.7, 27.1, 3.3
VF sensitivity (Nasal) Continuous 180 7.6, 35.1 30.6, 29.9, 3.3
VF sensitivity (Nasal-Superior) Continuous 180 12.9, 32.4 27.5, 26.8, 3.1
VF sensitivity (Nasal-Inferior) Continuous 180 13.4, 33.0 29.3, 28.6, 3.0
Pointwise VF Sensitivity 1 Continuous 180 0, 33 23, 20.7, 8.91
Pointwise VF Sensitivity 2 Continuous 180 0, 32 23, 20.7, 8.72
Pointwise VF Sensitivity 3 Continuous 180 0, 32 22, 19.9, 8.82
Pointwise VF Sensitivity 4 Continuous 180 0, 32 23.5, 19.9, 9.06
Pointwise VF Sensitivity 5 Continuous 180 0, 32 24, 22, 8.81
Pointwise VF Sensitivity 6 Continuous 180 0, 33 25, 22.3, 8.76
Pointwise VF Sensitivity 7 Continuous 180 0, 34 27, 23.4, 8.87
Pointwise VF Sensitivity 8 Continuous 180 0, 34 26, 22.8, 8.84
Pointwise VF Sensitivity 9 Continuous 180 0, 32 25, 22.3, 8.84
Pointwise VF Sensitivity 10 Continuous 180 0, 31 25, 22.3, 8.95
Pointwise VF Sensitivity 11 Continuous 180 0, 34 24, 21, 9.16
Pointwise VF Sensitivity 12 Continuous 180 0, 34 26, 23.7, 8.91
Pointwise VF Sensitivity 13 Continuous 180 0, 35 29, 25.6, 9.11
Pointwise VF Sensitivity 14 Continuous 180 0, 35 29, 25.1, 9.49
Pointwise VF Sensitivity 15 Continuous 180 0, 34 28, 24.3, 9.51
Pointwise VF Sensitivity 16 Continuous 180 0, 34 27.5, 24.6, 9.01
Pointwise VF Sensitivity 17 Continuous 180 0, 36 26, 23.7, 8.94
Pointwise VF Sensitivity 18 Continuous 180 0, 32 26, 23.2, 8.8
Pointwise VF Sensitivity 19 Continuous 180 0, 31 23, 18.3, 10.3
Pointwise VF Sensitivity 20 Continuous 180 0, 35 25, 21.7, 9.65
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Pointwise VF Sensitivity 21 Continuous 180 0, 33 29, 24.5, 9.64
Pointwise VF Sensitivity 22 Continuous 180 0, 38 30, 25.9, 9.68
Pointwise VF Sensitivity 23 Continuous 180 0, 35 31, 26.4, 10.5
Pointwise VF Sensitivity 24 Continuous 180 0, 36 30, 26.8, 10.5
Pointwise VF Sensitivity 25 Continuous 180 0, 34 30, 25.3, 10.1
Pointwise VF Sensitivity 26 Continuous 180 0, 33 23, 20, 9.56
Pointwise VF Sensitivity 27 Continuous 180 0, 35 27, 24.4, 9.27
Pointwise VF Sensitivity 28 Continuous 180 0, 32 24, 19.8, 9.44
Pointwise VF Sensitivity 29 Continuous 180 0, 32 26, 22.9, 9.27
Pointwise VF Sensitivity 30 Continuous 180 0, 34 29.5, 25.7, 9.43
Pointwise VF Sensitivity 31 Continuous 180 0, 35 31, 26.7, 9.62
Pointwise VF Sensitivity 32 Continuous 180 0, 36 31, 27.8, 9.81
Pointwise VF Sensitivity 33 Continuous 180 0, 35 31, 28.2, 9.65
Pointwise VF Sensitivity 34 Continuous 180 0, 35 29, 26.6, 9.53
Pointwise VF Sensitivity 35 Continuous 180 0, 32 0, 3.31, 6.43
Pointwise VF Sensitivity 36 Continuous 180 0, 34 28, 24.9, 9.06
Pointwise VF Sensitivity 37 Continuous 180 0, 34 26, 22.6, 9.21
Pointwise VF Sensitivity 38 Continuous 180 0, 34 28, 24.7, 9.27
Pointwise VF Sensitivity 39 Continuous 180 0, 36 30, 26.6, 9.58
Pointwise VF Sensitivity 40 Continuous 180 0, 33 29, 26.3, 9.53
Pointwise VF Sensitivity 41 Continuous 180 0, 36 30, 26.6, 9.64
Pointwise VF Sensitivity 42 Continuous 180 0, 36 30, 26.3, 9.35
Pointwise VF Sensitivity 43 Continuous 180 0, 34 28, 25.4, 9.01
Pointwise VF Sensitivity 44 Continuous 180 0, 34 28, 24.8, 9.01
Pointwise VF Sensitivity 45 Continuous 180 0, 34 27, 23.8, 8.88
Pointwise VF Sensitivity 46 Continuous 180 0, 33 27, 24.8, 8.83
Pointwise VF Sensitivity 47 Continuous 180 0, 36 28, 25.4, 9.17
Pointwise VF Sensitivity 48 Continuous 180 0, 33 29, 25.5, 9.14
Pointwise VF Sensitivity 49 Continuous 180 0, 36 29, 26, 9.23
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Pointwise VF Sensitivity 50 Continuous 180 0, 36 28, 25.5, 9.23
Pointwise VF Sensitivity 51 Continuous 180 0, 34 26, 23.2, 8.88
Pointwise VF Sensitivity 52 Continuous 180 0, 33 27, 23.7, 8.71
Pointwise VF Sensitivity 53 Continuous 180 0, 36 28, 24.8, 8.95
Pointwise VF Sensitivity 54 Continuous 180 0, 34 28, 24.7, 8.84
Table A.2: Dataset B.
Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Patient ID Nominal 629 - -
Condition Nominal (Glau-
coma, Healthy)
629 - -
Gender Nominal (M, F) 629 - -
Eye Nominal (Left,
Right)
629 - -
Age Continuous
(Months)
629 248, 991 820, 792, 115
Disc Area (Total) Continuous 629 1.22, 2.92 1.80, 1.86, 0.43
Disc Area (Temporal) Continuous 629 0.27, 0.72 0.42, 0.44, 0.11
Disc Area (Temporal-Superior) Continuous 629 0.15, 0.38 0.24, 0.24, 0.06
Rim Area (Total) Continuous 629 0.63, 2.43 1.11, 1.16, 0.32
Rim Area (Temporal) Continuous 629 0.03, 0.55 0.17, 0.186 0.08
Rim Area (Temporal-Superior) Continuous 629 0.04, 0.33 0.14, 0.13, 0.05
Rim Area (Temporal-Inferior) Continuous 629 0.01, 0.29 0.14, 0.13, 0.05
Rim Area (Nasal) Continuous 629 0.11, 0.66 0.34, 0.35, 0.10
Rim Area (Nasal-Superior) Continuous 629 0.07, 0.33 0.17, 0.17, 0.05
Rim Area (Nasal-Inferior) Continuous 629 0.09, 0.31 0.17, 0.17, 0.04
MRA Score (Total) Continuous 629 -0.28, 0.27 0.05, 0.03, 0.10
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
MRA Score (Temporal) Continuous 629 -0.50, 0.20 0.08, 0.048, 0.12
MRA Score (Temporal-Superior) Continuous 629 -0.27, 0.17 0.03, 0.01, 0.08
MRA Score (Temporal-Inferior) Continuous 629 -0.40, 0.23 0.06, 0.03, 0.13
MRA Score (Nasal) Continuous 629 -0.50, 0.61 0.22, 0.20, 0.19
MRA Score (Nasal-Superior) Continuous 629 -1.09, 0.34 0.05, 0.02, 0.18
MRA Score (Nasal-Inferior) Continuous 629 -0.37, 0.39 0.09, 0.08, 0.15
RNFL thickness (Total) Continuous 629 0.01, 0.46 0.19, 0.19, 0.07
RNFL thickness (Temporal) Continuous 629 -0.32, 0.31 0.07, 0.07, 0.05
RNFL thickness (Temporal-
Superior)
Continuous 629 -0.12, 0.62 0.22, 0.22, 0.10
RNFL thickness (Temporal-
Inferior)
Continuous 629 -0.2, 0.46 0.19, 0.18, 0.09
RNFL thickness (Nasal) Continuous 629 -0.02, 0.61 0.22, 0.23, 0.11
RNFL thickness (Nasal-
Superior)
Continuous 629 -0.05, 0.72 0.27, 0.27, 0.10
RNFL thickness (Nasal-Inferior) Continuous 629 -0.02, 0.59 0.28, 0.28, 0.10
VF sensitivity (Temporal) Continuous 629 1.6, 30.4 24.5, 23.4, 4.2
VF sensitivity (Temporal-
Superior)
Continuous 629 13.5, 32.2 26.4, 26.0, 2.8
VF sensitivity (Temporal-
Inferior)
Continuous 629 8.0, 33.8 27.2, 26.7, 3.1
VF sensitivity (Nasal) Continuous 629 10.3, 34.6 30.5, 30.0, 3.0
VF sensitivity (Nasal-Superior) Continuous 629 11.2, 31.7 26.8, 26.3, 3.0
VF sensitivity (Nasal-Inferior) Continuous 629 15.1, 33.5 28.8, 28.5, 2.3
Pointwise VF Sensitivity 1 Continuous 180 0, 32 24, 22.2, 5.6
Pointwise VF Sensitivity 2 Continuous 180 0, 32 23, 22.3, 5.7
Pointwise VF Sensitivity 3 Continuous 180 0, 31 23, 21.8, 5.94
Pointwise VF Sensitivity 4 Continuous 180 0, 33 23, 21.4, 6.54
Pointwise VF Sensitivity 5 Continuous 180 0, 32 25, 24.7, 4.22
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Pointwise VF Sensitivity 6 Continuous 180 2, 37 26, 25.3, 4.23
Pointwise VF Sensitivity 7 Continuous 180 0, 33 26, 25.6, 4.26
Pointwise VF Sensitivity 8 Continuous 180 0, 34 26, 25.1, 4.32
Pointwise VF Sensitivity 9 Continuous 180 0, 36 26, 25.1, 4.15
Pointwise VF Sensitivity 10 Continuous 180 0, 33 25, 23.8, 5.38
Pointwise VF Sensitivity 11 Continuous 180 0, 34 26, 24.8, 4.3
Pointwise VF Sensitivity 12 Continuous 180 9, 32 26, 26.4, 3.18
Pointwise VF Sensitivity 13 Continuous 180 10, 37 28, 27.9, 2.96
Pointwise VF Sensitivity 14 Continuous 180 9, 35 29, 28, 3.23
Pointwise VF Sensitivity 15 Continuous 180 10, 36 28, 28.1, 2.93
Pointwise VF Sensitivity 16 Continuous 180 15, 34 28, 27.5, 2.93
Pointwise VF Sensitivity 17 Continuous 180 10, 32 26, 26, 3.61
Pointwise VF Sensitivity 18 Continuous 180 0, 32 26, 24.1, 5.17
Pointwise VF Sensitivity 19 Continuous 180 0, 35 25, 23.7, 6.37
Pointwise VF Sensitivity 20 Continuous 180 0, 35 27, 26.4, 4.65
Pointwise VF Sensitivity 21 Continuous 180 7, 37 29, 28.9, 3.32
Pointwise VF Sensitivity 22 Continuous 180 0, 36 30, 29.3, 3.85
Pointwise VF Sensitivity 23 Continuous 180 0, 36 30, 29, 5.12
Pointwise VF Sensitivity 24 Continuous 180 0, 43 30, 28.6, 5.39
Pointwise VF Sensitivity 25 Continuous 180 0, 34 28, 26.1, 6.46
Pointwise VF Sensitivity 26 Continuous 180 0, 0 0, 0, 0
Pointwise VF Sensitivity 27 Continuous 180 0, 33 27, 23.8, 6.83
Pointwise VF Sensitivity 28 Continuous 180 0, 34 26, 24, 6.25
Pointwise VF Sensitivity 29 Continuous 180 0, 35 28, 27, 4.4
Pointwise VF Sensitivity 30 Continuous 180 5, 36 30, 29.6, 3.47
Pointwise VF Sensitivity 31 Continuous 180 6, 37 31, 30.3, 2.94
Pointwise VF Sensitivity 32 Continuous 180 16, 39 31, 30.7, 2.69
Pointwise VF Sensitivity 33 Continuous 180 0, 40 31, 30.4, 3.01
Pointwise VF Sensitivity 34 Continuous 180 3, 34 29, 28.3, 3.78
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Pointwise VF Sensitivity 35 Continuous 180 0, 0 0, 0, 0
Pointwise VF Sensitivity 36 Continuous 180 0, 35 26, 25.2, 5.26
Pointwise VF Sensitivity 37 Continuous 180 0, 34 26, 25.7, 4.77
Pointwise VF Sensitivity 38 Continuous 180 5, 36 28, 27.7, 3.31
Pointwise VF Sensitivity 39 Continuous 180 15, 36 30, 29.5, 2.67
Pointwise VF Sensitivity 40 Continuous 180 16, 39 30, 29.5, 2.51
Pointwise VF Sensitivity 41 Continuous 180 17, 38 30, 29.7, 2.4
Pointwise VF Sensitivity 42 Continuous 180 19, 36 30, 29.5, 2.52
Pointwise VF Sensitivity 43 Continuous 180 4, 34 28, 27.7, 3.74
Pointwise VF Sensitivity 44 Continuous 180 1.5, 38 28, 26.5, 3.81
Pointwise VF Sensitivity 45 Continuous 180 6, 33 27, 26.5, 3.73
Pointwise VF Sensitivity 46 Continuous 180 10, 35 29, 27.6, 3.2
Pointwise VF Sensitivity 47 Continuous 180 8, 37 28, 27.8, 3.27
Pointwise VF Sensitivity 48 Continuous 180 10, 36 28, 28.1, 3.16
Pointwise VF Sensitivity 49 Continuous 180 6, 35 29, 27.9, 3.23
Pointwise VF Sensitivity 50 Continuous 180 8, 36 28, 27.2, 3.83
Pointwise VF Sensitivity 51 Continuous 180 0, 34 26, 25.9, 3.88
Pointwise VF Sensitivity 52 Continuous 180 0, 35 27, 26.4, 4.07
Pointwise VF Sensitivity 53 Continuous 180 0, 33 27, 26.6, 3.98
Pointwise VF Sensitivity 54 Continuous 180 0, 48 26, 26.3, 4.25
Table A.3: Dataset C.
Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Patient ID Nominal 912 - -
Condition Nominal (Pre-
Surgery,Post-
Surgery)
912 - -
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Variable Name Type/Domain Entries Min, Max Median, Mean,
SD
Gender Nominal (M, F) 912 - -
Eye Nominal (Left,
Right)
912 - -
Age Continuous
(Months)
912 521, 1003 800, 803, 102
VF sensitivity (Temporal) Continuous 629 10, 28.6 21.6, 20.8, 4.4
VF sensitivity (Temporal-
Superior)
Continuous 629 10, 35.8 26, 26, 5.1
VF sensitivity (Temporal-
Inferior)
Continuous 629 10, 30.8 23.8, 22.5, 4.8
VF sensitivity (Nasal) Continuous 629 10.7, 33.8 27.3, 26.3, 4.9
VF sensitivity (Nasal-Superior) Continuous 629 10.7, 37 27.9, 27.7, 5.4
VF sensitivity (Nasal-Inferior) Continuous 629 10.3, 31.5 25, 24.4, 3.8
A.2 Chapter 4 Additional Tables and Results
Silhouette average index for clustering techniques can be found in Table A.4.
A.3 Dynamic Stages Bayesian Network Clustering Experi-
ment
This section reports the results obtained using the DSBN model on a non-glaucoma dataset,
provided by Transport for London. The model was trained using an unsupervised approach.
The longitudinal dataset is a set of counts of London Underground passengers during a
weekday in 2009. Counts are the number of entries in 30 stations during two-hour intervals
over 24 hours. Therefore, each station presents 11 ordered values. Data was discretized in 20
states using a frequency based approach to obtain uniform values and expose the qualitative
patterns in the data. A discrete variable was added to each time series, representing the
unobserved group of belonging for each station. The results are shown in Figure A.1.
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Table A.4: Silhouette average index for clustering techniques. Values are presented for healthy, converters
and with all subjects (Mean). The models included are Clustering Naiive Bayes (CNB), Structural
Expectation-Maximization (SEM), K-Means (K-M) and Clustering Structural Annealing (CSA).
Classifier (Class) Silhouette Mean Silhouette
K-M (Healthy) 0.26 0.19
K-M (Glaucomatous) 0.12
CNB (Healthy) 0.12 0.10
CNB (Glaucomatous) 0.08
SEM (Healthy) 0.10 0.11
SEM (Glaucomatous) 0.13
CSA (Healthy) 0.15 0.08
CSA (Glaucomatous) 0.02
Figure A.1: Mean and SD values for each clusters over the 5 key stages identified for London Underground
dataset.
Each of the four clusters is shown as a continuous line passing through the mean values
estimated for each stage. Typical patterns are observed, including peaks in certain hours
corresponding to the beginning and end of office hours (morning and evening) and high
values throughout the day. Furthermore, underground stations located near to train stations
(e.g. Euston, assigned to Cluster 2) present double peak patterns because of commuters,
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while stations associated with nightlife (e.g. Covent Garden, assigned to Cluster 4) present
a peak at night time (before closure of the station at midnight). All-day busy stations are
also identified, such as Kings Cross (which is home to six different tube lines and is next
to St. Pancras International rail station) and Green Park (which is located near to many
tourist attractions) do not show clear peaks, and are instead busy for most of the day almost
uniformly. These stations were assigned to Cluster 3.
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